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ABSTRACT 
The dinoflagellate, Karenia brevis, produces hannful algal blooms in the Gulf of 
Mexico that cause extensive marine animal mortalities and human illness nearly annually. 
The molecular mechanisms controlling cell cycle entry in this dinoflagellate are 
important because bloom development occurs through asexual cell division. The cell 
cycle of K. brevis is phased to the diel cycle such that any cells entering the cell cycle on 
a given day do so synchronously. However, a microarray study of gene expression over a 
diellcell cycle found no change in cell cycle transcript levels in actively dividing 
populations, including genes that code for replication fork proteins, typically activated in 
eukaryotes by transcription at the G liS transition. There are many examples of post-
transcriptional regulation of physiological processes in dinoflagellates and this suggests 
that cell cycle progression may also be regulated post-transcriptionally. The studies 
presented in this dissertation address the question of whether the cell cycle in K. brevis is 
regulated at the level of translation. We first characterized the global pattern of 
translation activity over the diel cycle using polysome profiling. We found that, unlike 
Lingulodinium polyedrum, a dinoflagellate widely used to study diurnal rhythms, 
translation was not limited to the dark phase. We next used a 2-DE gel proteomic 
approach to identify diel patterns of global and specific changes in protein expression, 
with particular interest in cell cycle proteins. Although a number of proteins displayed 
diel patterns of expression, we were unable to characterize the behavior of cell cycle 
proteins using this method. We therefore selected four DNA replication fork genes 
(PCNA, Replication factor C, Replication protein A, and Ribonucleotide reductase 2 ) 
that are classically regulated via transcription at the G liS phase transition, and 
Vll 
characterized their expression by qPCR, western blotting and immunolocalization. 
Sequence analysis revealed a 5' spliced leader sequence on each of these transcripts, 
indicative that they are likely under post-transcriptional control, and qRT -PCR confirmed 
that their transcript levels were indeed unchanged over the cell cycle. Sequence analysis 
and protein modeling were next used to develop peptide antibodies for western blotting to 
investigate their protein abundance over the cell cycle. The K. brevis replication fork 
proteins, PCNA, RFC, RPA and RnR2 were shown to change over the cell cycle with 
highest expression at S-phase, suggesting translational control. Furthermore, a post-
translational modification appeared to occur on the K. brevis PCNA protein in S-phase 
cells, resulting in a --9 kDa increase in size. We hypothesize that this represents 
modification by either SUMO or ubiquitin, two post-translational modifications observed 
on PCNA in other eukaryotes during S-phase. The occurrence of this post-translational 
modification coincided with a shift in nuclear location of PCNA from peripheral to 
chromatin bound, as determined by immunolocalization. Since the expression of 
replication fork proteins appears to change over the cell cycle without changes in 
transcription, CDKs were investigated to begin to understand how these drivers of the 
cell cycle may be controlling S-phase entry at the translational level. Both the CDK4-
specific inhibitor, fascaplysin, and the pan-CDK inhibitor, olomoucine, inhibited 
progression through the G liS transition as well as the production of the PCNA protein. 
These results lead us to propose the dinoflagellate utilizes CDK-dependent translational 
control of cell cycle entry as opposed to transcriptional control which is seen in most 
eukaryotes. 
VIlt 
Chapter 1: Introduction 
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Dinoflagellates are ancient, unicellular, eukaryotic protists. Dinoflagellates, along 
with ciliates and apicomplexans, are members of the superphylum Alveolata. To place 
the unusual molecular characteristics of K. brevis in an evolutionary context, it is useful 
to note that most of the eukaryotes on the planet are microbial, in terms of abundance and 
evolutionary diversity, and make up the vast majority of the phylogenetic tree of 
eukaryotes (Lukes et aI., 2009). The position of dinoflagellates in the tree of life (Figure 
1), shows that they have a long evolutionary history, of900 million years during which 
they have solved biological problems in remarkable ways that often differ from the 
models of eukaryotic cell biology (Lukes et aI., 2009). Dinoflagellates possess an 
unusually large amount of DNA in their haploid genomes, up to 1 x 10 12 bp, or ",6 times 
the human genome (Taylor, 1987). K. brevis has a genome of approximately 1 x 1011 bp 
contained within 121 chromosomes (Lidie et aI., 2005 and references therein). 
Dinoflagellates represent the only eukaryotic phylum that lacks nucleosomes that 
typically aid in chromatin packaging. Their DNA is fully eukaryotic in sequence 
organization with large amounts of repetitive DNA(Minguez et aI., 1994), but is unusual 
in that many genes occur in large arrays of tandem repeated copies. It is thought that the 
high copy number of genes and expansion of the genome is due to gene or whole genome 
duplication events as well as possible retroposition of cDNA back into the genome (Lin, 
2011). Also, dinoflagellates genomes have undergone extensive horizontal gene transfer 
2 
which is due to multiple endosymbiotic events where a dinoflagellate ancestor engulfed 
both a prokaryote (genes transferred from plastid to nucleus) and eukaryotes (nucleus to 
nucleus gene transfer) (Nosenko and Bhattacharya, 2004; Hackett et aI., 2004; 
Andersson, 2005). To date, unlike other eukaryotes with large genomes, few introns have 
been identified in dinoflagellate genes. The chromosomes of dinoflagellates exist in a 
liquid crystal state in which a core is tightly condensedand thought to be made up on non-
coding sequence whileperipheral arches of exposed DNA are thought to be areas 
undergoing active transcription (Costas and Goyanes, 2005). The large sizes of 
dinoflagellates genomes have to date made whole genome sequencing impractical. 
However, genes for many conserved cellular processes have been found through 
dinoflagellate EST sequencing projects (Amphidinium carterae and Lingulodinuim 
polyedrum, Bachvaroff et aI., 2004; K. brevis, Lidie et aI., 2005; Alexandrium tamarense, 
Hacket et aI., 2005; Symbiodinium, Leggat et aI., 2007). 
The majority of dinoflagellates are marine phytoplankton that are important 
contributors to the base of the foodweb and can grow to high abundance or "blooms". 
The blooms of certain dinoflagellates are termed harmful algal blooms (HABs) because 
potent toxins produced by these species, when present at high concentrations, have 
adverse effects on human and ecosystem health. The unarmored, fucoxanthin-containing 
dinoflagellate, Karenia brevis, produces the lipophilic neurotoxins known as brevetoxins 
andis responsible for causing red tides in the Gulf of Mexico, particularly off the west 
coast of Florida. Both humans and marine fauna are detrimentally affected by the 
ingestion and inhalation of brevet ox ins produced by K. brevis. In Florida, red tides cost 
an estimated US$ 20 million in remediation and lost tourism revenue annually (Anderson 
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et aI., 2000). Although toxic red tides have been observed in Florida since the 1840s, the 
occurrence of these HABs appears to have increased in frequency and extent over the 
past quarter century (Hallegraeff, 1993; Van Dolah, 2000; Anderson et ai., 2002). 
Therefore, understanding the mechanisms that control the proliferation of dinoflagellates 
is critical in order to develop the capacity to predict the occurrence, monitor the 
development, and mitigate the impacts of blooms. 
The development of a harmful algal bloom can be divided into four sequential 
stages: initiation, growth, maintenance and termination (Steidinger et ai., 1998). K. 
brevis is found in background concentrations (1-1000 cells liter-I) throughout the Gulf of 
Mexico (Tester and Steidinger 1997; Steidinger et ai., 1998). Initial growth of blooms 
occurs offshore at depth where K. brevis can outcompete faster growing phytoplankton 
because of its low light adaptation and its ability to swim directionally to acquire 
nutrients near the bottom, including inorganic as well as organic sources of nitrogen and 
phosphorus (Sinclair et aI., 2009; Stumpf et ai., 2008). Recent studies on circulation 
patterns in the Gulf of Mexico suggest that K. brevis blooms may initiate by the transport 
of nutrients from the northern Gulf of Mexico onto the West Florida Shelf in the summer 
via circulation driven by normal summer northward winds and the Mississippi River is a 
source of these nutrients at depth (Stumpf et ai., 2008). Another hypothesis is that 
nutrient input from large scale processes such as dust storms originating in the Sahara 
desert is involved in bloom initiation (Steidinger et aI., 1998; Walsh and Steidinger, 
2001). Once initiated, K. brevis exhibits a low division rate, averaging 0.3 div/day in both 
field and laboratory populations (Heil et aI., 2001; Magana and Villareal, 2006; 
Richardson, 2000; Richarson et aI., 2006; Redalje et ai., 2008). K. brevis is able to adapt 
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to a broad range of light intensities (Evans et aI., 2001; Schaffer et aI., 2007) and 
aggregated cells can occur in daylight where nutrients from coastal water egress or fish 
kills can maintain populations in near surface waters (Walsh et aI., 2004). Lab studies 
have shown that K. brevis actively seeks nutrients and these findings support the 
hypothesis that offshore, near-bottom aggregates of K. brevis cells may be the seed 
populations for bloom initiation, since upwelling and winds transport these populations 
toward the coast to form near surface blooms (Janowitz and Kamykowski, 2006). 
Although extensive research has gone into understanding the oceanographic 
conditions that permit the initiation and dispersal of K. brevis blooms, the molecular 
mechanisms controlling cell proliferation in this dinoflagellate remain poorly understood. 
Since growth of K. brevis results almost entirely from vegetative cell division, cell cycle 
entry is a key regulator of bloom progression. Therefore in order to understand factors 
affecting the growth of these blooms and to potentially develop a growth specific 
biomarker it is necessary to understand the cell cycle of this organism. 
The Influence of Photoperiod and Circadian Rhythms in Dinoflagellate Biology 
Many dinoflagellate cellular and molecular processes are not only adapted to the 
photoperiod, but display circadian entrainment. Numerous studies in dinoflagellates have 
shown that the cell cycle is linked to the photoperiod (Sweeney and Hastings, 1958; 
Olsen and Chisholm, 1986; Homma and Hastings, 1989; Roenneberg, 1996; Taroncher-
Oldenburg, 1997; Van Dolah and Leighfield, 1999; Leighfield and Van Dolah, 2001, 
Litaker et aI., 2002; Dagenais-Bellefuielle et aI., 2008), resulting in synchronous cell 
cycle progression in populations dividing at a rate of one division per day. In "phased" 
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populations, cell division rates are <l/day. Either the light/dark or dark/light transition 
provides the entraining cue in a species specific manner. In the dinoflagellate 
Lingulodiniumpolyedrum (formerly Gonyaulax polyedra), cell division is restricted to the 
early hours of the subjective morning (Roenneberg, 1995). In Amphidinium operculalum, 
S-phase begins 10 hours after the onset of light and mitosis begins 14-16 hours after this 
cue (Leigh field and Van Dolah, 2001). A. operculalum is dawn cued, such that a delay 
in the dark/light transition results in an equivalent delay in cell cycle phases. In contrast, 
Gambierdiscus loxicus was found to be dusk cued, with mitosis occurring 6 hours after 
the onset of the dark phase (Van Dolah et aI., 1995).In K. brevis, the dark to light 
transition serves to entrain the cell cycle, with S-phase beginning approximately 6 hours 
after onset of light, as determined by flow cytometry (Van Dolah and Leighfield, 1999). 
When placed in continuous light K. brevis continues to proceed through the cell cycle in a 
phased manner and the amount of the cell population progressing through the cell cycle 
increases to 70%. This formally demonstrates that the cell cycle is under control of a 
circadian rhythm (Brunelle et aI., 2007).Although the cell cycle behavior of K. brevis has 
been characterized, the molecular mechanisms controlling cell cycle progression and the 
genes and proteins involved in these processes are not as well described and warrant 
further investigation. 
The Dinoflagellate Cell Cycle 
Dinoflagellates have a eukaryotic cell cycle consisting of a G 1 phase, 
characterized by growth, S-phase, consisting of DNA replication, a G2 phase, also 
characterized by growth as well as editing of DNA, and mitosis, or cell division (Vaulot 
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et aI., 1986; Van Dolah et aI., 2007, Brunelle et aI., 2007). However, they have acquired 
some unique characteristicssuch as permanently condensed chromosomes, a nuclear 
envelope that does not break down during mitosis, and a mitotic spindle that is 
extranuclear (Taylor, 1987), that suggest that there may be unique adaptations to some of 
the classical eukaryotic cell cycle regulatory processes. Nonetheless, many conserved 
cell cycle genes appear to be present in dinoflagellates, based on EST library analysis, 
including the central cell cycle regulatory complexes made up of cyclins and cyclin 
dependent kinases (CDKs). 
CDKs regulate two checkpoints in the eukaryotic cell cycle, the G liS transition 
and the entry into mitosis. Differential transcript abundance of cell cycle genes is 
centrally driven by the phosphorylation activity of CDK at the G liS and G2/M 
checkpoints. At S-phase entry, CDKs are activated by the binding of newly expressed 
cyclin, upon which both proteins are phosphorylated. The activated CDK/cyclin complex 
then initiates DNA synthesis by phosphorylating the retinoblastoma protein (pRb). The 
pRb represses gene transcription, required for the G 1 to S phase transition, by binding to 
the transactivation domain of the E2F transcription factor (Giacinti and Giordano, 2006). 
In late G 1, when the CDKlcyclin complex phosphorylates pRb, pRb releases E2F, 
allowing the expression of genes that encode the proteins necessary for S-phase 
progression. Surprisingly, a microarray study of the global transcriptome in K. brevis 
over the cell cycle reported the absence of any change in the transcript levels of either S-
phase or M-phase specific cell cycle genes (Van Dolah et aI., 2007). Further evidence of 
post-transcriptional regulation of cell cycle genes in K. brevis comes from PCR data, 
which shows that the spliced leader sequence is present in all cell cycle genes examined 
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to date. Additionally, no members of E2F transcription factor family have been 
identified in dinoflagellates to date. We therefore hypothesize that the cell cycle of K. 
brevis is controlled at the translational or post-translational level. 
Post-transcriptional Control of Gene Expression in Dinoflagellates 
Processes typically under transcriptional control in most eukaryotes are not in 
K.brevis, including stress response genes and cell cycle genes, as demonstrated in 
microarray studies (Van Dolah et aI., 2007; Lidie, 2007). A possible explanation for 
predominance of translational control in K. brevis came from a study by Lidie and Van 
Dolah (2007) that identified an identical 22 bp5' spliced leader sequence on a diverse K. 
brevis mRNAs, indicative of a trans-splicing mechanism. The spliced leader trans-
splicing mechanism was first characterized in trypanosomes (Murphy, Atkins and 
Agabian, 1986) which are kinetoplastid parasites only distantly related to dinoflagellates. 
In trypanosomes, transcription is constitutive and generates polycistronic messages. 
These polycistronic transcripts are processed to mature messages when the mRNA 
splicing machinery binds to polypyrimidine stretches located in the intergenic regions of 
the primary transcripts. Trans-splicing of a 37 nt spliced leader results in these regions 
being cleaved and results simultaneously in capping and polyadenylation (Vanhamme 
and Pays, 1995). It is during and after these mRNA processing steps that the expression 
of individual genes is controlled. Through this process, as well as differential rates of 
translation and RNA degradation, rapid changes in protein levels can occur (Archer et aI., 
2011). All mRNAs from trypanosomes are substrates for the trans-splicing reaction. 
Since its initial discovery in trypanosomes, a variety of protists and some metazoans 
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display smaller,varying percentages ofmRNAs that are processed throughtrans-splicing 
(Davis, 1996). Zhang et aI., 2007, have reported that this spliced leader (SL) sequence is 
common to all dinoflagellates, and present on most ifnot all nuclear-encoded mRNAs. 
Thus it appears that post-transcriptional control plays a major role in dinoflagellate gene 
expreSSIon. 
Translational Control in Dinoflagellates 
Although there are steps between transcription and translation that are possible 
levels of control, such as differential mRNA stability, there are numerous examples of 
translational control of specific proteins in dinoflagellates, where mRN A levels are 
constant but protein levels change. In L. polyedrum, luciferin-binding protein (Mittag et 
aI., 1994), NADP-dependent isocitrate dehydrogenase (Akimoto et aI., 2005) and 
GAPDH (Fagan et aI., 1999) are all controlled at the translational level. These processes 
are all under circadian control. Iron-superoxide dismutase (Okamoto et aI., 2001) and 
nitrate reductase (Ramalho et aI., 1995) were also shown to be regulated at the 
translational level by a circadian rhythm in L. polyedrum. To better understand the 
dynamics of translational regulation over the circadian cycle, studies have been carried 
out investigating circadian rhythms duringtranslation. In L. polyedrum, the bulk 
production of poly somes was shown to be under circadian control with bound polysomes 
and protein synthesis occurring mainly during the subjective night when placed in 
constant dim light (Schroder-Lorenz and Rensing, 1987). The presence of this rhythm in 
L. polyedrumfurther complicates understanding how specific cell cycle proteins might be 
regulated in a timely manner that does not coincide with circadian controlled pattern of 
nighttime bulk translation. 
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The studies presented in this dissertation were undertaken to further our 
understanding of cell cycle regulation in the Florida red tide dinoflagellate, Karenia 
brevis by addressing three specific aims: 
1. To characterize the extent and patterns of changes in the protein expression and 
translation over the diel cycle. 
2. To characterize S-phase specific genes and determine if their proteins are 
regulated at the level of translation. 
3. To identify possible post-translational modifications ofPCNA observed in S-
phase,determine if the expression ofPCNA is CDK dependent, and examine its 
utility as a biomarker for growth in K. brevis blooms. 
To better understand the extent to which gene expression is regulated at the level 
of protein synthesis in K. brevis,Chapter 2 first investigated circadian patterns of protein 
translation using polysome profiling. A proteomic approach was then used to examine 
global changes in protein abundances over the diel cycle and nuclear proteomic methods 
were then optimized to improve the study of cell cycle proteins in the future. Chapter 3 
then investigates the expression and behavior of specific S-phase proteins involved in the 
DNA replication fork, using western blotting and immunolocalization. These studies 
revealed that these S-phase proteins are regulated at the level of translation, as opposed to 
transcriptional control found in most eukaryotes, and identified some apparent post-
translational modifications to PCNA. The studies in Chapter 4 focus on PCNA, to 
determine the CDK dependence of this S-phase protein. Chapter 4 also explores post-
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translational modification mechanisms, ubiquitin and SUMO, identified for the first time 
in a dinoflagellate, that may be responsible for changes in localization and molecular 
weight of K. brevis PCNA during S-phase. Lastly, Chapter 4 demonstrates the potential 
ofPCNA as to be employed as a biomarker for the growth status of toxic blooms of K. 
brevis. Finally, Chapter 5 provides a synthesis of the above studies, conclusions that can 
be drawn from the results, and identifies future directions for this research. 
11 
Figure 1: Tree of life showing the placement of the dinoflagellates within the eukaryotic 
crown group Alveolata. This group includes the dinoflagellates (outlined in red), ciliates 
and Apicomplexa. Adapted from Baldauf, 2003. 
Tree of Life 
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Many physiological processes appear to be under post-transcriptional control in 
dinoflagellates. The best studied examples to date include proteins shown to be under 
circadian control, in particular those involved in bioluminescence in the model 
dinoflagellate, Lingulodinium polyedrum. In L. polyedrum, circadian expression of genes 
involved in bioluminescence, such as luciferin-binding protein and luciferase is 
controlled by changes in rates of protein translation while mRNA levels remain constant 
(Morse et aI., 1989; Mittag et aI., 1998). Differential expression of luciferin-binding 
protein and luciferase over circadian time is controlled by the RNA-binding protein, 
CCTR (circadian-controlled translational repressor), which binds to the 3 'untranslated 
region (UTR) and prevents translation (Mittag 1996). The binding of CCTR to RNA is 
under circadian control and its activity is highest during the light phase. During the dark 
phase, CCTR releases the mRNAs of lucifer in-binding protein and luciferase, allowing 
for translation to occur. Other genes under circadian, translational control in 
dinoflagellates include GAPDH (Fagan et aI., 1999), peridinin-chl a-binding protein (Le 
et aI., 2001), and superoxide dismutase (Okamoto et aI., 2001). These proteins show 
highest abundance during the day. Therefore, it appears that different proteins in 
dinoflagellates have distinct circadian patterns. 
Circadian Rhythms 
Circadian rhythms are defined as oscillations in biochemical, physiological and 
behavioral functions of an organism with a periodicity of approximately 1 day (Sancar et 
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aI., 2000). Evolutionarily, circadian rhythms confer adaptive advantage, allowing 
organisms to anticipate and prepare for environmental changes (Hastings, 2003) and this 
has been demonstrated in some organisms, such as cyanobacteria (Ouyang et aI., 1998) 
and ground squirrels (DeCoursey et aI., 1997). Unicellular, photosynthetic, marine 
organisms were most likely the first to evolve a circadian clock, utilizing the 24-hour 
periodicity of their early environment to optimize their use of energy resources and 
minimize their exposure to damaging UV irradiation (Roenneberg et aI., 1997). 
Circadian oscillations function at the cellular level, even in multicellular organisms, 
where oscillations in one cell type may differ from those in another (Roenneberg and 
Mittag, 1996). There are three main components of the circadian clock: a central 
oscillator that regulates the 24-hour periodicity, an input pathway that entrains the 
oscillator to environmental cues such as light, and an output pathway that couples the 
oscillator to circadian responses (Christie and Briggs, 2001). The photoperiod is the 
main external signal, or zeitgeber (German = time giver), in setting circadian rhythms 
(Roenneberg et aI., 1997). Although light is what entrains the rhythm, a rhythm is 
identified as circadian if it continues in the absence of the light cue or other external cues 
such as temperature. 
A number of intracellular processes have been shown to have a circadian pattern. 
In plants, many processes that are controlled by the circadian clock include gene 
expression, Ca2+ levels, and some enzyme activities (Somers, 1999). Circadian 
regulation of gene expression may occur at the level of transcription, transcript 
abundance, translation and/or posttranslational processing (Somers, 1999). A microarray 
study of Arabidopsis thaliana showed that expression of approximately 2% of genes 
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cycled with a circadian rhythm (Schaffer et aI., 2001). Circadian rhythms regulate 
bioluminescence, cell aggregation, photosynthesis and cell division in dinoflagellates. 
Similar to other systems, dinoflagellate RNA and protein synthesisare required for the 
maintenance of circadian rhythms and protein phosphorylationevents playa role in 
determiningperiod length (Wijnen and Young, 2006). Microarray analysis of circadian 
gene expression in dinoflagellates Pyrocistis lunula and K. brevis showed approximately 
2 and 3% of genes changing, respectively, over 24 h in continuous light (Okamoto and 
Hastings, 2003; Van Dolah et aI., 2007). However, the expression patterns did not reveal 
any concerted changes in transcript levels associated with many known circadian 
processes. Since all circadian regulated genes studied to date are under translational 
control in dinoflagellates, it may be that these organisms use translational control for all 
circadian regulated functions. The degree to which dinoflagellates use translational 
control in the cell overall is not known. Until recently, it was accepted that circadian 
rhythms in most eukaryotes are transcriptionally controlled. However, it was recently 
found that in the eukaryotic green alga Ostreococcus tauri, circadian rhythms persisted in 
the absence of transcription (O'Neill et aI., 2011). The recent discovery of a spliced 
leader sequence in dinoflagellates (Lidie and Van Dolah, 2007; Zhang et aI., 2007) which 
is used in trypanosomes for post-transcriptional regulation of gene expression also leads 
to the idea that dinoflagellates may be using post-transcriptional control as well. 
The Central Role of the Photoperiod in Dinoflagellate Physiology 
The diel cycle plays a key role in many aspects of dinoflagellate physiology, 
including photosynthesis, vertical migration behavior, and bioluminescence. Cells ofK. 
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brevis are positively phototactic and negatively geotactic (Kamykowski et aI., 1998) 
which results in their concentration in the upper water column during the day where they 
can access light for photosynthesis. Therefore, the photoperiod has a strong influence on 
K. brevis' swimming behavior. In addition, it has been shown that cell division is 
regulated by the diel cycle in many dinoflagellates (Sweeney and Hastings, 1958; Olsen 
and Chisholm, 1986; Homma and Hastings, 1989; Roenneberg, 1996; Taroncher-
Oldenburg, 1997; Van Dolah and Leighfield, 1999; Leighfield and Van Dolah, 2001, 
Litaker et ai., 2002; Dagenais-Bellefuielle et aI., 2008). The dinoflagellate has a 
eukaryotic cell cycle consisting of a G 1 phase, characterized by growth, S-phase, 
consisting of DNA replication, a G2 phase, in which cells edit replicated DNA, and 
mitosis, or cell division (Vaulot et aI., 1986; Partensky and Vaulot, 1991; Van Dolah et 
aI., 2007; Brunelle et aI., 2007). In K. brevis, the dark-to-light transition serves to entrain 
the cell cycle, with S-phase beginning approximately 6 hours after onset of light (Van 
Dolah and Leighfield, 1999). The persistence of this rhythm in constant light 
demonstrated that cell cycle progression is under control of a circadian rhythm, which is 
in tum entrained to the diel cycle (Brunelle et aI., 2007). 
A global transcriptome analysis in K. brevis using a microarray found 
approximately 10% of genes changing with respect to light/dark cycle. However, many 
genes involved in diel-dependent processes, including cell cycle genes, did not change 
mRNA levels in a diel-dependent fashion (Van Dolah et aI., 2007). This raised the 
question as to whether the cell cycle, like other circadian regulated processes in 
dinoflagellates, is regulated post-transcriptionally and whether a change in protein 
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expression over the celli diel cycle might be observable using a parallel proteomic 
approach. 
A complicating aspect to using proteomic analysis of the cell cycle is the 
observation in the dinoflagellate, L. polyedrum, of a diurnal rhythm of translation. In this 
species, polysome analysis demonstrated that the bulk of messages are translated during 
the dark (Schroder-Lorenz and Rensing, 1987). Little actively translated, polysome-
associated RNA was present during the subjective day, and the relative proportion of 
messages associated with polysomes increased to reach a maximum during the subjective 
night period, which corresponds to G2 phase of the cell cycle (Figure 1). This 
corresponds with the time when the rate of protein synthesis reaches its maximum as 
measured in a cell-free extracts by in vitro protein synthesis using 
[35S ]methionine(Schroder-Lorenz and Rensing, 1987). 
The studies in herein were undertaken to better understand the extent to which 
protein levels in Karenia brevis vary over the over the diel cycle, and in particular, 
whether cell cycle proteins change in expression. Because there is currently no data on 
translation patterns in K. brevis, we first sought to determine if a circadian rhythm 
controls the bulk translation of messages over the diel cycle as in Lingulodinium. The 
polysome analysis indicates that bulk translation does not change over the diel cycle. 
However, this does not preclude the likelihood that specific proteins needed for diel 
dependent processes are differentially expressed. A proteomic approach was therefore 
taken to assess diel changes in global protein expression and to potentially identify 
proteins that were differentially expressed. Few proteomic studies have been attempted 
to date in dinoflagellates because the lack of genome sequence information limits the 
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ability to make accurate identifications of peptides (Akimoto et aI., 2004; Chan et aI., 
2004; Chan et aI., 2005). With the recent availability of a K. brevis cDNA library 
containing approximately 22,671 unique genes to provide a database of K. brevis specific 
amino acid sequences (Lidie et aI., 2005), a proteomic approach for investigations into 
this organism became feasible for the first time. Protein extraction methods were first 
optimized for a two dimensional gel electrophoresis proteomic protocol for K. brevis. 
This method was then adapted for difference in-gel electrophoresis (DIGE) analysis for 
quantitative comparison between timepoints collected within a diel cycle. DIGE has 
been shown to broaden the dynamic range of analysis by detecting low abundance 
proteins without saturating the highly abundant ones and provides quantitative results 
(Renaut et aI., 2006). 
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METHODS 
Cultures and Culturing Conditions 
K. brevis (Wilson isolate) was grown in 0.22 Jlm filtered seawater (36%0) obtained 
from the seawater system at the Florida Institute of Technology field station, Vero Beach, 
Florida, enriched with j/2 nutrients (Guillard, 1973), modified with the use of ferric 
sequestrene in place ofEDTA'Na2 and FeCl3 ·6H20 and the addition ofO.OlJlM selenous 
acid. Cultures were maintained in 1 liter glass bottles at 2SoC + 1°C with a 16:8 
lightdark cycle, and cool white light at SO-60 flmol photons m-2 sec-I, determined using a 
LI-COR LI-2S0 Light Meter (LI-COR BioSciences, Lincoln, NE). Experimental cultures 
of K. brevis were grown to mid log phase under nutrient replete conditions in order to 
maximize the cell division rate, which has previously been established at ",O.S div/day. 
Cultures for Polysome Analysis 
Triplicate one liter cultures were harvested on culture day 7, during log phase 
growth. Cells were sampled at LDT2, 6, 10, 14, 18 and 22, where LDT refers to light-
dark-time, where "lights-on" is LDTO and "lights-off' is at LDT 16. At LDT2 and 6 cells 
are in Gl of the cell cycle, LDTI0 and 14 represent S-phase and LDT18 and 22 represent 
G2/Mitosis. Cells were harvested by centrifugation at 600 x g for 10 min. and sea water 
was removed by aspiration. Cell pellets were then extracted for polysome analysis (see 
below). 
Cultures for 2-Dimensional Electrophoresis 
Cultures for 2-DE analysis were harvested in triplicate during log phase on day 7 
at LDT 2, 10 and 18, corresponding with G 1, S phase and G2/Mitosis of the cell cycle, 
respectively, for initial proteomic analysis. Cells were harvested by centrifugation at 600 
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x g for 10 min. and sea water was removed by aspiration. Protein was then extracted 
from cell pellets (see below). 
Cultures for Difference In-Gel Electrophoresis 
One liter cultures were harvested in quadruplicate during log phase on day 7 at 
LDT2, 8, 14, 20 to increase statistical power. Again, cells were harvested by 
centrifugation at 600 x g for 10 min. and sea water was removed. Protein was then 
extracted from cell pellets ( see below). 
Cultures for Nuclear Isolations 
One liter cultures of cells were harvested from mid log phase cultures to study the 
nuclear proteome during Gland S-phase. Cells were harvested by centrifugation at 600 
x g for 10 min. and sea water was removed. Protein was then extracted from nuclear 
pellets as described below. Nuclear proteins from two liters were pooled due to the low 
protein concentration of lysates. 
Cell Cycle Analysis 
Samples for flow cytometric analysis were taken fromall experimental cultures to 
verify their progressionstatus through the cell cycle. At each experimental time point, 
15mL of culture were fixed with 2% gluteraldehyde and stored at 4°C for at least 24 
hours. Cells were then centrifuged 10 min at 600 x g. To extract cellular pigments, cells 
were resuspended in -20°C methanol for a minimum of 4 hours. The cells were then 
centrifuged 10 min. at 2000 x g and DNA was stained by the addition of 1 o Jlg/mL 
propidium iodide (PI, Sigma, St. Louis, Missouri) (final concentration) in 1 mL PBS 
containing 10mg/mL RNase (Sigma) and 0.5% Tween 20. Flow cytometry was 
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perfonned on an Epics MXL4 flow cytometer (Beckman Coulter, Miami, Florida). 
Multicycle software (Phoenix Flow Systems, San Diego, CA) was used to obtain the 
percentages of cells in each stage of the cell cycle, or cell cycle distribution. 
Polysome profiles 
One liter cultures of K. brevis were harvested by centrifugation, 600 x g for 10 
min., and cell pellets were resuspended in 1 ml of res us pension buffer (0.2 M Tris, pH 
7.5, 2.5M KCI, 100 mM MgCI2, 0.5% (v/v) Triton X-lOa, 1 mM DTT, and 100 mg/ml 
cycloheximide). The resuspended cells were homogenized by pipettingwith a PIOOO 
pipetman (Gilson Inc., Washington, GA) on ice and drawing the suspension through a 
syringe 10 times using a 10 cc syringe with a 22 g needle. Homogenates were 
centrifuged for 10 min. at 10,000 xg to pellet nuclei, mitochondria, and chloroplasts. To 
prepare polysomes, supernatants were layered onto 15-50% linear sucrose gradients and 
centrifuged for 100 min. at 40,000 rpm in an SW-55Ti rotor (Beckman Instruments) at 
4°C. Gradients were profiled using an ISeO fractionation system equipped with a flow 
cell and UV detector (A254). Based on the A254 profiles, absorbance peaks were identified 
as the 40s and 60s ribosomal RNA, monosome (80s), and polysomes containing 
increasing numbers of ribosomes. Confirmation of the identity of the monosome and 
polysomes was obtained by running an identical gradient in the presence of EDT A, which 




A matrix was designed to test multiple homogenization and rehydration 
(solubilization) buffers that are typically used in two-dimensional electrophoresis in order 
to optimize conditions for K. brevis proteins. Urea-detergent based homogenization 
buffers, Gooley (5.8M urea, 2.3% CHAPS (3-[(3-cholamidopropyl)dimethylammonioJ-l 
-propane sulphonate ), 2mM tributyl phosphine and 40mM Tris) and Modified 
Whitzman's (9M urea, 4% NP-40, and 1 % dithiothreitol (OTT)) were tested as well as 
trifluoroethanol buffer (11.6mM Tris-HCI, 5.8M urea, 2.3M thiourea, 2.3% CHAPS, 65 
mM 1,4-dithioerythritol in a 50:50 mixture oftrifluoroethanol). Other homogenization 
buffers tested included SDS boil buffer (5% sodium dodecyl sulfate, 5% p-
mercaptoethanol, 10% glycerol, 60 mM Tris, pH 6.8), 1M sucrose in triethanolamine, and 
a 10% trichloroacetic acid/acetone precipitation. In each case the protein pellet from one 
1 L culture, containing about 106 cells total, was suspended in the rehydration buffer and 
applied to the isoelectric focusing strip to run in the first dimension followed by SDS-
PAGE. 
Proteins were also extracted using TRIzol® Reagent (Invitrogen, Carlsbad, CA) 
(phenollchlorofonn reagents) following the manufacturer's protocol with slight 
modifications. Four mLs ofTRIzol® Reagent were used per 106 cells to ensure removal 
of pigments which interfere with 2D analysis. RNA was then removed by chloroform 
extraction, followed by DNA precipitation with ethanol, and subsequently proteins were 
precipitated with isopropanol. After washing 4 times with 8 mLs of 0.3 M guanidine 
hydrochloride, protein pellets were dried and resuspended a "DIGE buffer" consisting of 
7M urea, 2M thiourea, 4% w/v. CHAPS, 30 mM Tris, pH 8.5. 
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2D Gel Analysis 
Following optimization (above), proteins were extracted using TRIzol® Reagent 
as described above. Protein concentrations were determined using the Bradford (Bio-
Rad, Inc., Hercules, CA) assay. One hundred micrograms of protein were rehydrated in 
DIGE buffer with 1M DTT and 0.2% Biolytes (Bio-Rad) for a total volume of 155JlL and 
isoelectrically focused on 11 cm Bio-Rad ReadyStrip IPG (Immobilized pH Gradient) 
strips pH 3-10 using a Bio-Rad Protean IEF Cell. The IPG strips were then loaded and 
run in the second dimension on 8-16% acrylamide Criterion gels (Bio-Rad, Inc . ., 
Hercules., CA). 
Gels were then fixed with 10% methanol/ 7% acetic acid for 30 minutes at room 
temperature and stained with SYPRO Ruby (Bio-Rad, Inc., Hercules, CA) protein stain 
overnight, then destained with 10% methanol! 7% acetic acid for 30 minutes at room 
temperature before imaging in PDQuest 2-D Analysis software (Bio-Rad Laboratories, 
UK). After imaging gels, protein spots were matched using PDQuest software. A G I 
(LDT2) sample was chosen as the master gel against which protein abundances on all 
gels were compared within. A t-test was used in PDQuest to analyze any potential 
changers relative to LDT2. Significantly changing proteins were then determined using a 
I-way ANOV A of spot intensities in Microsoft Excel. 
Difference In-Gel Electrophoresis (DIGE) 
TRIzolTM Reagent was used to isolate protein from each sample as described 
above. After extraction, protein pellets were dried and resuspended in 200JlL DIGE 
labeling buffer (7M urea, 2M thiourea, 4% w/v. CHAPS, 30 mM Tris, pH 8.5). The 
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Bradford protein (Bio-Rad, Inc., Hercules, CA) assay was then used to obtain protein 
sample concentration.For the CyDye labeling, twenty-five micrograms of whole cell 
protein lysate from each replicate at each time point were labeled with fluorescent 
cyanine dyes, Cy5 or Cy3, following the manufacturer's recommended protocols (GE 
Healthcare, Piscataway, NJ). A pooled sample containing equal amounts of protein from 
all samples was used as a normalizer, or internal control run on each gel, which improves 
gel-to-gel repeatability in differential expression calculation. Two hundred micrograms of 
the pooled sample was labeled with Cy2 (twenty five micrograms per each of the 8 
experimental gels). All protein samples were labeled with 400 pmol of the amine 
reactive cyanine dyes, freshlydissolved in anhydrous dimethyl formamide. The labeling 
reaction was incubated on ice in the dark for 30 minutes and the reaction was terminated 
by addition of 1 Onmollysine. Twenty-five micrograms of experimental protein samples 
labeled with Cy3 and Cy5 were mixed with 25 micrograms of the Cy2 labeled pooled 
normalizer, and focused on 11 cm Bio-Rad ReadyStrip IPG (Immobilized pH Gradient) 
strips, pH 4-7, using a Bio-Rad Protean IEF Cell. After isoelectric focusing, the strips 
were run in the second dimension on 8-16% Criterion acrylamide gels (Bio-Rad 
Laboratories, Hercules, CA). Gels were then fixed in 100/0 methanol/ 7% acetic acid for 
30 minutes. The gels were imaged using an Fx laser imager equipped with a blue laser. 
The image files were imported into DeCyder software (GE Healthcare, Piscataway, NJ) 
for analysis and the scanned gel images were processed to find all possible protein spots. 
A master gel was determined using the software and all gels were matched to the master 
gel for mobility in both dimensions. Difference In-gel Analysis was used to normalize 
and quantify protein spots in all gels. Biological Variation Analysis (BVA) was then 
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used for statistical analysis (one-way ANOV A) to test for significantly changing proteins 
across gels and a t-test for proteins changing between LDT2 and each of the other three 
time points with a Bonferroni correction. BV A processes multiple gel images, performs 
gel-to-gel matching of spots, allowing for quantitative comparison of protein expression 
across multiple gels. Once significantly changing protein spots were determined, all gels 
were post stained with SYPRO Ruby (Bio-Rad Laboratories) and spots of interest were 
excised using a Bio-Rad Spot Cutter (Bio-Rad Laboratories., Hercules, CA) for protein 
isolation. 
Gel plugs were washed with 50 mM ammonium bicarbonate/50% acetonitrile, 
vortexed for 20 min. and sonicated 3 times for 20 min. at room temperature in a water 
bath. After dehydrating with 1000/0 acetnonitrile for 5 min., gel plugs were digested with 
O.lJlg/JlL trypsin (Promega Trypsin Gold) overnight at 37°C to produce peptides. The 
peptides were then extracted from the gel plugsand washed with 50 mM ammonium 
bicarbonate and dried using a Savant speed vacuum (Thermo scientific, Waltham, MA). 
After the peptide samples were dried, they were resuspended in 10 uL 0.1 % 
trifluoroacetic acid. Samples were vortexed for 20 min., sonicated for 20 min. to 
solubilize and applied to CI8 ZipTips® (Millipore, Billerica, MA) to further concentrate. 
Samples were then elutedin 2 uL of a matrix consisting of 10mg of a-cyano-4-
hydroxycinnamic acid (Sigma-Aldrich, St. Louis, MO) in 500/0 acetonitrile and 0.5% 
trifluoroacetic acid for MALDI-TOF analysis. After applying the samples in matrix to a 
MALDI-TOF target plate, MALDI-TOF analysis was performed at MUSC by A. Bland. 
MALDI-TOF-TOF target plates similarly prepared were sent to the MUSC Mass 
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Spectrometry Core Facility and data was acquired using aMALDI TOF TOF (Applied 
Biosystems 4800 Proteomics Analyzer TOF -TOF). 
Mass spectra results from the MALDI-TOF were used for peptide mass 
fingerprinting, using the K. brevis EST library and NCBI (GenBank) non-redundant 
sequence database as sources of theoretical peptide masses of proteins stored in the 
databases. The K. brevis eDNA library was translated in 6 frames by Dr. John Schwacke 
(Dept. of Epidemiology and Biostatistics, MUSC) using the EMBOSS (European 
Molecular Biology Open Software Suite) program Transeq that translates nucleotide 
sequences to amino acid sequences using the standard coding table and uploaded into the 
MASCOT search engine (Matrix Science, Boston, MA). Tandem mass spectra from the 
MALDI-TOF TOF were searched against the K. brevis database and non-redundant 
sequences on GenBank using MASCOT using the fixed modification of 
carboxamidomethylation of cysteine (+57) software for identification of proteins. 
Fragment ion scores were generated using MALDI-TOF TOF analysis. Protein scores for 
MS data and ion scores for MS/MS data above 95% C.1. (confidence interval) were 
considered a significant match. 
Nuclear Isolations 
Cells were harvested by centrifugation at 600 x g for 10 minutes. Cell pellets 
were then resuspended in 10mL of buffer consisting ofO.25M sucrose, 10 mM Tris and 5 
mM CaC12 . Cells were allowed to equilibrate in buffer for 20 minutes on ice and 
homogenized with a Dounce homogenizer 10 times. Homogenized cells were then 
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centrifuged at 2200 x g for 6 minutes at 4°C and the pellets were resuspended in the 
aforementioned buffer. This homogenization step was repeated, followed by 
centrifugation for 5 minutes at 3000 x gat 4°C. Pellets were resuspended in 5 mLs of 10 
mM Tris, with 5 mM MgCI2. This resuspension was layered over a gradient of 4 mL of 
2.2 M sucrose and 12 mL of 1.6 M sucrose. The gradients were then centrifuged at 
12,000 x g for 25 minutes at 4°C. The bottom of the tube contained a pellet of purified 
nuclei. The sucrose was removed by aspiration and an aliquot of the nuclei was brought 
up in phosphate buffered saline and stained with 1 ° Jlg/mL propidium iodide for 
examination under a fluorescent microscope to assess purity_ One mL TRIzol® Reagent 
was then added to the nuclear fraction for protein extraction following the manufacturer's 
protocol. After washing 4 times with 8 mLs of 0.3 M guanidine hydrochloride, protein 
pellets were dried and resuspended in 100uL ofDIGE buffer for 2D gel analysis. One 
hundred micrograms of protein were rehydrated and run using the 2D gel methods 
described above. Nuclear proteins were also cut from the 2D gels using the Bio-Rad Spot 
cutter and trypsin digested and these samples were run on a Finnigan L TQ (linear ion trap 
mass spectrometer) at the MUSC Proteomics Core Facility. The resulting spectra were 
searched using SEQUEST software (Thermo Finnigan, West Palm Beach, FL) using the 
variablemodification oxidation of methionine (+ 16) and the fixed modification 
carboxamidomethylation of cysteine (+57) against the translated K. brevis database and 
the GenBank non redundant species database. Spectra were also manually inspected for 
band y ions. 
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RESULTS 
Global Translational Activity over the Diel Cycle 
In order to determine whether protein translation occurs primarily during the dark 
phase as observed in L. polyedrum, active translation in K. brevis over the diel cycle was 
investigated using polysome profiling. Polysome extraction and profiling methods were 
first optimized for K. brevis and the initial studies examined light (LOTS) vs. dark 
(LDT20) phase cultures in mid log phase growth (Figure 2). We were able to clearly 
distinguish fractions containing free ribosomes, represented by 40S and 60S ribosomal 
RNA, RNA present as monosomes (80S), and polysomal RNA containing up to six 
ribosomes (Figure 2A). The identity of the monosome and polysome peaks was 
confirmed by treating the ribosome preparation with 30 mM EDT A, which causes the 
release of ribosomes from the mRNA and thereby the loss of monosome and polysome 
peaks (Figure 2C). There did not appear to be any major difference in the polysome peak 
sizes between light (Figure 2A) and dark (Figure 2B) phase polysome profiles. (The 
difference in slopes is due to variability in the sucrose gradients). This is dramatically 
different from the nighttime ribosomal loading reported in L. polyedrum (Figure 1). 
However, since this preliminary experiment investigated only two time points over the 24 
hour diel cycle, it is possible that we missed a window of more active translational 
activity. Therefore we next obtained polysome profiles from triplicate cultures harvested 
every 3 hours throughout the diel cycle. To more closely mimic conditions in the L. 
polyedrum study, cells were kept in continuous light, which enabled us to assess if any 
resulting pattern is circadian in nature. To confirm that the cells in this experiment were 
actively growing, and therefore requiring the expression of known diel-dependent 
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metabolic processes, we performed cell cycle analysis on the cell populations used for 
polysome preparations (Figure 3). Approximately 40% of the cell population of all 
cultures was synchronously proceeding through the cell cycle. However, no major 
changes in polysome loading were observed at any time point (Figure 4). Thus, it does 
not appear that a circadian rhythm of translation occurs in K. brevis. Instead, K. brevis 
may be producing individual proteins as demanded by physiological and metabolic 
processes over the die! cycle. Since these polysome studies did not show a pattern of 
bulk translation, a proteomic approach was used to investigate patterns of total cellular 
protein expression on 2-DE gels to investigate the behavior of individually resolved 
proteins. 
Optimization of Protein Extraction Methods for K. brevis 2-DE analysis 
Numerous buffers are used for proteomic studies depending on the type of tissue 
(plant, animal, etc) and the proteins of interest (membrane, nuclear, cytoso lic, etc.). 
Therefore, optimization of protein extractions for 2-DE analysis of K. brevis was first 
necessary since there are limited studies employing these techniques in dinoflagellates. 
Traditional buffers that are often used in 2-DE proteomic analyses were tested for 
efficiency in extracting proteins from K. brevis. For 2-DE analysis, it is necessary to 
obtain protein extracts that will produce the highest number of protein spots and 
minimize nucleic acid contamination so that the proteins will be clearly resolved on the 
gels without streaking patterns. Multiple buffers for homogenization of proteins were 
tested, including: Gooley buffer, Modified Witzmann's buffer, SDS Boil buffer, 
trifluoroethanol buffer,sucrose/triethanolamine buffer, a trichloroacetic acid/acetone 
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precipitation, and phenol/chloroform (TRIzol® Reagent; Invitrogen, Carlsbad, CA). 
Many of the buffers tested were not suitable for protein isolation as evidenced by a lack 
of protein spots on the 2-0E gels. Three extraction buffers (Gooley, modified 
Witzmann's, and TRIzol® Reagent) were successful for protein extraction as evidenced 
by protein spots on a 2-0E gel. Of the three best results, protein extracts using TRIzol® 
Reagentclearly resulted in gels containing a greater number of protein spots compared to 
gels run with traditional urea/detergent based homogenization buffers (Figure 5). This 
extraction method was therefore used in further studies in K. brevis. 
Global Analysis of Protein Expression over the Diel Cycle using 2D and SYPRO 
Ruby 
F or initial insight into the K. brevis proteome over the diel cycle, protein samples 
were obtained from triplicatecultures at 3 time points, LDT 2, LOTIO and LOTI8. These 
time points were chosen since LOT2 displays the highest proportion of cells in G I, 
LDTIO represents early S-phase when cell cycle proteins necessary for S-phase 
progression should be abundant and LOT 18 is a dark phase time point when the cycling 
cell population is in G2 or mitosis. Flow cytometry data shows that approximately 50% 
of the cell population was proceeding through the cell cycle in this experiment (Figure 6) 
and therefore if changes in the proteome were to occur over the cell cycle they might be 
visible on the 2-0E gels. When G I (LOT2), S-phase (LOTIO) and G2/Mitosis (LOTI8) 
protein profiles on the 20 gels were compared using PDQuest software and a built-in 
student's t-test, 47 protein abundances, out of 304 protein spots detected, 
changedsignificantly over the diellcell cycle. Figure 7 illustrates changing intensities of 3 
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protein spots between G 1, S phase and G2/Mitosis time points. Although these 2DE gels 
showed promise in terms of spot resolution, these preliminary results from the 2-DE 
using SYPRO did not provide adequate matching between gels for powerful statistical 
analysis. The difficulty in protein spot matching using PDQuest in this initial study 
warranted the use of a more stringent and quantitative approach with additional 
replication at each time point. 
Global Proteomic Analysis over the Diel Cycle Using DIGE 
For the next set of analyses, DIGE was used to increase the quality of matching of 
proteins between gels, facilitated by the use of a normalizer sample on each gel, which 
allows for a higher accuracy of statistical analysis and increased sensitivity. For the 
DIGE studies, samples were collected for flow cytometry and proteins were extracted 
from quadruplicate cultures at 4 time points (every 6 hours) over the diel cycle: LDT2 
(G 1), LDT8 (early S-phase), LDTI4 (mid-S-phase) and LDT20 (late G2/early mitosis). 
Flow cytometry results show that --50% of the cell population was proceeding through 
the cell cycle (Figure 8). Proteins were labeled with Cy3 or Cy5, run pairwise in two 
dimensions in the presence of the pooled normalized labeled with Cy2 and analyzed 
using DeCyder software. A minimum of 470 proteins were reproducibly detected on 
each 2-DE gel (Figure 9). Of these, 21 proteins were found to change significantly 
(ANOVA, p<O.05) over the diel cycle (Table I).This accounts for 4.5% of the proteome 
represented in this study.Many of these significant changeswere observed between LDT8 
and LDTI4, with protein abundances either increasing or decreasing. Individual proteins 
changing in abundance between LDT8 and 14 are shown in Figure 10. Because all initial 
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gels compared either LDT2 to LDT8 or LDT14 to LDT20, thereported changes in protein 
abundances were verified by running the same samples in gels that compared LDT8 and 
LDTI4 directly, and 83.3% were shown to have the same trend (Table 1). 
After statistical analysis was carried out using DeCyder, all gels were stained with 
SYPRO Ruby for total protein (Figure 11). Proteins were matched and compared to the 
matching pattern in DeCyder software in order to pick the significantly changing proteins 
for identification by mass spectrometry. Fourteen of the significantly changing proteins 
were sent to the MUSC Mass Spectrometry Core for analysis by MALDI-TOF-TOF. The 
other 7 significantly changing proteins did not have high enough abundance for mass 
spectrometry analysis. Comparison of the peptide sequences obtained from MALDI TOF 
TOF with the translated K. brevis EST library provided putative matches; however, none 
of these met the generally accepted significance cut-offs of greater than C.1. 95%. This 
may be because there was a mixture of proteins samples in the gel pugs that were not able 
to be separated using MALDI- TOF TOF or the proteins may have been of low 
abundance. Although no proteins could confidently be assigned identity, this study 
identified several trends in protein abundance over the diel cycle, in which the most 
dramatic changes occurred late in the light phase from LDT8 to LDTI4, which also 
corresponds to S-phase of the cell cycle. The three general trends that were observed 
over the diel cycle in these proteins are shown in Figure 12. 
Proteomic Analysis of Isolated Nuclei 
Because 2D gel analysis of whole celllysates detected only ----500 of the most 
highly expressed proteins in the cell, subcellular fractionation wasnext used to increase 
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the possibility of identifying proteins that localized to the nucleus, particularly those 
involved in cell cycle regulation, by removing highly expressed proteins from other 
cellular compartments. Nuclear isolations should facilitate the analysis of both proteins 
that are differentially expressed and proteins that are imported to and exported from the 
nucleus over the cell cycle. 
A wider range of isoelectric points, 3-10 pI, was used to allow for better 
separation of potentially basic proteins, as expected for nuclear proteins. SYPRO Ruby 
was used for staining and PDQuest software was used to identify spots and analyze 
intensity. Twenty-six prominent nuclear spots were then picked, extracted, and trypsin 
digested. Nuclear peptides were sent to MUSe Mass Spectrometry Core Facility for 
analysis on the LTQ MS/MS to determine if these proteins could be identified using 
SEQUEST softwareto search the translated K. brevis EST library and GenBank nr 
database. 
The number of nuclear proteins detected was much smaller ('"" 1 00) than that found 
in whole celllysates (Figure 13). Positive matches to the K. brevis EST library were 
obtained for eighteen nuclear proteins by L TQ MS/MS, or approximately 18% of the 
proteins detected on the gels (Table 3). Ten of the 18 proteins had hits to contigs in the 
EST library that have significant homology to known genes on GenBank. Of the proteins 
with known function, most of these proteins are of known nuclear localization. Table 3 
shows the number of peptides identified in each sample and the total ion score generated 
from the identification of these peptides. The total ion score is calculated by weighting 
the ion scores for all individual peptides nlatched to the protein that is associated \vith 
this peptide and the MS/MS spectrUlTI. The ion score is calculated for each peptide 
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matched fronl MS/MS peak lists and is significant if it meets the 95% confidence 
interval. The substantially improved success rate for identifying proteins from the 
nuclear preparations is most likely a combination of the highly conserved nature of many 
nuclear proteins and the use of reverse phase C 18 LC-MS/MS which is moresensitive and 
permits separatation of peptide mixtures. 
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DISCUSSION 
The studies in Chapter 2 were undertaken to gain insight into diel patterns of 
protein expression in K. brevisand, in particular, whether a proteomic approach would be 
infonnative of changes in the expression of cell cycle proteins since the cell cycle is 
tightly linked to the diel cycle. Mounting evidence from studies of circadian rhythms 
(Mittag, 1996; Fagan et aI., 1999; Le 2001; Okamoto et aI., 2001), microarray studies 
(Okamoto and Hastings 2003; Van Dolah, 2007; Lidie 2007) and the identification of 
spliced leader trans-splicing in dinoflagellates (Lidie and Van Dolah, 2007; Zhang et aI., 
2007) point to a predominance of translational control in this group of protists. 
Schroder-Lorenz and Rensing (1987) demonstrated that translational activity in 
the dinoflagellate L. polyedrum occurs almost exclusively during the night based on 
polysome profiles (Figure 2D). In that species, little RNA was associated with ribosomes 
at the time of cell division, ---CTO. By CT6, a large monosome peak appears suggesting 
the initiation of translation has occurred, but little RNA is present in the polysome pool. 
However, by CTI2, which corresponds with the beginning of dark in the circadian day, 
polysome peaks increase in size relative to the monosome and by CT17 much of the 
RNA is found in the larger polysome classes with 3 or more ribosomes. This time 
corresponds roughly to when cells are exiting S-phase and entering G2 phase in the diel-
phased (LD 8: 16) cell cycle of Lingulodinium (Dagenais-Bellefeuille et aI., 2008). By 
CT24, when cells have once again moved into mitosis, little translation activity is 
evident. Using protein synthesis in cell free extracts, it was also shown that the protein 
degradation displayed the same circadian rhythm as the synthesis rate (Schroder-Lorenz 
and Rensing, 1987). This suggests concerted protein turnover and replacement prior to 
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cell division. The polysome experiments in this chapter were undertaken to determine if 
a similar pattern of protein synthesis is evident in K. brevis. Somewhat surprisingly, the 
polysome profiles in K. brevis over the diellcell cycle did not show any time point where 
"bulk translation" was evident (Figures 2 and 4). A large monosome peak was present at 
all timepoints examined over the diel cycle, with the peaks corresponding to messages 
containing two ribosomes always being the dominant form of polysome. At no time point 
did the larger polysomes dominate, although peaks representing up to six ribosomes were 
resolved at most time points. We are confident that the absence of a time point 
representing "bulk translation" is not an artifact due to ribosomal runoff, because 
increasing the cycloheximideconcentration two-fold to 200 mg/ml did not alter the 
profiles (data not shown). Furthermore, flow cytometry demonstrated that approximately 
50% of the cell population was proceeding through the cell cycle on the day the study 
was performed; therefore the absence of a strong protein synthesis peak cannot be related 
to the lack of metabolic activity although it could be diminished by out-of-phase cells. 
There are limited studies on diel and circadian translation patterns in 
dinoflagellates which mostly have been carried out in Lingulodinium. The study by 
Schroder-Lorenz and Rensing (1987) which identified a circadian rhythm of polysome 
production, was based on previous findings that a circadian rhythm of protein synthesis 
occurs in this dinoflagellate (Volknandt and Hardeland, 1984; Donner et aI., 1985; 
Cornelius et aI., 1985) and that the bulk of total protein appeared to be synthesized 
mainly during the phase corresponding to the night period (Rensing and Schill, 1985). 
However, a study in Alexandriumfundyense measuring total protein concentration every 
2 hours over the diel cycle showed a protein production pattern where protein 
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concentration peaked at the end of the light phase and reached a minimum at the end of 
the dark phase (Taroncher-Oldenburg, 1997), the opposite of what was observed in L. 
polyedrum. In eukaryotes such as yeast and mammals, there does not appear to be a time 
point of bulk translation during the cell cycle. However, during mitosis, 5'cap-dependent 
translation is turned off (Pyronnet and Sonenberg, 2001). During this process, translating 
ribosomes are stalled on mRNAs to protect the messages from degradation during mitosis 
and this allows for the cells to rapidly resume active translation upon entry into the next 
G 1 phase of the following cell cycle, which is energy efficient for the cell (Sivan and 
Stein, 2008). K. brevis undergoes mitosis during the dark phase of the diel cycle with the 
peak occurring from LDT18-LDT22. There was a small decrease in polysomes at the 
LDT22 time point relative to the preceding time points that may reflect mitosis; however, 
with only 50% of the cells proceeding through the cell cycle, the other 50% must still be 
in Gland this may account for the continued presence of translationally active RNA at 
this time point. However there was no evidence of bulk translation at any time during the 
diel cycle, leaving open the question of whether we might expect diel dependent changes 
in individual proteins, based on their needs at different times during the photoperiod or 
cell cycle. 
The analysis of proteomes using 2D gel separation of proteins followed by 
identification using MALDI-TOF mass spectrometry has been used successfully in many 
organisms for which whole genome sequences have been obtained (Gevaert and 
Vandekerckhove, 2000). Although a complete genome of a dinoflagellate is not currently 
feasible due to their massive sizes and complexity (5 x 10 10 bp for K. brevis, or almost 
30x the human genome), recent large scale EST sequencing projects in dinoflagellates 
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provide the first tools to investigate global protein products using MALDI-TOF based 
peptide mass fingerprinting or MALDI-TOF/TOF analysis of peptide sequences. In the 
current project, an EST database of K. brevis was used that contained 22,671 unique 
genes. Based on the analysis of dinoflagellate genome sizes (Hou and Lin, 2010) we 
estimate that that this database contains at approximately one-half of the expressed 
sequences in this organism (Brunelle and Van Dolah, 2011). The traditiona12-DE gel 
analysis with SYPRO Ruby staining used in this study allowed for resolution of 
approximately 300 K. brevis proteins from 10 - 200 kDa and pI 4 t07 (Figures 5 and 7). 
Preliminary data from using this method to compare protein profiles from G 1, S -phase 
and G2/Mitosis showed that there did appear to be changes in abundant proteins over the 
cell cycle (Figure 7). This preliminary analysis suggested we pursue the question of diel 
dependent proteome changes using a method that results in less intergel variability and 
offers higher sensitivity, DIGE. 
The use of an internal standard in DIGE, run on every gel, allows for less inter-gel 
variability and a lower limit of detection. This also allows for more statistically accurate 
analysis across multiple gels by normalizing individual samples compared with the 
internal standard (Renaut et aI., 2006). Using the DIGE approach, ----470 protein spots 
were detected (Figure 9) and 4.5% of these proteins were found to change significantly. 
This percentage is somewhat lower than anticipated, based on the prevalence of circadian 
as controlled processes in dinoflagellates. There are limited published studies using 
proteomics in dinoflagellates. However, a study using traditional 2-DE methods in L. 
polyedrum on larger format gels showed that only 3.1 % of detected proteins (28 of900) 
changed over the course of the diel cycle (Akimoto et at, 2004). Of these, Rubisco made 
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up the majority of the spots identified, with the other nine proteins representing largely 
chloroplast functions. The behavior of the differentially expressed proteins in 
Lingulodinium fell into three patterns: 1) increasing during early day, with maximum 
abundance during late day and into night, 2) increasing during late day with maximum 
abundance during night, and 3) decreasing during the day, absent or minimal in late day, 
then increasing to maximum abundance in late night. This is interesting in light of the 
previous observations of bulk translation and protein turnover at night in this species. 
The patterns of abundance among eight of the twenty-one changing proteins in K. brevis 
showed similar trends: 1) decreasing during early day, increasing during late day and into 
the night with maximal abundance in late night, 2) decreasing in early day with 
maximum abundance attained in late day and maintaining at night, 3) proteins decreasing 
during the day and minimal at night (Figure 11). Fourteen of twenty-one significantly 
changing proteins from the K. brevis DIGE study were analyzed by MALDI-TOF TOF 
mass spectrometry but nosignificant matches were found to either the K. brevis EST 
library or to the GenBank database. Our current limitation due to incomplete ESTs to 
provide peptide mass fingerprints, in addition to the incomplete coverage of the 
expressed genome in any dinoflagellate to date is the likely source of our limitations in 
identifying proteins. Additionally, protein spots extracted from gels often contain a 
mixture of proteins; therefore a liquid chromatography step such as using LC-MS will 
provide better separation of peptides. Efforts to develop full length cDNA libraries from 
dinoflagellates using the spliced leader sequence to amplify from the 5' ends may 
improve the quality of the existing sequence data available for peptide analysis (Lin et aI., 
2010). 
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Since our particular focus for this study was cell cycle related proteins, we 
reasoned that nuclear proteomics may be a more successful approach for identification of 
proteins of interest since high abundance cytoplasmic and chloroplast proteins are 
removed from the sample. Nuclear proteomics have been used to successfully identify 
DNA replication proteins under cell cycle regulation such as replication factor C (subunit 
5), proliferating cell nuclear antigen, and replication protein A (14 kDa subunit) in human 
lymphoma cells (Henrich et aI., 2007). It has been estimated using a bioinformatic 
approach that 31.5%,21.9%,26.3%,25.7% and 25% of the proteins in the total cell 
proteome are nuclear in S. cerevisiae,C. elegans, D. melanogaster, mouse and human, 
respectively (Kumar and Raghava, 2009). Therefore, the 2D analysis of nuclear proteins 
in K. brevisin the current study most likely grossly underestimates the number of nuclear 
proteins since only --100 protein spots were detected. This number was also much 
smaller than the number of nuclear proteins detected in plants using 2D gels, MALDI 
TOF and peptide mass fingerprinting, which has been reported as 500-700 proteins in 
Arabidopsis (Bae et aI., 2003). However, the --100 proteins detected on the gels 
containing K. brevis nuclear protein, eighteen proteins were significantly matched to 
sequences in the K. brevis EST library when using when analyzed by LC-LTQ MS/MS 
after tryptic digestion (Table 3). Seven of these proteins have been experimentally shown 
to have nuclear localization. Eight of the proteins are hypothetical; therefore little can be 
said of their function in the nucleus. One of the seven nuclear proteins identified 
included a eukaryotic initiation factor (eIF4A-3). This translation factor has been shown 
to be nuclear in mammalian cells (Holzmann et aI., 2000; Ferrailuolo et aI., 2004) and 
plant cells (Koroleva et aI., 2009). Since eIF4A-3 interacts with translation initiation 
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factors elF4G and eIF4B, and is localized to the nucleus, Ferrailuolo et aI., 2004, suggest 
that this elF is involved in the "pioneer round" of translation and show that this protein is 
a nucleocytoplasmic shuttling protein. The pioneer round of translation refers to the first 
time the reading frame of an mRNA is read, possibly occurring in the nucleus (lshigaki et 
aI., 2001). Additionally, nuclear proteomic studies in mammalian systems, specifically 
human Raji lymphoma cells, have identified elF3 subunit 2, and elF6 in the nucleus and 
eIF4B, elF2 subunit 3, elF 4H, elF 5A and elF lA in the DNA binding proteome isolated 
from nuclei (Henrich et aI., 2007). Two of the significantly identified proteins in the K. 
brevis proteome, tropomodulin and a calpain family cysteine protease containing protein, 
have cytosolic localization. These proteins are both involved in actin organization and 
cytoskeletal remodeling (Sung et eI., 1992; Smith et aI., 2000) and may reflect 
contamination of other cellular components. Cytoskeleton components, such as tubulin, 
have been identified in nuclear proteomic studies; therefore this does not seem to be an 
unusual result (Henrich et aI., 2007). To be most informative, subcellular proteomics 
requires highly purified fractions; however cross-contamination is a common problem 
(Schirmer and Gerace, 2002). In order to identify a higher number of nuclear proteins, a 
larger of number of nuclei will need to be isolated from K. brevis and likely other 
dinoflagellates. Obtaining a pure, concentrated sample is non-trivial and will be 
necessary for successful dinoflagellate proteomics. The use of large format gels would 
also be beneficial for separating an increased number of spots. Additionally, since the 
nucleus is a dynamic cellular structure with proteins constantly moving in and out with a 
short residence time, a time course study using nuclear proteomics may be a way to 
identify more nuclear proteins. Chromatin associated proteins should be able to be 
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identified since the extraction method used here (phenoVchloroform: TriZol or 
TriReagent) has been used to extract such proteins as PCNA, which binds to chromatin, 
in K. brevis. The proteins selected for mass spectrometry analysis were the most 
abundant proteins within the nuclear gels, therefore it will be interesting to see what other 
proteins can be identified that may be involved in gene regulation, cell cycle, and other 
metabolic processes involving the nucleus in K. brevis. However, the use of a sensitive 
mass spectrometry method, and separation chemistry prior to MS/MS such as LC-
MS/MS, as well as additional sequence information from large scale sequencing projects 
in dinoflagellates will yield more biological data. 
The presence of eukaryotic initiation factors in dinoflagellates indicates that these 
organisms have the eukaryotic protein synthesis machinery. Eukaryotic IF -5A has been 
identified in Crypthecodinium cohnii (Chan et aI., 2002); and eIF4A, eIF3-8 as well as an 
elongation factor (1 alpha) are present in Amphidinium carterae (Bachvaroff and Place, 
2008). Also, a gene data set from Alexandrium catenella identified eIF4A and 3 
elongation factors (Toulza et aI., 2010). The K. brevis cDNA library has 9 ESTs to eIFs, 
with differing homology scores or e-values, including eIF2B (low homology), eIF5 (high 
homology) and as mentioned above eIF4A-3 (high homology) (marinegenomics.org). 
Therefore, although dinoflagellates may be using translational machinery to regulate 
cellular processes in a manner that is divergent from other well-studied eukaryotes, the 
necessary components appear to be present within the dinoflagellate genome/proteome. 
Further investigation into the translational machinery of dinoflagellates should yield 
information about how these factors that are similar to other eukaryotes are being used in 
these unusual protists. 
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The few dinoflagellate proteomic studies for which published data exists have 
used a traditiona12-0E approach for species identification between different HAB 
species including Prorocentrum micans, P. minimum, P. sigmoides, P. den tatum, 
Scrippsiellatrochoidea, Karenia longicanalis, K. digitata, K. mikimotoi, as well as K. 
brevis (Chan et aI., 2004). This study focused only on species specific 2D gel spot 
patterns and no protein identifications were attempted for any of the above species. 
Another study in a dinoflagellate investigated the protein profiles between toxic and non-
toxic strains of Alexandrium minutum (Chan et aI., 2005). Although the protein profiles 
between the toxic and non-toxic strains differed, no protein identifications were made. 
Lastly, a study investigating protein profiles of P. triestinum under different 
environmental stress conditions showed that they were indeed different, but again 
proteins were not identified (Chan et aI., 2004b). Akimoto et ai. (2005) is the only study 
published to date that successfully identified any dinoflagellate proteins, or attempted to 
assign meaningful physiological inference from their expression, although the proteins 
identified were dominated by different forms of rubisco, a highly expressed chloroplast 
protein. The current study demonstrates that isolation of the cellular compartment of 
interest is a useful approach to enrich for proteins of interest. 
For the proteomic analysis in this chapter, three different mass spectrometers were 
used: MALOI-TOF, MALDI-TOF TOF and LTQ (LC/MS). Unfortunately, the peptide 
mass finger printing using the MALO I-TO F did not provide useful data since protein 
coverage is low from K. brevis ESTs. When more complete sequence information is 
available for dinoflagellates, peptide mass finger printing may become be a useful tool 
since it is a fast, single mass spectrometry approach based on known peptide sequences. 
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Although the MALDI-TOF TOF is more sensitive providing another layer of identifying 
data and yields sequences information, since peptides are generated and then MS/MS 
spectra from these peptides are produced, we were still unable to identify K. brevis 
proteins. However, this may be due to low abundance or again, mixtures that were not 
able to be separated. LC/MS using an L TQ is sensitive, can separate mixtures that may 
be present in sample proteins, and can detect post-translational modifications using high 
resolution and accurate mass. The fact that peptides are separated and concentrated 
before they are introduced to the ion source greatly enhances the ability to obtain useful 
sequence information. Using this technique, significant matches of nuclear proteins to 
the K. brevis EST library were successfully made. This approach is more costly and time 
consuming, but appears to be essential for successful identification of proteins in an 
organism for which genome sequence data is not available. 
SUMMARY 
The studies presented in Chapter 2 provide the first analysis of the proteome of K. 
brevis with respect to one of its most important physiological drivers, the diel cycle. 
Unlike L. polyedrum, the only other dinoflagellate studied, K. brevis does not display diel 
pattern of bulk translation. Rather, it appears that proteins are differentially expressed 
over the diel cycle, with patterns that likely reflect their daytime or nighttime peak in 
activity. Using DIGE, we found 4.5% of total cellular protein significantly changing in 
expression, although we were not successful in identifying them based on peptide mass 
fingerprints. For the analysis of cell cycle related proteins, proteomic analysis of isolated 
nuclei proved to be more productive, with 18 of ~ 100 proteins being matched to ESTs in 
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the K. brevis library when analyzed by L TQ MS/MS. Although limited significant 
matches were made using the K. brevis EST library, these studies show the feasibility and 
usefulness of proteomics in this dinoflagellate, even in the absence of genomic sequence 
data. Although transcriptomic studies have contributed a wealth of information to 
dinoflagellate molecular biology, mRNA levels are even less likely to correlate well with 
protein levels in dinoflagellates than in most eukaryotes, due to the presence of 
widespread post-transcriptional regulation of gene expression. Proteomics studies, as well 
as those studies investigating translational activity and post-translational modifications, 
can begin to address the cellular state in a more accurate capacity. Genome sequencing 
or the large scale production of full length eDNA libraries in dinoflagellates will provide 
the means for increased protein identifications in the future. 
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Increasing # of Ribosomes 
Figure 1: Polysome profile of L. polyedrum over circadian time (Schroder and Lorenz, 
1987). This study served as a positive control for the K. brevis polysome analysis. Shown 
are the 80S, or monosome fraction (arrow). To the right of the monosomes are the 
polysomes, or those mRNAs with increasing number of ribosomes. On the x-axis is 
increasing number of ribosomes present in the polysome factions, based on sedimentation 
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Figure 2: (A) Polysome profile of a K. brevis culture during the light phase, or subjective 
day. Shown are the 80S, or monosome fraction, the 40S and the 60S ribosomal subunits; 
and bracketed to the right of the monosomes are the polysomes, or those mRNAs with 
increasing number of ribosomes. (B) Polysome profile of a dark phase culture. (C) 
Polysome profile of a K. brevis culture treated with 30mM EDTA which causes 
ribosomal run-off (negative control). On the x-axis is increasing number of ribosomes 
present in the polysome factions, based on sedimentation in a sucrose gradient and on the 
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Figure 3: Flow cytometry over the K. brevis cell cycle showing that approximately 50% 
of the cell population was proceeding through the cell cycle in this study. LDT, or 
light/dark time, is shown on the x -axis with the percent of the cell population in each 
phase of the cell cycle on the y-axis. LDT2 and 6= Gl, LDTIO= early S-phase, 
LDT14=mid S-phase and LDT18= transition from S-phase to G2/Mitosis, and 
LDT22=mitosis. 
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Figure 4: Analysis of translational activity over the cell cycle/diet cycle of K. brevis, 
using polysome fractionation. The arrow shows the 80S or monosome fraction 
(combination of the 408 and the 608 ribosomal subunits) and to the right of the 
monosome are the polysomes, or those mRNAs with increasing number of ribosomes. 
LDT2 and 6 represent GI, LDTIO and 14, S-phase, and LDT18 and 22, G2/Mitosis. 
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Figure 5: 2D gels using traditional urea/detergent based homogenization buffers: (A) 
Gooley buffer and (B) a modified Witzmann's buffer and 2D gel using 
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Figure 6: Flow cytometry over the K. brevis cell cycle. LDT, or light/dark time, is 
shown on the x-axis with the percent of the cell population in each phase of the cell cycle 
on the y-axis. LDT2= G 1, LDT10= early S-phase, and LDT18= transition from S-phase 
to G2/Mitosis. 
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Figure 7: 2D gels displaying profiles of K. brevis proteins harvested over the cell cycle 
(G 1, S phase and G2/Mitosis). Proteins that appear to be changing in relative abundance 
are boxed in yellow and represented in the histograms to the right. LDT = Light/Dark 
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Figure 8: Flow cytometry over the K. brevis cell cycle. LDT, or light/dark time, is 
shown on the x -axis with the percent of the cell population in each phase of the cell cycle 
on the y-axis. LDT2= G 1, LDT8= early S-phase, LDT14=mid-S-phase and LDT20= 
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Figure 9: Scans of three representative gels showing resolved proteins labeled with Cy2 
(a pooled sample from each experimental sample, used as a normalizer), Cy3 and Cy5. 
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Figure 10: Significantly changing proteins as determined by DIGE. Dotted lines depict 
the change in log abundance of a protein spot labeled with Cy3 vs Cy5 at two time points 
within a given gel. The solid lines represent the average intensity of the same across all 
gels. Where dotted lines are missing, the spot was absent from individual gels. A) Spot 
333 decreases during the light phase, appears to increase during the dark phase and is 
present in all 16 experimental samples and 8 normalizer, or pooled, samples. (B) Spot 
189 increases from LDT8 to LDT14 and in present in 12 of24 samples. (C) Spot 396 
follows a similar trend to spot 333 and is present in all 24 samples. (D) Spot 235 
increases during the light phase and is present in all 24 samples. (E) Spot 627 increases 
from LDT8 to 14 and is present in all samples. (F) Spot 204 also increases during the 
light phase (LDT8 to 14) present in all samples. (G) Spot 43 is present in all samples and 
increase during the light phase. (H) Spot 117 steadily increase during the light phase and 
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Figure 11: Scans of all experimental gels showing resolved proteins after final staining 
with SYPRO Ruby. Spots determined to significantly change were picked from all gels 
in which the proteins were present and were then pooled for tryptic digestion. This was 
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Figure 12: Trends of significantly changing proteins in K. brevis. Trend 1, proteins-
decreased during early day, increased during late day and into the night with maximal 
abundance in late night; Trend 2, proteins decreased in early day with maximum 
abundance attained in late day and maintaining at night; Trend 3, proteins decrease 
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Figure 13: 2DE gels of K. brevis nuclear proteins. LDT5 (G1) and LDT14 (S-phase) 
were compared. Approximately 100 protein spots were detected. 
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Table 1: Proteins found to significantly change over the diel cycle using OIGE. Shown 
are the master spot numbers assigned by OeCyder software, the number of samples in 
which the spot was present (of 24, including Cy2, Cy3 and Cy5 from each of 8 gels), the 
results from a Student's t-test comparing each time point to LOT2, the average ratio 
compared to LOT 2, and the results from a one-way ANDV A comparing the means 
across all time points. Note: Not all spots were detected by SYPRO Ruby staining in 
order to be cut from gels. Additional gels were run, swapping the original Cy dyes, in 
order to verify the trend that was occurring between LOT 8 and 14 and 15 of 18 protein 
abundances agreed (83.3%). 
T-Test 
(LOT2 VS. other time A NOVA Original Trend Repeated with dye 
Master No. Appearance points) Pvalue LOT8-14 swap Note 
333 24(24} 0.00073 0.00015 down down (2/3) 
189 12(24} 0.056 0.00062 up up 
369 24(24} 0.11 0.0016 down down 
235 24(24} 0.77 0.0032 up up 
8 6(24) 0.0041 not confirmed with SYPRO 
627 24(24} 0.58 0.0092 up up 
204 24(24} 0.21 0.0099 up up (2/3) 
43 24(24) 0.89 0.011 up up 
117 21(24} 0.06 0.012 up down 
340 24(24} 0.69 0.014 down down (2/3) 
573 9(24} 0.014 not confirmed with SYPRO 
314 24(24) 0.85 0.016 up up (2/3) 
367 24(24) 0.47 O.Ola down down 
223 12(24} 0.022 not confirmed with SYPRO 
339 24(24) 0.14 0.026 down down (2/3) 
192 24(24) 0.73 0.035 up up (2/3) 
608 24(24) 0.92 0.036 up up 
595 18(24) 0.34 0.042 down up not confi rmed with SYPRO 
629 21(24) 0.44 0.042 up up (2/3) not confirmed with SYPRO 
176 15(24) 0.82 0.045 up up not confirmed with SYPRO 
271 24(24) 0.91 0.045 up down not confirmed with SYPRO 
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Table 2: Nuclear protein identifications using tandem MS (LTQ). Shown are the number 
of peptides identified in each sample, the peptide sequences of each peptide, the total ion 
scores, the match to the contig sequence in the K. brevis cDNA library using SEQUEST, 
the protein ID of the top hit to the K. brevis Contig from GenBank with BLASTx e-value, 
and the species to which the sequence has the highest homology. Shown in bold are the 
























APSILDLK, IDLQLLR, LLDVRICR, DPGAILPDER, 
ATHELSEGIYN, QKLLDVRICR, ICRQCLHQLR, 
HSGQILQRHVCVALR, LLDVRICRQCLHQLR 
DELTLEGI, ELAEQSQK, FMNNPFR, RDELTLEGI, VFHMIQQR, 
EQVYDIYR, DVIVQAQSGTGK, DPQVLFLSPTR, 
FMNNPFRVlVK, AlEAGVHIVSGTPGR, FMNNPFRVLVKR, 
VKGQIVCLNVLAGMASKMFVLDEADEMLNR 
GVAGQRARR, SSATGEQTGSI, GCRVSESSPR, SARQNTRCTR, 
SlPGASlSRRER, VSESSPRDERSAR, 
G PGITE HARG HQPGAAHTK, PPGSCRPMEPGESRVAS, 
AGGGQPDPGLSSPAWR 
RELTCH, RKCMQR, CLTKVHR, ARCRCl TK, AWGAQHHR, 
KCMQRIPR 
GQALTLPR, ARGQALTLPR 
NACPSLPR, LHDCLGR, LQTMLLCK, QAHSSPVLLGR, 




GLPPCSKG, SSPQSLPR, GPALASFSR, SSPQSlPRHR 
NLQQMR, SRISNCK, ISNCKVK, ERLSlPR, TALSSKER, 
VKDGAQSTGIDWAK 
LSAQELR, DRWVDK, ASTDALPR, ETRTAMK 
YQPTVGR, QEQRKR, CVIRLSR, VAEVSPLR, LLGVRCWSVKR, 
HCDDVHDWPLK 
LSAQElR, DRWVDK, ASTDALPR, ETRTAMK, ETRTAMKDR 
SSPQSLPR,SSPQSLPRHR 
GSLCTLAR, KRGGSPGGR, GTPPCPRWR, 
GSLFEGSVPCECRHlEK, RGSGASLGCGEIliHANCSGTMSR 
CKSAELR, EDWQLFR, ERHQTLR, WQVQMGEGR, 
CPMCGTVQPR, GKPQAQMMMR, LGESVPSASAASAR, 
TQWAEAlREGR, AKRTQWAEALR, AVRTISEQMMGGK, 
KERPIRLGESVPSASAASAR, FQARGFEYEVLLDRlVQR, 
WQVQMGEGRWEDFAESEQR 




DELTLEGI, HAEQSQK, FMNNPFR, RDELTLEGI, VFHMIQQR, 
EQVYDIYR, DVIVQAQSGTGK, DPQVLFLSPTR, FMNNPFRVlVK, 
ALEAGVHIVSGTPGR, MFVLDEADEMLNR, 
VKGQIVCLNVLAGMASK 
RDGRFR, ACYDQR, NFKVWR, EQCGKRGS, VWRGDCTR, 
DGAGTQGADCGR, CASLSEIASAAR, HSGASSRLQCR, 
DGCREQCGKR, DGRFRALPNLR, YAWSWAISQPR 
RALHCGR, SLSCEHS, CCDIRR, RLLHHR, QAPAIVCR, CNSELDPR, 
IIIRCCDIR, FLVLQRNR, CIIITSVTDPIIIR, AHDlLLTIGKV, 
LHEASCSRGSK, HQIIIRllCRVD, PWLRCIIITSVTDPIliR 
Protein 10 
Contig from Librarv 
Contig 6616 tropomodulin 
eukaryotic initiation factor 4A-3 
Contig 5255 (eIF4A-3) 
Contig 5491 hypothetical protein 




Rev 3965 hypothetical protein 
Rev 25 Major basic nuclear protein 
Contig 3542 hypothetical protein 
\JUIILlYi U,J""tL, 
Rev 2952 
VVIILl~ vVoJ, J'\'VY 
hypothetical protein 
4727 hypothetical protein 
.... UIIUY VV.:JV. 
Rev 1495 hypothetical protein 
Contig 305 hypothetical protein 
Contig 3542 hypothetical protein 
Rev 7203 similar to SOX3 (DNA binding) 
Calpain family cysteine protease 
Contig 9679 containing protein 
Contig 9664, DJ-1 family protein (pos. 
Rev 832 regulator of transcription) 
eukaryotic initiation factor 4A-3 
Contig 5255 (eIF4A-3) 
Contig 4790, SNF2 family chromodomain-
Rev 4075 helicase (chromatin assembly) 














































The dinoflagellate cell cycle is typical of that in other eukaryotic organisms, with 
distinct G 1, S, G2, and M phases. In K. brevis, the cell cycle is under circadian control 
(Brunelle et aI., 2007), and is thereby entrained to the lightldark cycle, with S-phase 
beginning approximately 6 hours after onset of light, and mitosis occurring late in the 
dark, peaking at 20-22 hours of a 24 hour diel cycle (Van Dolah and Leighfield, 1999). 
Conserved eukaryotic cell cycle regulatory proteins, cyclins and cyclin dependent kinases 
(CDK) are present in dinoflagellates (Liu et aI., 2005, Zhang et aI., 2006, Toulza et aI., 
2010, Bertomeu et aI., 2007, Bertomeu and Morse, 2004, Barbier et aI., 2003) and appear 
to be necessary for cell cycle progression through G liS and G2/M (Van Dolah and 
Leighfield, 1999; Bertomeu and Morse 2004). In higher eukaryotes, CDK-dependent 
phosphorylation at G liS activates the transcription of a core set of S-phase genes in a cell 
cycle dependent manner, thereby ensuring that specific processes are limited to the 
appropriate cell cycle phase (Rustici et aI., 2004; Spellman et aI., 1998). Late in the cell 
cycle, CDK dependent phosphorylations trigger entry into mitosis, including nuclear 
envelope breakdown and chromatin condensation. However, dinoflagellates have a 
number of unusual features that suggest modification of some of these cell cycle control 
mechanisms. 
Dinoflagellate chromosomes are permanently condensed and lack nucleosomes 
that typically control the degree of chromatin condensation and thereby access for 
transcription and replication. Instead, the chromatin occurs throughout the cell cycle in a 
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tightly packed liquid crystal state, with peripheral arches of exposed DNA thought to be 
areas undergoing active transcription (Costas and Goyanes, 2005). Several lines of 
evidence point to the possibility that transcription in dinoflagellates is constitutive (Van 
Dolah et aI., 2007). No recognizable promoter sequences (e.g., TATA boxes or other) 
have been identified in dinoflagellate genes. Further, all nuclear encoded gene transcripts 
examined in K. brevis possess an identical 22 nucleotide leader sequence on their 5' end 
termed the spliced leader (SL; Lidie and Van Dolah, 2007; Zhang et aI., 2007). SL 
trans-splicing was first observed in trypanosomes, an early diverging branch of 
unicellular eukaryotes that carry out constitutive transcription and produce polycistronic 
messages (Murphy et aI., 1986). Trans-splicing of the SL about 100 nucleotides 
upstream of an open reading frame serves to process these polycistronic pre-mRNAs into 
individual mature messages, each with a 5' capped SL and a 3' poly A tail. With 
messages produced constitutively, differential gene expression in trypanosomes is 
regulated by differential rates ofmRNA turnover and differential rates of trans-splicing 
(Vanhamme and Pays, 1995). The presence of the SL mechanism in dinoflagellates 
suggests that their transcription may take place constitutively as well. Indeed, many 
physiological processes in dinoflagellates appear to be under translational control, 
including bioluminescence (Morse et aI., 1989; Mittag et aI, 1998), carbon fixation 
(RUBISCO, Nassoury et aI., 2001), glycolysis (GAPDH, Fagan et aI., 1999), and 
photosynthesis (PCP, Le et aI., 2001). In K. brevis, a microarray study of diel dependent 
gene expression suggested that cell cycle control is also post-transcriptional, based on the 
absence of differential expression of cell cycle gene transcripts (Van Dolah et aI., 2007). 
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During the cell cycle of animals and plants, the G 1 IS phase transition is triggered 
by CDK phosphorylation of the retinoblastoma protein (Rb), a "pocket protein" that 
serves to sequester the transcription factor E2F in inactive cytosolic complexes during 
G 1. Phosphorylation of Rb results in the release of E2F, which translocates to the 
nucleus and orchestrates the transcription of genes required for DNA synthesis. The 
Rb/E2F pathway is present in green algae(Robbens et al. 2005, Umen and Goodenough 
2001) and diatoms (Huysman et al. 20 1 O),but is absent from Apicomplexa (Gardner et al. 
2005), the nearest relatives to dinoflagellates, and has not been identified in 
dinoflagellates. Nonetheless, S-phase entry in K. brevis appears to be CDK dependent, as 
inhibiting CDK activity with the inhibitor, olomoucine, causes a G 1 cell cycle block (Van 
Dolah and Leighfield, 1999). Given the current paradigm for CDK controlled S-phase 
entry, it is unclear how transcription-independent S-phase entry might be achieved. 
The study in Chapter 3 therefore investigates the regulation of a suite of S-phase 
specific genes and their protein products that are critical to the DNA synthesis phase of 
the cell cycle. A survey of S-phase genes present in an extensive EST collection from K. 
brevis was first carried out to gain insight into how conservedthe dinoflagellate S-phase 
processes are in comparison with other eukaryotes. From this survey, four S-phase genes 
that have strong sequence homology with orthologs in other eukaryotes were selected for 
study, all of which are typically under CDK-dependent transcriptional control at the G liS 
transition through its activation of E2F. The genes investigated include: proliferating cell 
nuclear antigen (PCNA), replication factor C (RFC), replication protein A (RPA), and 
ribonucleotide reductase (RnR2). PCNA, RFC, and RPA are members of the replication 
fork complex where PCNA is a sliding clamp that forms a homotrimeric ring structure 
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around DNA, endowing DNA polymerase 8 with a high degree ofprocessivity (Kuriyan 
and O'Donnell, 1993). RFC is a complex of 5 subunits that loads PCNA onto the 3' 
hydroxyl end of the primer strand of the DNA primer-template in an ATP-dependent 
process (Loor et aI., 1997). RP A is a trimeric single stranded DNA binding protein that 
stabilizes the replication fork, stimulates DNA polymerase 8 activity in the presence of 
the PCNAlRFC complex and is involved in both initiation and elongation of DNA 
replication (Lee and Hurwitz, 1990). Ribonucleotide reductase is a tetramer, consisting 
of two large and two small subunits, that reduces ribonucleotides to deoxyribonucleotides 
during S-phase and in response to DNA damage. 
To assess the regulation of these genes, their transcript levels were first analyzed 
over the course of the cell cycle using quantitative PCR. Peptide antibodies designed 
from these sequences were next employed in western blotting and immunolocalization to 
investigate cell cycle specific changes in protein abundance and/or localization. 
Although there were no significant changes in transcript levels of these S-phase genes, 
there were S-phase specific increases in protein abundances. Furthermore, in the case of 
PCNA, an S-phase specific -"-J9 kDa increase in molecular weight was observed that may 
be attributed to a post-translational modification. This S-phase specific shift in the 
molecular weight ofPCNA coincided with its chromatin association as determined by 
immunolocalization. Together these results suggest that the expression of S-phase 
specific proteins in K. brevis is independent of their transcription upon entry into S phase. 
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METHODS 
Survey of Cell Cycle Genes in K. brevis 
Sequences with significant homology (BLASTx E-value < 10-04) to cell cycle 
genes were identified from a K. brevis expressed sequence tag (EST) database containing 
65,292 sequences housed at NOAA (Charleston, SC) and available at 
marinegenomics.org. ESTs were previously assembled into 22,671 unigene contigs using 
Cap3, with a minimum 30 bp overlap and 70% identity set as assembly criteria. 
Annotation of contigs and gene ontology analysis were performed in Blast2Go. 
Analysis of Selected S-phase Gene Sequences 
Among the cell cycle genes, sequences for several genes with significant 
homology (E-value < 10-5°) to S-phase genes on GenBank were selected for further 
analysis. These include PCNA, RFC, RPA and RnR. To confirm the presence of the 
spliced leader on contigslacking the 5' end of the transcripts, PCR was carried out using 
gene specific reverse primers (Table 1) in conjunction with a truncated primer for the 
dinoflagellate-specific spliced leader (TCCGTAGCCATTTTGGCTCA). Total RNA 
(200 ng) was reverse transcribed (Ambion RETROscript kit, Austin, TX) using an oligo 
(dT) primer (Ambion, Austin, TX). PCR was conducted using Qiagen HotStar master 
mix (Qiagen, Valencia, CA) with a 400 nM final concentration of each primer. PCR 
parameters were as follows: 95°C for 1 min; 25 cycles: 94°C for 1 min, 60°C for 1 min, 
and 72°C for 1 min.; and 72°C for 10 min. PCR products were analyzed on an Agilent 
Bioanalyzer 2100. Amplicons were cloned using a TopoTA cloning kit (Invitrogen, 
Carlsbad, CA), and purified plasmid DNA was sequenced in both forward and reverse 
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directions using the universal M13 primer (Seqwright, Houston, TX). Sequenced 
products were aligned with existing sequences using Bioedit software. 
Multiple Alignments of Amino Acid Sequences 
In silico translationsofthe full length open reading frames of K. brevis PCNA, 
RPA1, RFC3, RFC5, RnRland RnR2 were performed using BioEdit software. To obtain 
the predicted theoretical molecular weight for each protein, the amino acid sequences 
were analyzed using the Compute pIlMw tool on the ExP ASy Proteomics server 
(http://expasy.org/tools/pi tool.html). For multiple alignments of each protein sequence, 
the amino acid sequences from other eukaryotes were obtained from GenBank. Species 
used for this analysis included: Trypanosoma brucei, Chlamydomonas reinhardtii, 
Arabidopsis thaliana,Saccharomyces cerevisiae, and Homo sapiens, to include 
representatives across multiple diverse phyla. Once imported into BioEdit software, 
multiple alignments of the 6 species were done using the ClustalW Multiple Alignment 
application. 
Cultures and Culture Conditions 
K. brevis (Wilson isolate) was grown in 0.22 f.lm filtered seawater (36%0) obtained 
from the seawater system at the Florida Institute of Technology field station, Vero Beach, 
Florida, enriched with j/2 nutrients (Guillard, 1973), modified with the use of ferric 
sequestrene in place ofEDTA'Na2 and FeC13·6H20 and the addition of 0.01 f.lM selenous 
acid. Cultures were maintained in 1 liter glass bottles at 25°C + 1°C with a 16:8 
light:dark cycle, and cool white light at 50-60 f.lmol photons m-2 sec-I, determined using 
aLI-COR LI-250 Light Meter (LI-COR BioSciences, Lincoln, NE). To compare the 
transcript abundance and protein expression levels of the S-phase genes over the cell 
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cycle, replicate 1 L cultures were grown to mid-log phase when cell concentrations were 
approximately 104 cells/mL. Cells were harvested at times corresponding to G 1 (LDT2 
and LDT6), S phase (LDTIO and LDT14), and G2/Mitosis (LDT18 and LDT22), where 
"LDT" designates "light-dark" time, or hours after lights-on in a 24 hour light-dark cycle. 
A total of five independent cultures were harvested at each time point for qPCR and 
Western blot analysis. At least three independent cultures at each time point were used 
for immunolocalization studies. From each culture, a 10 mL aliquot of cells was 
processed for flow cytometric cell cycle analysis while the remaining cells were used for 
RNA and protein extractions. 
Cell Cycle Analysis 
Ten milliliters of culture were collected from each 1 L biological replicate culture 
(n=5) at each time point Cells were fixed in 2% gluteraldehyde by adding 50% 
gluteraldehyde directly to culture medium containing cells and stored at 4°C for at least 
12 hours. Cells were then centrifuged at 1750 x g to remove fixative and growth 
medium. To extract cellular pigments, cells were stored in -20°C methanol for a 
minimum of 4 hours, centrifuged at 1000 x g and methanol was removed. The cells were 
then stained with 10 Jlg/mL propidium iodide (final concentration) in phosphate buffered 
saline (PBS) containing 10 mg/mL RNase and 0.5% Tween 20. DNA analysis was 
performed on an Epics MXL4 flow cytometer (Beckman Coulter, Miami, FL) using a 5 
W argon laser with a 488 nm excitation wavelength and 635 nm emission wavelength. 
Multicycle software (Phoenix Flow Systems, San Diego, CA) was used to obtain the 
percentages of cells in each stage of the cell cycle. 
72 
qPCR 
Forward and reverse primers sets were designed for concensus PCNA, RFC, 
RPAl and RnR2 cDNA sequences (Tablel) and optimum annealing temperatures were 
determined prior to the analysis of experimental samples. The specificity of each primer 
set was verified by analysis of amplicon size determination on an Agilent Bioanalyzer 
(Santa Clara, CA)and by melt curve analysis. Efficiencies of the primer sets were 
determined using a standard curve of cDNA produced from K. brevis. Experimental 
samples were harvested at the aforementioned timepoints from the five independent 
cultures by centrifugation at 600 x g for 10 minutes and medium was removed. Total 
RNA was isolated by the addition of 1 mL of TriReagent to the cell pellet (Molecular 
Research Center, Inc., Cincinnati, OH) and processed according to manufacturer's 
instructions. Residual DNA contamination was removed by incubation with 27.3 units 
RNase-free DNAse and processed through a Qiagen RNeasy mini-column (Valencia, 
CA). RNA was quantified using a Nanodrop spectrophotometer (Wilmington, DE, USA) 
and qualified using anAgilent Bioanalyzer.For each sample, 200 ng of total RNA was 
reverse -transcribed (Ambion RETROscript kit, Austin, TX) with oligo (dT) primers in 
triplicate. Duplicate real-time assays were performed on each reverse-transcribed sample 
on an Applied Biosystems 7500 Real-Time PCR system (Foster City, CA, USA). A 
sample volume of25 f.lL was used for all assays, consisting of ABI SYBR green (Applied 
Biosystems) PCR master mix, nuclease-free water, gene-specific primers (400 nM final 
concentration), and If.lL eDNA. Assays were run using the following protocol: 95°C for 
15 min, 40 cycles of 94°C for 15 s, gene-specific annealing temperature (58°C-62°C) for 
40 s, and 72°C for 1 min. To quantify the fold change in mRNA expression ofPCNA, 
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RFC, RP A and RnR2, one cDNA sample from K. brevis was used to develop a standard 
curve for all primer sets relating efficiencies and slope values. PCR products were 
subjected to melt curve analysis to confirm the presence of a single amplicon. Statistical 
analysis of the fold-change values (log2 ratio= C-E, where C is the control and E is the 
experimental samples) was evaluated using a one-way ANOVA in GraphPad Prism 4 (La 
Jolla, CA). 
PCNA Phylogenetic Analysis 
Fourteen K. brevis PCNA contigs were aligned with a dinoflagellate (Pyrocystis 
lunula) PCNA and 4 higher plant PCNAs to generate a preliminary alignment in BioEdit. 
However, for simplicity of analysis, only one K. brevis contig was used for the final 
alignment. Contig 2450 was chosen for this analysis since it contained the full open 
reading frame and had a high e-value by BLASTx analysis. Sixty-four PCNA amino acid 
sequences were then obtained from NCBI's GenBank from the Archaea and Eucarya 
domains to produce the final alignment. Eukaryotes represented in the final alignment 
include animals (vertebrates and invertebrates), fungi, plants and various protists, 
including other algal species. The prokaryotic Eubacteria were not included in this 
alignment due to the low level of sequence identity of their clamp-loading protein 
sequences with Archaea and Eucarya (Indiani and O'Donnell, 2006). Archaeabacteria 
were included in this analysis because PCNA sequences from this domain have known 
sequence identity to eukaryotes. Alignments were performed in BioEdit to manually 
search for conserved domains.ProtTest 1.2.7 software was used to determine the best fit 
model for amino acid replacement. The JTT substitution model was used for PCNA 
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(Jones et aI., 1992). ClustalX and MEGA Software packages were used to perfonn 
phylogenetic analysis. MEGA software was used to generate a Neighbor-joining tree with 
1000 bootstrap replicates. 
PCNA Protein Homology Model 
K. brevis PCNA Contig 2450 was used to build a protein homology model. This 
protein, or amino acid, sequence was BLASTed (protein-protein) against NCBI's 
GenBank using the SwissProt database which is smaller and better annotated than the 
non-redundant. Cn3D 4.1 software was then used to detect the conserved domains in the 
K. brevis sequences. The K. brevis sequence was then loaded into SwissPBD Viewer 
software. A template upon which to build the model was chosen from the SwissModel 
database (http://swissmodel.expasy.org/cgi -binlhlastexpdb.cgi) of known crystal 
structures of proteins. Human PCNA was chosen as the template since the K. brevis 
PCNA sequence (Contig 2450) had the highest homology to this protein. The homology 
model was built after threading and aligning the K. brevis sequence with the template. 
This alignment was then submitted to the Swiss PBD Viewer Server for model 
refinement. Additionally, the exP ASY Proteomics 
(http://www.expasy.org/tools/pi_tool.html) server was used to calculate the theoretical pI 
(isoelectric point) and molecular weight of K. brevis PCNA. 
Antibody Development 
In order to study protein expression, it was necessary to obtain antibodies that 
specifically cross-react with proteins of interest in the organism under investigation. 
75 
Although the S-phase genes are highly conserved in eukaryotes, the dinoflagellates 
represent a distinct group of primitive eukaryotes, the alveolates, and commercial cell 
cycle antibodies tested did not cross-react with K. brevis proteins, with the exception of 
anti-RnR2 (Calbiochem). For PCNA, in silica translated sequences and the above protein 
model were analyzed to determine an optimal region for peptide antibody production 
suitable for use in immunolocalization, specifically, one occurring in an exposed area of 
the native folded protein. The resulting short peptide (DRIADFDLKLMQIESE) was 
BLASTed against an in-house K. brevis EST database and GenBank to ensure specificity. 
The resulting peptide sequence was submitted to EZBiolab (Carmel, IN, USA) for 
polyclonal antibody production. Affinity purification was carried out using a SulfoLink 
Immobilization kit (Thermo Scientific, Rockford, IL, USA). All other peptide antibodies 
(Table 2) were designed by ProSci, Inc. (Poway, CA, USA)using standard algorithms for 
hydrophilicity, antigenicity and surface probabilityand affinity purified polyclonal 
antibodies were generated. The peptides used for development of each antibody are 
listed in Table 2. 
Protein Extraction and Western Blotting 
Protein was extracted from the same experimental samples used for qPCR using 
TriReagent, following the manufacturer's protocol. A Bradford protein assay (Bradford, 
1976) was used to quantify protein concentration using the Bio-Rad Protein Assay Dye 
Reagent (Bio-Rad, Hercules, CA, USA). For Western blotting, 10 ~g of protein extract 
were loaded on a 4-12% Bis-Tris gradient gel (Invitrogen Corporation, Carlsbad, CA) 
and then transferred to a 0.2 J-tm polyvinylidene fluoride (PVDF) membrane using the 
76 
Invitrogen iBlot system (Invitrogen Corporation, Carlsbad, CA). The PVDF membrane 
was then blocked in 5% non-fat milk in Tris buffered saline (TBS) with 0.1 % Tween 20 
for 1 hour at room temperature. Membranes were then incubated in primary antibodies 
overnight at 4°C. Peptide antibodies developed against translated K. brevis cDNAs were 
used at the following dilutions (v/v) in TBS with 0.1 % Tween 20 and 5% non-fat milk: 
anti-KbPCNA, 1:5000; anti-KbRFC5, 1:2000; and anti-RPA1, 1:2000 (Table 2). A 
commercial antibody was used for the detection of ribonucleotide reductase 2 at a 
dilution of 1 :60 (v/v) (Calbiochem, San Diego, CA). Membranes were washed 3 x 10 
minutes in TBS with 0.1 % Tween 20. Horseradish peroxidase-linked donkey anti-rabbit 
Ig was then incubated with the PVDF membrane at 1 :2000 in TBS with 0.1 % Tween20 
for 1 hour at room temperature. After rinsing membranes in TBS with 0.1 % Tween 20 (2 
x 10 minutes) and TBS (Ix 10 minutes), the Pierce ECL Super Signal West Pico Kit 
(Pierce, Rockford, IL) was used for detection. Membranes were exposed to film (Pierce 
CL-XPosure Film, Thermo Scientific, Rockford, IL) and developed for visualization. 
Densitometry of the bands of the biological replicates (n=5) was carried out using Alpha 
Innotech (San Leandro, CA) FluorChem 8900 software. The band intensities of all time 
points were normalized to LDT2 and significant differences were determined with a one-
way ANOV A using GraphPad Prism 4 (La Jolla, CA) software. 
Peptide Competition Assay 
Ten micrograms of protein extract from cells in S-phase (LDT 10 andLD14) were 
used for the PCNA peptide competition experiment. The anti-K. brevis PCNA antibody 
(3.6Jlg) was incubated with 1 DO-fold excess of the peptide (360f.lg) to which the antibody 
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was developed, in TBS with 0.1 % Tween 20 and 5% milk for 1 hour at 4°C. The 
experimental membrane was incubated overnight at 4 °C with the peptide blocked anti-
PCNA. The control blot was incubated overnight at 4°C in the anti-K. brevisPCNA 
antibody at 1 :5000 (v/v) in TBS with 0.1 % Tween20 and 5% non-fat milk. Western blot 
procedures were then followed as described above. 
Immunolocalization 
Triplicate cell samples were fixed in 2% paraformaldehyde in seawater for 10 
minutes and centrifuged for 10 minutes at 250 x g. Cell pellets were then washed in 
Phosphate Buffered Saline (PBS), resuspended in 2 mL of -20°C methanol and incubated 
at 4°C for 10 minutes. The pelleted cells were incubated with normal goat serum (Vector 
Laboratories, Inc., Burlingame, CA) at 4°C for 45 minutes and then incubated overnight 
at 4°C with the K. brevis anti-PCNA antibody diluted at 1: 100 in PBS with 0.1 % 
Tween20. Cells were also incubated with the K. brevis anti-PCNA antibody blocked 
with 100-fold excess of peptide ( above) to test for specificity. All cells were then 
incubated with fluorescein isothiocyanate (FITC)-labeled goat anti-rabbit (Sigma-
Aldrich Corp., St. Louis, MO, USA) at 1: 100 for 1 hour at room temperature. After 3 X 
5 minutes washes in PBS with 0.1 % Tween20, cells were counterstained with 0.1 Ilg/mL 
DAPI (4',6-diamidino-2-phenylindole) (Molecular Probes) in PBS for 5 min at room 
temperature to visualize nuclei. The cells were mounted in Fluoromount-G (Southern 
Biotech, Birmingham, AL, USA). An Olympus Fluorescent Microscope with a FITC 
filter set was used for imaging. One hundred individual cells from each replicate were 
counted to determine the percentage of cells stained positively for PCNA. 
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RESULTS 
Survey of Cell Cycle Genes in K. brevis 
In order to gain insight into the conservation of genesinvolved in the K. brevis cell 
cyclea survey of genes present in a K. breviswas carried out on a cDNA sequence 
database containing 65,292 ESTs. Based on the genome size prediction of Hou and Lin 
(2009), we predict that this EST database contains approximately half of the K. brevis 
expressed genes. A total of 130 cell cycle genes were identified based on BLASTx and 
Gene Ontology,assigned using Blast2Go (Appendix 1). This is the largest sampling of 
cell cycle genes in a dinoflagellate to date and provides preliminary insight into the 
conservation of the eukaryotic cell cycle in this divergent protist. These included 
conserved eukaryotic genes involved in central cell cycle control, pre-replication 
complexes, such as mini chromosome maintenance proteins, S-phase specific genes 
involved in DNA replication, and mitotic genes, such as centrins and members of the 
anaphase promoter complex. Genes directly involved in DNA replication are shown in 
gray. Six highly conserved S-phase genes were chosen for further analysis in this study 
and are shown in bold: PCNA, RFC3, RFC5, RPAl, RnRI and RnR2. The conservation 
and diversity of these transcripts in K. brevis is shown in Table 3. 
Characterization of Selected S-phase genes 
PCNA 
PCNA gene transcripts were among the most highly expressed ESTs in the 
library, with 10 1 identified using an expect value <10-1°. Among the PCNA ESTs, 
significant sequence variability exists, as previously reported in other dinoflagellates 
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(Zhang et aI., 2006), with the 10 lK. brevis ESTs assembling into 11 unique contigs. 
These sequences have been submitted to Genbank as KbPCNAs (Accession Numbers 
IF491177-1F491185). Most of the sequence differences between these contigs reside in 
single nucleotide substitutions found in third codon positions, resulting in synonymous 
substitutions. Thus the 11 contigs encode nine unique proteins with substitutions found 
at only 20 conserved sites among 259 amino acids (Table4). None of the amino acid 
sequences was identical to any of the nine K. brevis PCNA sequences previously 
submitted to GenBank (Accession numbers FJ1805026.1 - FJI805034.1), although all 
represent different combinations of substitutions at the same 20 sites. Altogether, a 
minimum of20 unique PCNA genes have been described from K. brevis. All PCNA 
open reading frames for which full length sequences were obtained are of the same 
length, 780 nucleotides, with a predicted protein molecular weight of 28 kDa. This 
predicted molecular weight is similar to what has been identified in other eukaryotes and 
K. brevis shows a high degree of conservation with model eukaryotes across phyla 
(Figure lA). 
A neighbor-joining tree ofPCNA sequences from diverse eukaryotic phyla and 
archaea found the K. brevis PCNA to be distant from animals and higher plants, each of 
which formed monophyletic clades with moderate bootstrap support (81 and 74%, 
respectively). The dinoflagellates similarly formed a monophyletic group with 99% 
bootstrap support and fell out most closely with other protists, the kinetoplastids and 
Apicomplexa, although these deeper branches are not strongly supported (Figure 2). 
After several unsuccessful attempts to use commercial antibodies for PCNA (made to 
metazoans), we used this information, along with the multiple alignment in Figure lA to 
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guide antibody development. A conserved 16 amino acid peptide 
(DRIADFDLKLMQIESE) was identified in all K. brevis PCNA sequences and 
BLASTed against the K. brevis EST database and GenBank to ensure its specificity. The 
full length PCNA protein sequence (from Contig 2450) was next used to produce a 
computational 3D protein model in order to determine where on the protein the antibody 
would bind (Figure 3, top). The K. brevis PCNA monomer has the conserved structure 
seen in archaea and yeast (Figure 3, bottom) that enables it to form a trimeric DNA 
clamp. From the computational model of PCNA, it appears that the peptide 
DRIADFDLKLMQIESE is located on the outside surface of the protein, making this 
good candidate for use in immunolocalization. 
Replication Protein A 
Expressed sequence tags with homology to RPA were analyzed next. RPA is a 
single strand DNA binding protein that typically consists of three subunits. Only ESTs 
for RPA1, the largest subunit, responsible for DNA binding, were identifiable in the K. 
brevis library (Table 3). Twenty-eightESTs were found, which fold into three contigs. 
The two full length contigs were submitted to Genbank as KbRP A 1 a and KbRP Alb 
(Accession numbers JF491189 and JF491176). These encode for proteins of 464 and 465 
amino acids, respectively, and have highest homology to Perkins us (e-value 1.0-129; 
GenBank Accession number XP002779439). The predicted molecular weight of these 
proteins is 51 kDa. This is somewhat smaller than the 70 kDa RP A 1 protein identified as 
RPAI in mammals, but is similar in size to that found in trypanosomes (Zicket at, 2005) 
and other protists. This can be seen in the multiple alignment of RP A 1 (Figure 1 B). 
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Consistent with this finding, a peptide antibody made to K. brevis RPA1 recognizes a 
protein of 51 kDa. 
Replication Factor C 
RFC is made up of five subunits in eukaryotes, of which only subunits 3 and 5 
were identified in the K. brevis library. A single EST was identified for RFC subunit 3. 
The K. brevis RFC3 protein sequence shows high conservation when aligned with other 
eukaryotes (Figure IC). The predicted molecular weight of K. brevis RFC3, ---39kDa, is 
also highly conserved. This sequence was submitted to GenBank as KbRFC3 (GenBank 
accession number JF491186). Seven ESTs for RFC subunit 5 folded into two unique 
contigs, one of which is full length. Similar to RFC3, the K. brevis RFC5 protein 
sequence also shows homology and all species investigated in the multiple alignment 
have an amino acid sequence of approximately the same size, with a predicted molecular 
weight of 39 kDa (Figure ID). A peptide antibody developed to RFC5 using the 
translated sequence indeed recognizes a band at 39 kDa (below). These sequences have 
been submitted to GenBank as KbRFC5a and KbRFC5b (GenBank accession numbers 
JF491187 and JF491188). 
Ribonucleoside Diphosphate Reductase 
The two subunits that make up the RnR tetramer, interestingly, are not equally 
represented in the K. brevis library. RnRl is highly expressed, with 54 ESTs that fold 
into 12 unique contigs, encoding at least 3 unique proteins (Table 3). RnRI shows a very 
high degree of homology with other eukaryotes until the C-terminus (Figure IE). C. 
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reinhartii and S. cerevisiae have longer sequences with predicted molecular weights of 
98 and 97.5 kDa, respectively, whereas, unexpectedly, the K. brevis sequence has a 
molecular weight (--90 kDa) more similar to that of H. sapiens (90kDa) and A. thaliana 
(92 kDa). In contrast to RnR1, sequence representation of its partner RnR2 is much 
lower in the K. brevis EST library, with only 2 ESTs present, which form a single contig 
(submitted to GenBank as KbRnR2 (Accession No. JF699608). RnR2 is also highly 
conserved (Figure IF). There is some sequence variation in the N-terminus between the 
species investigated; however, the predicted molecular weights of all sequences are 
within a tight range of ---40-45kDa. Sufficient conservation is present in K. brevis RnR2 
that we were able to successfully use an antibody made to human RnR2 for studies in K. 
brevis (Figure IF, boxed region), which recognizes a doublet of bands at --40, as also 
found in yeast (Hurd et aI., 1987) (below). 
Identification of the Spliced Leader Sequence on S-phase Genes 
Given the widespread presence of the SL of dinoflagellate gene transcripts, and 
its importance to gene expression, we next sought to determine ifit is present on the S-
phase genes under study. Several of the PCNA contigs were found to possess the 5' SL 
sequence (Table 4) and where the SL was missing, the full 5' UTR sequence is lacking 
(i.e., this represents incomplete sequence data, not the absence of the SL on a full-length 
sequence). To confirm the presence of the SL on the other S-phase genes, PCR 
amplification was carried out on one representative of each using a spliced leader primer 
and gene-specific primer. We found that the SL was present on each representative 
examined, in each case approximately 50-100 nucleotides 3' of the start codon (Figure 4). 
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Th,ese sequences have been submitted to GenBank (Accession numbers: KbRPAla -
IF491189; KbRFC3 - JF491186; RnRl -lF491190). 
Cell Cycle Dependent Expression of S-phase Gene Transcripts 
Flow cytometry (Figure 5) was first carried out to confirm that the cells used in 
this experiment were actively cycling through the cell cycle. The flow cytometric cell 
cycle distribution indicated that approximately 50% of the cells were actively proceeding 
through the cell cycle in a diel phased manner as previously described (Van Dolah and 
Leighfield, 1999). Essentially all cells ('"-'95%) were in G 1 at LDT2. The peak of S-
phase occurred at LDT14 with the peak ofG2+M at LDTI8, which accounted for 
approximately 50% of the cell population proceeding through the cell cycle (viewed most 
easily as the minimum in % G 1). Most cells had completed mitosis and returned to G 1 
by LDT22. Since the cultures were not 100% synchronous, some variability in the rate at 
which cultures entered S-phase is evidenced by the variability at the LDTIO time point. 
Transcript abundance of the S-phase genes was next assessed by quantitative PCR 
in five replicate cultures at each time point. There was no significant change in 
expression of any of the S-phase genes over the cell cycle relative to LDT2 (ANOV A, 
p>0.05; Figure 6). In particular, during S-phase (LDTIO-LDT14) expression levels were 
either level or lower than at LDT2, the opposite behavior from that found in most 
eukaryotes. These results are consistent with their post-transcriptional regulation in S-
phase and confirm previous observations in K. brevisfrom in a microarray study (Van 
Dolah et aI., 2007). 
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Abundances of S-phase Proteins Over the K. brevis Cell Cycle 
Given the absence of S-phase specific transcription of these genes, their 
proteinswere next investigated to determine if they are differentially expressed, 
suggesting S-phase specific translation, or if they are constitutively produced and their 
activity is regulated post-translationally. Protein abundances were compared in cultures 
during Gl (LDT2 and LDT6), S-phase (LDTI0 and LDTI4) and G2+M (LDTI8 and 
LDT22) (Figure7). The Western blots shown are representative of five replicate cultures 
at each time point with the mean + S.E.M. of the band intensities normalized to the mean 
intensity at LDT2. Although averaged densitometry of RP Al (Figure7 A) did not indicate 
a significant increase in band intensity, the blots generally showed that a small increase in 
abundance typically appeared around LDTI0-LDT14, with the protein sometimes, but 
not always, largely absent by LDT22. RnR2 (Figure 7B) peaked during S-phase, with 
highest abundance at LDT14 and LDT18. RFC also typically peaked at LDT14 (Figure 
7C), but the levels of RFC late in the ceB cycle varied. In some replicates, RFC remained 
nearly as high late in the cell cycle as at LDT 14, but in others it was nearly absent. 
PCNA (Figure7D and E) showed both increased protein abundance during S-phase and 
an increase in molecular weight of ---9 kDa beginning at LDTI0, with the larger band 
maximally expressed at LDT14 and LDTI8, and both the 28 kDa form and the 37 kDa 
forms largely disappearing at LDT22. 
Since 28 and 37 kDa bands appeared consistently during S-phase in the PCNA 
Western blots, a peptide blocking experiment was performed to ensure that both bands 
were specific to PCNA. Figure8shows that both bands represent specific binding to the 
K. brevis PCNA antibody. Therefore, this larger band may be due to a post-translational 
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modification since the 28 kDa band is the expected size of eukaryotic PCNA and 
detennination of the amino acid sequence on http://expasy.orgltools/pi_ too1.html also 
predicts K. Brevis PCNA to have a mass of approximately 28 kDa. 
Subcellular Localization of PCNA 
The subcellular localization pattern ofPCNA in GI (LDT 2), S-phase (LDTI4) 
and G2+M (LDT18) was examined next to detennine if there was a correlation between 
localization and the appearance of the 37 kDa PCNA band observed by Western blotting. 
Immunofluorescence showed that, unlike most eukaryotic cells, PCNA was present in the 
nucleus at all timepoints investigated, with 53% of the cells staining positive for PCNA 
in G 1 (LDT2). There was an increased percentage of PCNA positive cells (70%) at the 
peak ofS-phase (LDTI4), and 52% remained positive in G2+M at CTl8 (Figure9A). 
Qualitatively, the S-phase cells stained more brightly and showed a distinctive punctate 
pattern of chromatin-associated PCNA suggestive of localization to replication forks 
(Figure 9C), whereas staining in the LDT2 cells was frequently more intense around the 
periphery of the nucleus (LDT2, arrow) and at LDT18 cells staining was more diffuse 
rather than punctate. PCNA was not observed in the cytosol. 
In the experiment above, the cells at LDT2 showed 52% positive for PCNA 
(Figure 9B). What is not clear is whether these represent cells that, although they are in 
G 1 as assessed by flow cytometry, have already passed the restriction point and thus have 
started expressing PCNA. Therefore, to further synchronize the cells in G 1, cultures 
were placed in constant darkness for two and a half light cycles, such that any residual 
cells "primed" to enter the cell cycle would have completed their cycle. The idea was 
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that when the dark-synchronized cells, arrested in G I, are released into light, PCNA-
positive cells would represent only cells proceeding into S-phase unless PCNA is 
constitutively expressed. Flow cytometry of the dark synchronized cells showed that 
approximately 20% of the cell population entered S-phase by LDTI4 following release 
into the light (Figure lOA). Both the total percentage ofPCNA positive cells and the 
percentage of cells with chromatin-associated PCNA increased significantly as cells 
proceeded into S-phase (LDTI4; Figure lOB). The results suggest both that PCNA was 
newly synthesized and that the chromatin association ofPCNA corresponds temporally 




Eukaryotic cell cycle progression is controlled largely by the transcriptional 
and/or post-translational activation of highly conserved protein complexes precisely 
during the cell cycle stage at which they are needed. In humans, yeast, and Arabidopsis, 
several hundreds of genes are differentially transcribed over the cell cycle, yet recent 
comparative analyses reveal that which genes are regulated by transcription or by post-
translational mechanisms varies considerably among eukaryotic lineages (Jensen et aI., 
2006). Thus there is not one universal mechanism for eukaryotic cell cycle regulation. 
Instead, it appears that transcription and post-translational regulation have co-evolved, 
yielding different solutions to achieve the cell cycle dependent activation of orthologous 
protein complexes (Jensen et aI., 2006). Trypanosomes, which lack transcriptional 
control, have evolved yet a different level of regulation, in which differential expression 
of cell cycle genes is achieved post-transcriptionally by increasing the stability of phase-
specific messagesthrough the binding of RNA binding proteins (Archer et aI., 2009). S-
phase genes possess a conserved octameric post-transcriptional control element, 
CA TAGAAG, in either the 5' or 3' UTR that regulates cell cycle-dependent 
accumulation of these mRNAs (Brown and Ray, 1997; Zick et aI., 2005). Since 
dinoflagellates, although evolutionarily distant from trypanosomes, also appear to rely 
largely on SL mediated post-transcriptional regulation of gene expression,we investigated 
whether K. brevis also uses a post-transcriptional solution to S-phase gene expression. In 
the current study, no changes were observed in message abundance of four S-phase 
genes, but increases in their protein expression levels during DNA replication were 
observed, suggesting that in the dinoflagellate regulation of S-phase takes place at the 
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level of translation. It is possible that the absence of observable increases in S-phase 
associated transcript levels reflects the fact that only about 50% of the population was 
proceeding through the cell cycle (Figure 5). However, even when cell cycle synchrony 
of70% (the maximum attained for K. brevis) was achieved whenK. brevis was placed 
under continuous light, there were no changes in any cell cycle transcripts (Van Dolah et 
aI., 2007). 
Three of the genes investigated in this study, PCNA, RFC5, and RPA1, work 
together as components of the replication fork complex that facilitates DNA synthesis, 
while the fourth, RnR2 converts ribonucleotides to deoxyribonucleotide substrates for 
DNA synthesis. Given the coordinated roles of their proteins in DNA synthesis, their 
relative expression levels in the cDNA library revealed some surprising differences. 
Dinoflagellates are well known for gene amplifications, with many genes being present in 
high copy numbers, often in tandem repeat units (Le et aI., 1997; Zhang and Lin, 2003; 
Bertomeu and Morse, 2004; Liu and Hastings, 2006; Bachvaroff and Place, 2008). 
PCNA is a highly amplified gene, present in 41 copies in Pfiesteria (Zhang et aI., 2006). 
In the K. brevis library, 101ESTs assembled into 11 unique contigs, all of which are 
unique from the 9 sequences in GenBank, for a minimum of20 unique PCNA genes in K. 
brevis. RnRI ESTs were similarly highly expressed, with a minimum of 12 unique genes 
represented. In contrast, RnR2, RFC and RPA appear to be low-copy genes and their 
expression levels in the library are similarly low. Although expression ofESTs cannot be 
considered a quantitative measure of relative expression, the sampling of 65,292 ESTs 
should be sufficient that this difference in representation is not random. Such 
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mismatches in expression levels of functionally related genes have previously been noted 
in K. brevis, e.g., 0 a and ~ 0 and tubulin (Lidie et aI., 2005). 
Cell Cycle Dependent Expression 
Replication Protein A 
Replication Protein A, the single strand DNA binding protein that serves to hold 
the replication fork open, is an example of a cell cycle protein whose cell cycle regulation 
differs among eukaryotic lineages. In Saccharomyces cerevisiae, all three subunits are 
differentially transcribed., whereas in Schizosaccharomyces pombe only subunit ssbl 
changes at the transcript level, and only RP A2 is differentially expressed in humans. In 
this study., the behavior of the large subunit ofRPA (RPAl) was investigated, the only 
subunit identified in the K. brevis EST library. The data presented here suggest that the 
RPAI gene has not undergone the extensive gene duplication as seen in PCNA. No 
changes in transcript level were observed. There was no statistically significant change 
in RPAI expression although visual inspection of the Western blots suggests a trend 
toward higher expression during S-phase and minimal expression in mitosis. 
Ribonucleotide Reductase 
The activity of ribonucleotide reductase., a tetramer consisting of two large and 
two small subunits that reduces ribonucleotides to deoxynucleotides., is maximal during 
S-phase in all eukaryotes and in the yeasts, human, and Arabidopsis its activity is 
regulated in part by the S-phase dependent transcription of its large subunit (Trachana et 
aI., 2010). In K. brevis, neither RnRl (Van Dolah et aI., 2007) nor RnR2 (this study) 
show a cell cycle-dependent change in transcript levels. Cell cycle activity of RnR in 
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mammalian cells is further controlled post-translationally by an S-phase specific 
stabilization of the RnR2 subunit lasting until cells pass into mitosis, when it is 
polyubiquitinated for degradation (Chabes et aI., 2003). This stabilization ofRnR2 
ensures a sufficient supply of dNTPs for replication as well as repair during G2 (Chabes 
and Thelander, 2000). In K. brevis, the RnR2 protein was present throughout the cell 
cycle with a significant increase during S phase (LDTI4, p<O.05) and G2 (LDTI8, 
p<O.OI) when normalized to LDT2 (Gl) (Figure7B). In yeast, plant and mouse cells, the 
activity of the RnR2 protein is further modified by an S-phase specific translocation from 
the nucleus to the cytoplasm where it carries out its actions (Zhang et aI., 2006). In K. 
brevis, immunolocalization with the anti-RnR2 antibody showed that this protein was 
pr~sent throughout the cell cycle in the cytoplasm with nuclear staining not evident (data 
not shown). This is similar to the exclusive cytoplasmic location of RnR2 in mouse cells 
(Engstrom and Rozell, 1988). However, unlike the mammalian RnR2, K. brevis RnR2 
presence throughout the cell cycle is similar to what is observed in trypanosomatid, L. 
m.amazonensis(Lye et aI., 1999). 
Replication Factor C 
RFC consists of five subunits that together form the clamp loading protein which 
loads the PCNA homotrimeric ring onto replicating DNA. In yeasts the transcription of 
RFC subunits does not change during the cell cycle, whereas in humans, transcripts of 
RFC2-5 subunits increase during S-phase. In K. brevis, RFC5 transcript levels were 
unchanged while its protein expression, although it did not meet the cut-off for statistical 
significance, appears to increase in S-phase. An increase in RFC during S-phase would 
be expected since the PCNA protein, which RFC binds to and loads onto DNA during 
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replication and repair, changes over the K. brevis cell cycle, with highest abundance 
during S-phase. 
Proliferating Cell Nuclear Antigen 
PCNA, the homotrimeric ring that forms the replication fork sliding clamp is 
another protein that is regulated differently in various eukaryotic lineages. PCNA is 
transcriptionally controlled in budding yeast and humans, but constitutive in fission yeast 
over the cell cycle (Jensen et aI., 2006). In K. brevis, the transcript levels were similarly 
unchanged. In mammals, PCNA protein expression is widely used as a marker of 
actively growing cells because of its S-phase specificity (Elias, 1997). In K. brevis, this 
protein was present throughout the cell cycle, although barely visible during mitosis by 
Western blot. The most notable change in expression was a shift in band size of 
approximately 9 kDa dominating during S-phase. It is possible that the S-phase specific 
37kDa form ofPCNA represents the sequential replacement of the 28 kDa PCNA with a 
larger isoform. However, there is no precedence for this in other organisms and there 
were no such candidates found in the EST library. Alternatively, this shift in molecular 
weight may represent post-translational modification of PCNA. Two candidate modifiers 
arethe small ubiquitin-like modifier (SUMO; 9 kDa) or ubiquitin (8.5 kDa) since both 
modifications to PCNA are known in other eukaryotes. However, total PCNA, both the 
28 kDa and 37 kDa forms, are in low abundance by LDT22 which represents mitosis. 
The presence of these peptides in K. brevis and their possible roles in PCNA modification 
are addressed in Chapter 4. 
The immunolocalization data show that the PCNA protein is localized to the 
nucleus at all phases of the cell cycle, but its distribution within the nucleus changes. 
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Peripheral staining dominated in G 1, while an increase in brightly stained chromatin-
associated PCNA was found in S-phase and corresponds with the time at which there is 
an observed band size shift of PCN A. As the cells entered G 21M, the proportion of cells 
with chromatin-bound PCNA decreased and PCNA at the nuclear periphery increased. It 
may be that as the cell finishes DNA replication, PCNA is sequestered to the nuclear 
envelope for export and ubiquitination-dependent degradation by the 26S proteosome. 
This is consistent with the decreased expression at this time point observed by the 
Western blot. The observed nuclear localization throughout the cell cycle is unusual 
when compared to other eukaryotes, but has been observed in the promastigote stage of 
the trypanosomatid, Leishmania donovani, where PCNA is nuclear throughout the cell 
cycle but has distinct nuclear foci in S-phase, which are thought to be active sites of DNA 
replication (Kumar et aI, 2009). Like K. brevis, the PCNA protein was not found in the 
cytoplasm during any stage of the L. donovani cell cycle. In human cells, PCNA is 
absent in G 1, is present in a pool in the nuclear periphery in early S-phase and has a more 
nucleoplasmic pool ofPCNA later in S-phase (Essers et aI., 2005). However, it is not 
currently known if this change in localization is regulated by its post-translational 
modification. 
CONCLUSIONS 
Although dinoflagellates possess conserved cell cycle proteins present in all 
eukaryotes, they have many unusual cell cycle characteristics that suggest some aspects 
of their cell cycle regulation may differ from the established eukaryotic models. In 
particular, the presence of the spliced leader on K. brevis gene transcripts suggests post-
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transcriptional gene regulation. This study demonstrated that S-phase genes classically 
regulated at the level of transcription, appear to be under post-transcriptional control in K. 
brevis. Among the four S-phase genes studied, there was no evidence for transcriptional 
activation during S-phase. Nonetheless, their protein products had maximal expression 
levels during S-phase and, in the case of PCNA, a prominent apparent post-translational 
modification specific to S-phase. 
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Figure I: Multiple Alignments of the amino acid sequences of S-phase proteins. (A) 
Proliferating Cell Nuclear Antigen, black bar indicates the location of the peptide used to 
develop the anti-PCNA antibody used for immunolocalization and the red bar shows the 
peptide used to develop the anti-PCNA antibody used for Western blotting. (B) 
Replication Protein A, large subunit. Black bar indicates the location of the peptide used 
to develop the anti-RPA antibody used for Western blotting. (C) Replication Factor C, 
subunit 3 (D) Replication Factor C, subunit 5. Black bar indicates the location of the 
peptide used to develop the anti-RFC5 antibody used for Western blotting. (E) 
Ribonucleotide Reductase I and (F) Ribonucleotide Reductase 2, boxed region shows the 
highly conserved region in RnR2 to which the peptide antibody used in this study was 
developed against in human RnR2.No antibodies were developed for RFC3 or RnRI. 
Alignments include the eukaryotes Karenia brevis, Trypanosoma brucei, 
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RLLVTL GCERTYKAE1IPFDlfIm F I SL QGKTUFFEKRVGEYQ 
RLLVAF r11KKYYKVE1IPFDFUEIH S GKTlIFFEKRVSDYQ 
Figure 2: Phylogenetic (Neighbor-joining) tree of PCNA amino acid sequences with 
percent bootstrap support. Inset: dinoflagellates and kinetoplastids. 
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Zea mays1 PCNA 
Zea mays2 PCNA 
Oryza sativa PCNA 
Arabidopsis Q9M7Q7 PCNA 1 




Daucus carota PCNA 
Nicotiana benthamiana PCNA 
P . satiwm PCNA 
CA TRO PCNA (CYCLlN) 
periwinkle PCNA 
GI cine max PCNA 







Homo sapiens PCNA 
Rattus non.egicus PCNA 
Sus sc rofa PCNA 
'----- Mus musculus PCNA 
Danio rerio PCNA 
Xenopus lae'vis PCNA 
Bombus mori PCNA 
SuI. frugiperda PCNA 
Drosophila melanogaster PCNA 
S . crassipalpis PCNA 
Aedes aegypti PCNA 
,----- Aureococcus anophagefferens PCNA 
11 
8 9 
Ditylum brightwellii PCNA 
Skeletonema costatum PCNA 
Prorocentrum minimum PCNA 
Rhodomonas sp. CCMP768 PCNA 
Dunaliella tertiolecta PCNA 
C 160098 Chlamydomonas reinhrdtii PCNA 
Saccharomyc es cere'visiae PCNA 
Tetrahymena thermophila PCNA 
C . elegans PCNA 
Schizosaccharomyces pombe PCNA 
A . fumigatus PCNA 
Trypanosoma brucei TREU927 PCNA 
T.cruz i strain PCNA 
putatil.e Leishmania PCNA 
Pfiesteria piscicida PCNA 
Pyrocystis lunula PCNA 
Guillardia theta PCNA 
Plasmodium falciparum 3D7 PCNA 
,----- Ferroplasma acidarmanus PCNA 
Methanoculleus marisnigri PCNA 
Methanosarcina mazei PCNA 
Archaeoglobus fulgidus PCNA Chain A 
Sulfolobus tokodaii PCNA Chain D 
Sulfurisphaera ohwakuensis PCNA 
Pyrobaculum aerophilum PCNA 
Aeropyrum pemix PCNA 
Thermofilum pendens Hrk PCNA 
Thermococcus fumicolans PCNA 
62 Tkodakarensis KOD1 PCNA 
1-. ______ +-_________________ P .furiosus PCNA 
1-. _______ -+ _________________ Pyrococcus horikoshii 013 PCNA 
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Higher plants, 




Trypanosoma brucei TREU927 PCN 
T.cruzi strain PCNA 
putati-.e Leishmania PCNA 
Pfiesteria piscicida PCNA 
Pyrocystis lunula PCNA 
Karlodinium micrum PCNA 








Figure 3: Three-dimensional protein models of K. brevis PCNA monomer (top 2 panels). 
Top left panel shows where the peptide is located that was used for antibody development 
and subsequent immunolocalization studies. Top right model shows the L-A-P-K 
binding domain where PCNA binds to RFC. Bottom: trimeric Archaeabacterial (left) and 
yeast PCNA (right). 
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AGGCTCACCTGCAACAGGCTGTCCTCC TGAAGAAGGTTGTAGATGCCATGAAGGATCTTTGTAAAGAGGTGAACTTCGATTGTAGTGAGAAGGGTTTGCA 
ATGCCATGAAGGATCTTTGCAAAGAGGTGAACTTTGATTGCAGTGAGAAGGGCTTGCAGGTCCAGTCCATGGACAGCTCTCATGTT GCC TT GGTCGCCC T 
TTGTAGATGCCATGAAGGATCTTTGCAAAGAGGTGAACTT CGATTGTAGTGAGAAGGGCTTGCAGGTCCAGTCCATGGACAGCTCTCATGTGGCCTTGGT 
TGGATAAGCACCGCCCGAAGTCGCTT GATGAGATGGACTACCATCATGATCTTTCGGCACGGTTGAAGAAGTT GGCAGCC CAGGGCAATCAGCCACATAT 
~TGTCAGGT CCATTTATGCCAATTGCCGAGCTTTCCACCTACCGAACAAAGTGGACAATCAAGGGT CGT GTGACAAACAAGGGACCTCTGCGCACAT 
~CCGGACAGATGTACGT~GTCAAACGCGATGGCAGGCACCAGGAGGTGCGC TT CGACAGCATTACGAAGCGAATCCAGACGCTTTGCGATGGACTTG 
Figure 4: Spliced leader sequences on S-phase transcripts. Outlined are the spliced leader 
sequences on the 5' end of each representative transcript and the start codon (ATG) 
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Figure 5: Flow cytometry data showing the percent of the cell population proceeding 
through the cell cycle, which is phased to the diel, or light/dark, cycle (n=5 replicate 















Figure 6: Gene expression results for PCNA, RFC, RP A and RnR2 in K. brevis. The 
four S-phase transcripts showed no significant change over the cell cycle. LD time is on 
the x -axis and the log2 of the ratio of expression of each gene relative to its expression at 
LDT2 is on the y-axis(log2 ratio= C-E, where C is the control cycle threshold and E is the 
experimental cycle threshold). Significance was determined using a one-way ANOV A 
(PCNA, p=0.943; RFC, p=0.7943; RPA, p=0.8916; and RnR, p=0.8321). 
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Figure 7: Western blot analysis of the RP AI , RnR2, RFC5 and PCNA proteins over the 
cell cycle. Densitometry of the replicates (n=5) over time is shown in the graph below 
each blot. A representative blot is shown for each protein is shown. Changes in band 
density over time relative to LDT2 is shown in the graph below each blot (n=5 
replicates). RnR2 (B) and PCNA [both the 28 kDa (D) and 37 kDa forms (E)] were 
shown to significantly change over the cell cycle (ANOV A, p<0.05). RP Al (A) and 
RFC5 (C) did not meet statistical cutoffs, but did appear to increase in S-phase when 
observed visually. (F) Total combined PCNA protein did not significantly change over 
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Figure 8: Peptide competition assay of anti-K. brevis PCNA demonstrating that both the 
28kDa and the 37kDa band are specific to the anti-K. brevis PCNA antibody. Protein 
lysates tested were obtained during two S-phase time points (LDT10 and 14). 
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Figure 9: Immunolocalization ofPCNA (A) Representative labeling patterns observed in 
Gl, S, and G2/M cells probed with anti-PCNA and a FITC-Iabeled secondary antibody 
(green) (i-iii); overlay of FITC with DAPI stained nuclei (blue), where bright blue nuclei 
are negative for PCNA (v-vii). Negative controls probed with peptide blocked anti-PCNA 
and FITC-Iabeled secondary antibody (iv, viii). Numbers in parenthesis represent the % 
of PCNA positive cells counted in triplicate fields of a minimum of 100 cells each. n = 
nucleus, c = cytoplasm and p = periphery of the nucleus. (B) Flow cytometric cell cycle 
distribution of cells observed in A. (C) Enlarged image of an S-phase cell showing 
punctuate staining suggesting chromatin association of PCNA; inset DAPI overlay of the 
same cell. 
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C. Chromatin Association of PCNA 
52.50/0 
Figure 10: (A) Flow cytometry data showing the percent of the cell population entering 
the cell cycle when released into light after an extended dark phase during log phase. (8) 
Percent of cells positively stained for the PCNA protein that are chromatin associated or 
at the nuclear periphery. 
r 
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Table 1: Primers used for qPCR and SL - gene specific peR for identification of the 
presence of the 5' spliced leader sequence. 
Gene Forward primer 51-3 1 Reverse primer 51-31 Top hit GenBank Accession number 
PCNA ~CTTGAGGCTCACCTGCAAC GCAAGCCCTTCTCACTACAA EU078559(K.brev~) 
RPAl ~GCCAGCATTGACGCCATA GGTGCTGTGAAGCTGGTGATGA XP_002786176 
RFC ~AGGAAACAAGGACCGGGCAGT CGCCAGCATCCTCAATGACAAC EEY69117 
RnRl ~AGGCAACAGTATTCTTGT ~CAGATGTACGTGGTCAAA XP_002785979 
RnR2 ~CAAGAGGCGGTCAGCTACAAACT ~GTGGATGTGGAGCGGAAGTTCAT XP 002773236 
~Iiced Leader ~CCGTAGCCATTTTGGCTC 
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Table 2: Peptides used for antibody development. The ribonucleotide reductase 2 (RnR2) 
antibody is a commercially available peptide antibody developed against the human 
RnR2 amino acid sequence. 
Protein Peptide 
PCNA (Westen blot) NVM LKPRESEKPEEKVTLT 
PCNA (lmmunolocalization) DRIADFDLKLMQIESEH 
RFC GRAVYQSTGVPQPEDID 
RPA N LLKKPSEYSNGG R RAALH R 
RnR2 QIAMENIHSE 
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Table 3: Prevalence and diversity of selected S-phase specific genes represented in the K. 
brevis library. 
Unique Unique GenBank GenBank Non-alveolate 
ESTs Contigs Proteins Organism Top Hit Top E-value Organism Top Hit E-value 
PCNA 109 16 9 Karenia mikimotoi 1. 13E-141 Daucus carota 3.00E-64 
replication factor C I subunit3 1 1 1 Xenopus laevis 4.00E-76 Xenopus laevis 4.00E-76 
replication factor c, subunit 5 7 2 1 Phytophthora infestans 3.00E-87 Thalassiosira pseudonana 1.00E-80 
replication protein A, large subunit 30 3 2 Perkensis marinus 8.00E-71 Arabidapsis thaliana 9.00E-58 
ribonucleotide reductase, large subunit 54 12 3 Perkensis marinus 1. 17E-165 Ectocarpus silicolosus 1.00E-161 
ribonucleotide reductase, small subunit 2 1 1 Perkensis marinus 1.20E-129 Trypanosoma brucei 3.00E-128 
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Chapter 4: S-phase Expression of PCNA: Possible Post-translational Modifications, 
CDK Dependence, and its Potential Utility as a Biomarker of Growth Status in 
Karenia brevisRed Tides 
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INTRODUCTION 
Proliferating cell nuclear antigen (PCNA) is involved in many essential cellular 
processes. These include DNA replication, DNA damage repair, chromatin structure 
maintenance, chromosome segregation and cell-cycle progression (Stoimenov and 
Helleday, 2009). PCNA was originally detected as an antigen for autoimmune disease in 
systemic lupus erythematosus patients, detected only in the proliferating cell populations 
(Miyachi et aI., 1978). Since then it has also been used as a biomarker for actively 
dividing cancer cell populations. The crucial involvement ofPCNA in cellular 
proliferation and its tight association with cancer transformation has resulted in the 
frequent use ofPCNA not only as a diagnostic marker butas a prognostic cell cycle 
marker (Elias, 1997). Due to its usefulness as a biomarker for proliferation in 
mammalian systems, PCNA has received wide attention in other biological systems. In 
the causative malaria parasite Plasmodiumfalciparum, an organism that has 5 
developmental stages, PCNA expression is tightly regulated during the intraerythrocytic 
development; early, uninucleate ring stages (G 1 phase) contain little PCNA mRNA or 
protein and PCNA induction is first detected in the late ring stage and is maximally 
expressed in trophozoites (Kilbey et aI., 1993). This progression correlates with the onset 
of parasite DNA replication in the intraerythrocytic cycle. Following this logic, PCNA 
proteins have been identified in phytoplankton with the interest in their potential as in situ 
growth rate markers, including green algae (Dunelliela salina) and bloom forming 
dinoflagellates, including Crypthecodinium conhii, Amphidinium carterae and 
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Gymnodinium catenatum (Leveson and Wong, 1999) as well as in Prorocentrum 
donghaiense (Liu et aI., 2005) and P. piscicida (Zhang et aI., 2006). When PCNA 
expression was investigated over the growth curve in P. donghaiense, it remained at a 
comparatively high level during exponential growth and decreased during late stationary 
phase (Liu et aI., 2005). Similarly, in the green alga D. salina, PCNA protein abundance 
was low at the beginning of growth in lab cultures and peaked during exponential growth 
and was hardly detected in late stationary phase. However, in P. piscicida, the abundance 
ofPCNA changed only about two-fold between log and stationary phase, making it of 
little value as a quantitative marker of growth (Zhang et aI, 2006). An ideal biomarker for 
growth status of a cell population is absent in non-growing conditions but abundant in 
actively growing cells. In Chapter 3 we found a significant increase in the size ofPCNA 
from 28 to 37 kDa and abundant expression of the 37 kDa form only during S-phase in K. 
brevis. Theseproperties suggest it may be a useful biomarker for bloom growth. 
However, Chapter 3 also identified some unusual phenomena that warrant further 
investigation to better understand the regulation of PCNA in the dinoflagellate. First, we 
found PCNA transcript levels unchanged over the cell cycle, despite an S-phase specific 
increase in protein expression. Since PCNA expression is typically activated by CDK-
dependent transcription factors, this suggests an unusual regulation of the G I/S 
checkpoint. Second, the identity of the ~37 kDa protein remains in question. With no 
precedent for a larger form ofPCNA dominating during S-phase in any species studied to 
date and no evidence for a longer PCNA sequence in the K. brevis EST library, we 
hypothesized that this shift represents a post-translational modification. However, no 
post-translational modifications have been described in dinoflagellates to date. The 
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studies in Chapter 4 therefore address three questions that further our understanding of 
the S-phase specific expression ofPCNA in the dinoflagellate: 
(1) Does the S-phase specific change in PCNA molecular weight result from post-
translational modification, and if so, what is the post-translational modification of 
PCNA during S-phase? 
(2) What CDKs are present in K. brevis and what is the dependence ofPCNA 
protein abundance on CDK activity at the G l/S transition? 
(3) Does the S-phase specific form ofPCNA have utility as a biomarker for 
growth rate in K. brevis? 
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METHODS 
Analysis of Post-Translational Modification Proteins and eyelin-Dependent Kinases 
Sequences with significant homology (BLASTx E-value < 10-04) to genes 
involved in post-translational modifications, specifically ubiquitination and sumoylation, 
and cyclin-dependent kinases (CDKs) were identified from theK. brevis expressed 
sequence tag (EST) database housed at NOAA CCEHBR. Annotation of contigs and 
gene ontology analysis were performed in Blast2Go. 
In silico translationsof the full open reading frames of K. brevis SUMO, ubiquitin 
and CDKs were performed using BioEdit software. To obtain the predicted theoretical 
molecular weight of SUMO and ubiquitin, the amino acid sequences were analyzed using 
the Compute pIlMw tool on the ExP ASy Proteomics server 
(http://expasy.org/tools/pi tool.html). For multiple alignments of each protein sequence, 
the amino acid sequences from other eukaryotes were obtained from GenBank. Species 
used for the analysis of SUMO included: Pfiesteria piscicida, Phaeodactylum 
tricornutum, Homo sapiens, Schizosaccharomyces pombe, Arabidopsis thaliana, 
Chlamydomonas reinhardtii, andSaccharomyces cerevisiae; and for Ubiquitin included: 
Plasmodium jalciparum,H omo sapiens, Schizosaccharomyces pombe,Arabidops is 
thaliana, and Chlamydomonas reinhardtii, to include representatives across multiple 
phyla. Sequences used for CDKs includedPlasmodiumfalciparum CDK7, 
Arabidopsisthaliana CDK C, and Chlamydomonasreinhardtii CDK. Once imported into 
BioEdit software, multiple alignments of the species were done using the ClustalW 
Multiple Alignment application. 
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To determine sites of lysine modification by SUMO and ubiquitin on the K. brevis 
PCNA, a bioinformatic approach was used. The full length K. brevis PCNA amino acid 
sequence was uploaded into the SUMOsp 2.0 sumoylation site prediction program 
(http://sumosp.biocuckoo.org/prediction.php, Ren et aI., 2009). Similarly, the K. brevis 
PCNA amino acid sequence was submitted to UbPred, a predictor of protein 
ubiquitination sites (http://ubpred.org/ , Radivojac et aI., 2010). 
Cultures and Culturing Conditions 
K. brevis (Wilson isolate) was grown in 0.22 Jlm filtered seawater (36%0) obtained 
from the seawater system at the Florida Institute of Technology field station, Vero Beach, 
Florida, enriched withjl2 nutrients (Guillard, 1973), modified with the use of ferric 
sequestrene in place ofEDTA' Na2 and FeCb' 6H20 and the addition of O.OlflM selenous 
acid. Cultures were maintained in 1 liter glass bottles at 25°C + 1°C with a 16:8 
light:dark cycle, and cool white light at 50-60 flmol photons m-2 sec-I, determined using a 
LI-COR LI-250 Light Meter (LI-COR BioSciences, Lincoln, NE). Cell counts for 
growth curve analysis and division rate per day calculations were determined on a 
Multisizer 3™ Coulter Counter (Beckman Coulter, Inc., Brea, CA). 
Cyclin Dependent Kinase Inhibitor Experiments 
Flask cultures containing 125mL of K. brevis were grown to mid-log phase (Day 
6). On Day 6, cyclin dependent kinase inhibitors and carrier controls (fascaplysin/water, 
olomoucine/DMSO) were added just before LDTO (lights-on). Olomoucine was chosen 
as an inhibitor for the CDKI studies since this compound has broad CDK specificity and 
has been shown to block K. brevis in G 1 as well as mitosis (Van Dolah and Leighfield, 
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1999). Fascaplysin was chosen for its specificity to the G liS-phase transition CDK, 
CDK4. Carrier controls of the same volume were added to cell cultures for the duration 
of experiments (fascaplysin is soluble in water and olomoucine in DMSO). Structures of 
these compounds are shown in Figure 1. A series of range finding studies was carried out 
for each compound in order to optimize cell viability and the effectiveness of each 
compound to block the cell cycle prior to S-phase. Concentrations of fascaplysin that 
were tested included 10, 5, 2.5, 1.5, 1, and 0.75 J..lM; and olomoucine concentrations 
tested included 100, 50, 25, 12.5, and 6.25 J..lM. 
Five independent replicate cultures were sampled for each treatment. To ensure 
CDK inhibitor was not just poisoning the cells, viability was assessed at LDT12 (mid-S-
phase) using SYTOX (Molecular Probes, Invitrogen) staining after 12 hours of exposure 
to inhibitor or carrier control (Figure 2). Fifty J..lL of 5J..lM SYTOX were added to 5mL of 
K. brevis culture. Cells were incubated for 15 min. at room temperature followed by 
addition of 200J..lL of 50% gluteraldehyde for fixation and incubated for 5 min. Cells 
were centrifuged for 3 min. at 600 x g and placed on a microscope slide for enumeration 
under an Olympus Fluorescent microscope within 10 minutes. One hundred cells were 
counted to a get a percentage of cell viability. Fifteen milliliters of culture were fixed for 
flow cytometric analysis and the remaining cell culture (~100mL) was centrifuged at 600 
x g for 10 min. Protein was then extracted from the cell pellets for western blot analysis 
using TriReagent following the manufacturer's protocol. 
PCNA Expression Pattern in Flask Cultures over the Cell Cycle 
K. brevis cultures in 125mL flasks were grown to mid log phase (Day6). Four 
biological replicates were sampled at each time point every 2 hours over the course of S-
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phase and LDT2 samples (Gl) were taken to compare with the S-phase samples. S-phase 
time points included LDTI0, 12, 14, 16 and 18. Flow cytometry samples were taken 
from each culture at each time point for cell cycle analysis. The remaining culture was 
centrifuged for 10 min. at 600 x g to pellet the cells for protein extraction using 
TriReagent. Proteins were then used for analysis ofPCNA throughout S-phase by 
western blotting. 
Growth Rate Studies: Log vs. Stationary Phase Experiments 
Five replicate 125 mL flask cultures of K. brevis were grown to mid-log phase 
(Day 6), late log phase (Day 8 and Day 10), early stationary phase (D12) and stationary 
phase (D14) and sampled on the indicated days. Two mL samples were taken on Days 1, 
3, 5 and the day of sampling mentioned above (Day 6, 8, 10, 12 and 14) for all cultures in 
order to construct a growth curve and to calculate divisions rate. Cells were harvested for 
protein extractions at LDT12 (mid-S-phase) on each sampling day and a 15mL aliquot 
was taken for flow cytometric analysis. The remaining culture (---100mL) was 
centrifuged at 600 x g for 10 min. Protein was then extracted from the cell pellets for 
western blot analysis using TriReagent following the manufacturer's protocol. 
For analysis ofPCNA expression under different growth rates, 125mL flask 
cultures were grown at light intensity of 70 f,lE/m2/s to mid-log phase (Day 6, n=5) or 
stationary phase (Day 12, n=5). To obtain log phase cells with lower growth rates, 
another set of flasks were wrapped in "neutral density" mesh filters which attenuate the 
amount of light the cultures receive to 31 f,lE/m2/s (Day 6, n=4). All cultures were 
sampled at LDTI2, which corresponds to mid-S-phase, on the appropriate sampling day. 
Cell counts were obtained every other day during the course of the study in order produce 
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a growth curve and to calculate growth rate. The equation K'== In (n2/nl)/(t2-tl) was used 
to detennine growth rate, where fil and n2 are cell counts at the time points tl and t2. 
Divisions per day were then calculated by using the equation K'/ln2. Proteins were 
extracted and Western blotting (see below) was carried out with anti-K. brevis PCNA 
antibody_ Flow cytometric analysis was performed on 10mL of culture as described 
below in order to correlate PCNA band intensity with the percentage of cells in S-phase 
at LDT12. A linear correlation analysis in GraphPad Prism 4 software was used to 
determine the relationship between growth rate and PCNA abundance. 
Cell Cycle Analysis 
Ten milliliters of culture were collected from each 1 L biological replicate culture 
(n==5) at each time point. Cells were fixed in 2% gluteraldehyde by adding 50% 
gluteraldehyde directly to culture medium containing cells and stored at 4°C for at least 
12 hours. Cells were then centrifuged at 1750 x g to remove fixative and growth 
medium. To extract cellular pigments, cells were stored in -20De methanol for a 
minimum of 4 hours, centrifuged at 1000 x g and methanol was removed. The cells were 
then stained with 10 Jlg/mL propidium iodide (final concentration) in phosphate buffered 
saline (PBS) containing 10 mg/mL RNase and 0.5% Tween 20. DNA analysis was 
performed on an Epics MXL4 flow cytometer (Beckman Coulter, Miami, FL) using a 5 
W argon laser with a 488 nm excitation wavelength and 635 nrn emission wavelength. 
Multicycle software (Phoenix Flow Systems, San Diego, CA) was used to obtain the 
percentages of cells in each stage of the cell cycle. 
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Protein Extraction and Western blotting 
Protein was extracted from the experimental samples using TriReagent following 
the manufacturer's protocol. A Bradford protein assay (Bradford, 1976) was used to 
quantify protein concentration using the Bio-Rad Protein Assay Dye Reagent (Bio-Rad, 
Hercules, CA, USA). For western blotting, 10 Jlg of protein extract were loaded on a 4-
12% Bis-Tris gradient gel (Invitrogen Corporation, Carlsbad, CA). For the SUMO 
experiments, a human recombinant SUMO 1 protein was used as a positive control. This 
recombinant protein was a gift from Dr. Tilman Heise (Dept. of Biochemistry, MUSC). 
Proteins were then transferred to a 0.2 Jlm polyvinylidene fluoride (PVDF) membrane 
using the Invitrogen iBlot system (Invitrogen Corporation, Carlsbad, CA). The PVDF 
membrane was then blocked in 5% non-fat milk in Tris buffered saline (TBS) with 0.1 % 
Tween 20 for 1 hour at room temperature. Membranes were then incubated in primary 
antibodies overnight at 4°C.The anti-KbPCNA antibody developed against translated K. 
brevis was used at 1 :5000in TBS with 0.1 % Tween 20 and 5% non-fat milk. Commercial 
antibodies were used for the detection of SUMO at 1: 1000 (Rockland Immunochemicals, 
Inc., Gilbertsville, P A) and ubiquitin at 1: 1000 (Enzo Life Sciences, Inc., Plymouth 
Meeting, PA) in TBS with 0.1 % Tween 20 and 5% non-fat milk. Membranes were 
washed 3 x 10 minutes in TBS with 0.1 % Tween 20. Horseradish peroxidase-linked 
donkey anti-rabbit Ig was then incubated with the PVDF membrane at 1 :2000 for PCNA 
and SUMO or 1 :5000 for ubiquitin, in TBS with 0.1 % Tween20 for 1 hour at room 
temperature. After rinsing membranes in TBS with 0.1 % Tween 20 (2 x 10 minutes) and 
TBS (Ix 10 minutes), the Pierce ECL Super Signal West Pico Kit (Pierce, Rockford, IL) 
was used for detection. Membranes were exposed to film (Pierce CL-XPosure Film, 
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Thermo Scientific, Rockford, IL) and developed for visualization. Densitometry of the 
bands of the biological replicates (n=5) was carried out using Alpha Innotech (San 
Leandro, CA) FluorChem 8900 software. Significant differences were determined with a 
one-way ANOV A using GraphPad Prism 4 software (La Jolla, CA). 
Peptide Competition Assay 
Ten micrograms of protein extract from stationary phase cells at the time 
corresponding to S-phase (Day 12 and 14, LDT 12) were used for the PCNA peptide 
competition experiment. The anti-K. brevis PCNA antibody (1 :5000 or 3.6J.lg) was 
incubated with 100X peptide (360J.lg of peptide), to which the antibody was developed, in 
TBS with 0.1 % Tween 20 and 5% milk for 1 hour at 4°C. The experimental membrane 
was incubated overnight at 4 °C with the peptide blocked anti-PCNA. The control blot 
was incubated overnight at 4°C in the anti-K. brevisPCNA antibody at 1 :5000 in TBS 
with 0.1 % Tween20 and 5% non-fat milk. Western blot procedures were followed as 
described above. 
Immunoprecipitation 
Cells were harvested during S-phase (LDT12-14) and proteins were extracted 
using TriReagent following the manufacturer's protocol. Protein pellets were solubilized 
in 200 J.lL DIGE buffer (7M urea, 2M thiourea, 4% w/v. CHAPS, 30 mM Tris, pH 8.5). 
Two micrograms of antibody (anti-PCNA, anti-Ubiquitin or anti-SUMO) were added to 
the protein lysate and incubated at 4°C for 1 hour with rotation. Ten microliters of 
Protein AlG PLUS-Agarose beads (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) 
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were then added to the protein lysate/antibody mixture and incubated at 4°C overnight 
with rotation. Immunoprecipitates were collected by centrifugation at 1000 x g for 5 min. 
at 4°C. Supernatant was aspirated and discarded. Immunoprecipitates were washed 4 
times with PBS repeating the above centrifugation step for 5 min at 4°C. After the final 
wash, supernatant was aspirated and discarded and the pellet was resuspended in 40~L of 
IX LDS electrophoresis loading buffer (Invitrogen, Carlsbad, CA). Samples were boiled 
for 3 min. to remove agarose beads from the immunoprecipitate and centrifuged at 2500 
x g for 5 min. at 4°C. Three microliters of reducing agent were then added to 30~L of the 
sample and loaded onto 4-12% acrylimide gels for analysis by western blotting. 
Stripping of Western Blots 
To reprobe blots with a different antibody than had previously been used, a 
stripping protocol was used as follows. Stripping buffer was prepared using 0.93g of 
Tris-HCI, 2g of sodium dodecyl sulfate, 20 ~L of J3-mercaptoethanolbrought up to 
100mLs and adjusted to pH 6.7. Stripping buffer was warmed to 40°C. The blot to be 
reused was then incubated in buffer, rotating at 40°C for 20 min. The blot was then 
washed 4 times in phosphate buffered saline for 20 minutes each. The blot was then 
washed in 5% non-fat dry milk in Tris buffered saline with 0.1 % Tween-20 two times for 
20 minutes each. The new primary antibody for analysis was then added and incubated 
following the optimized procedure. 
129 
RESULTS 
Possible Post-translational Modifications of PCNA 
The presence of multiple forms of the PCNA protein observed in Chapter 3 led to 
further investigation of possible post-translational modifications ofPCNA in K. brevis. 
PCNA in eukaryotes that have been studied is known to be both sumoylated and 
ubiquitinated on lysine residues. Sequences with homology to the sumo and ubiquitin 
polypeptides are present in the K. brevis EST library. Multiple alignments of both K. 
brevis sequences with other eukaryotes show that they are highly conserved and possess 
the G-G motif which binds to the lysine of the modified protein and is present in these 
polypeptides across phyla (Figure 1). K. brevis ubiquitin has high homology to known 
ubiquitin sequences (BLASTx E value 10-33) andthe K. brevis SUMO sequence shows 
high conservation as well (BLASTx E value 10-38). Amino acid sequence analysis using 
the ExPASy compute pI/Mw tool predicts the K. brevis ubiquitin to code for a 
polypeptide of8.5kDa and sumo for 9kDa. Sequence analysis of the PCNA amino acid 
sequence using the ubiquitin prediction program UbPred, predicted that K184, K190, and 
K194 are ubiquitinated with medium confidence (Figure 2)based on the eight known 
ubiquitin binding domains that range from 20-150 amino acids in length (French et aI., 
2005). Sequence analysis of K. brevis PCNA using SUMOsp, a sumoylation prediction 
program, predicted that K190 is sumoylated with medium stringency (Figure 2). This 
was determined to be a Type II non-consensus motif (ESEKPEE). Other organisms with 
K190 ofPCNA predicted to be sumoylated include H sapiens and C. reinhardtii. Lysine 
238 of K. brevis PCNA was also predicted to be sumoylated with high stringency. This 
site (VKYE) was determined to be a Type I consensus site (\f-K-X-E) where \f is A, I, L, 
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M, P, F,or V and X is any amino acid residue. Lysine 164 of K. brevis PCNA was not 
identified as a possible modification site by ubiquitin and SUMO, which has been shown 
in S. cerevisiae to be the site of modification. 
Ubiquitin and SUMO are Expressed in K. brevis 
The presence of ESTs with homology to ubiquitin and SUMO in the K. brevis 
library and their predicted interactions with K. brevis PCNA identify these proteins as 
candidates for the post-translational modification of PCNA in S-phase. Numerous ESTs 
with homology to members of the ubiquitin pathway have been identified in K. brevis, 
including 133 sequences listed in Appendix 2. Commercial antibodies were found to 
have specificity to both polypeptides in K. brevis (Figure 3). The anti-ubiquitin antibody 
recognizes multiple bands in K. brevis protein lysates at all points in the cell cycle, as 
expected if it is used to modify other protein substrates. However, a short exposure of 5 
seconds of the western blot to film shows a band at ---6kDa, a band at r-.J 14kDa and a 
higher molecular weight band at ---55 kDa (Figure 3A). The last two lanes of this gel are 
samples from LDT16 and 18, respectively. The differential pattern may be different in 
these 2 samples due to the fact that the cell population is in the last part of S-phase, or it 
might reflect dark-phase specific protein modification, as these time points occur in the 
dark. The anti-sumo antibody recognizes the sumo polypeptide in K. brevis, shown to 
run at ---I 7kDa. This antibody also recognized the human recombinant proteins used as 
positive controls (Figure 3B). 
Immunoprecipitation of PCNA 
In an effort to identify if the 37 kDa band observed during S-phase represents 
ubiquitin or SUMO modification ofPCNA, PCNA was immunoprecipitated from S-
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phase cells and Western blot analysis was performed using the same PCNA antibody. 
The anti- K. brevis PCNA antibody immunoprecipitated four prominent forms of the 
PCNA protein (Figure 4). These included the 28 and ~37 kDa forms that were reported 
in Chapter 3 experiments over the K. brevis cell cycle and the growth curve. Additional 
bands were detected at ~47 kDa and 62kDa. In order to test whether any of these bands 
represented a sumoylated form of PCNA, which would be expected to occur most 
prominently during S-phase, once again PCNA was immunoprecipitated from S-phase 
cells and subsequently probed with anti-SUMO. This experiment showed that a 
sumoylated form ofPCNA at ---47kDa (Figure 5A). In order to determine whether this 
band represents sumoylated PCNA, this blot was stripped of the sumo primary antibody 
and the HRP-conjugated secondary antibody and reprobed with anti-PCNA. Indeed, this 
band was present; however the 28kDa was not present in this immunoprecipitate (Figure 
5B), leaving its interpretation open to question. 
If the 37 kDa band is a sumoylated form and limited to S-phase, we might expect 
its expression to decrease as cells proceed through the growth curve from log to 
stationary phase, where growth is diminished. Therefore, cultures of K. brevis (125mL 
flasks) were sampled in quadruplicate during mid-S-phase at LDT12 on Day 6, 8, 10, 12 
and 14, representing mid-log phase, late log phase, early stationary phase, stationary 
phase and late stationary phase, respectively (Figure 6A). Flow cytometry shows that on 
Day 6 at LDTI2, 60% of the cell population was in S-phase with 30% in S-phase on Day 
8, 11 % on Dayl0, 6% on Day 12 and 0% on Day14 (Figure 6B). On Day 14, only one 
culture was still alive and had high cell abundance. However, since the four other 
cultures on Day 14 were either dead or had low cell abundance, these samples were not 
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used for PCNA western blot analysis. Western blot data shows that the ---37kDa PCNA is 
present during S-phase in log phase cultures and decreases repeatably as cells approach 
stationary phase (Days 6 through 10) (Figure 7 A). In early stationary phase (D 1 0), 
PCNA is barely present. Unexpectedly, a prominent PCNA band at ""-J47kDa appears on 
some, but not all, Day 12 cultures. Given that on Day 14 these cultures began to decline, 
the presence of this 47 kDa band in some may indicate a tipping point, where some 
cultures are beginning to decline and others are not yet there. Densitometry of these 
proteins is shown in Figures 7B and C. Although there was no significant difference 
using a one-way ANOV A, there is a clear, repeatable trend over the growth curve for 
both forms of PCNA. The lack of significance may he due to the high variability with 
which K. brevis culture enter stationary phase. 
These results prompted a confirmatory study in which we compared the 
expression ofPCNA at LDT12 in log phase and stationary phase, 5 replicates each in 125 
mL flasks. In the log phase cultures at LDTI2, the ---37kDa PCNA protein is present in 
all replicates (Figure 8A). Flow cytometry data shows that 41.1-64.5% of the log phase 
cell population was in S-phase at LDT12 when sampling occurred (Figure 8A). In the 
stationary phase replicates, the ---37kDa PCNA is barely present in one replicate and 
absent from all others replicates (Figure 8B). In 3 of the 5 samples, the ---47 kDa hand 
wasprominent. Flow cytometry shows that the stationary phase cultures have only 0-
8.9% of the cell population proceeding through S-phase (Figure 8B). 
The presence ofa 47 kDa version ofPCNA was unexpected and warranted 
confirmation of its specificity. Therefore, we carried out a peptide competition assay to 
confirm that it is in fact PCNA. Figure 8C shows both the 47 kDa band and the 37 kDa 
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form ofPCNA are present. The antibody specificity is blocked with a 100-fold excess of 
peptide antigen. Given that it appears only in cultures that appear to be on the cusp of 
dying, we hypothesized that this band might represent a ubiquitinated form ofPCNA. To 
address this question, immunoprecipitation was carried out using the PCNA antibody and 
Western analysis with the anti-ubiquitin antibody. Unfortunately, none of the 
immunoprecipitations provided clear evidence of PCNA ubiquitination in K. brevis (data 
not shown). However, an intriguing result pointing to the possibility ofPCNA 
ubiquitination is shown in Figure 9. A changing pattern of ubi quit in at ion is apparent in 
protein lysates from LDT12 in Day 10 (early stationary phase) and Day12 (late stationary 
phase) cultures (Figure 9A), when protein degradation might be expected to increase. On 
both Day 10 samples and one Day 12 sample, the ubiquitin pathway components and 
substrates match. It is in these exact biological replicates that the --47kDa PCNA is not 
present (Figure 9B). Additionally, the ubiquitin monomer is abundant in these samples. 
In contrast, the Day 12 sample Kb19 shows an entirely different ubiquitination pattern. A 
prominent band of ---47 kDa appears, while the pool of mono ubi quit in almost disappears 
in this sample. It is in this exact biological replicate that the PCNA ---47kDa band is quite 
prominent (Figure 9B) and although this data is indirect, it provides evidence of 
ubiquitination that is consistent with the appearance of the 47kDa band recognized by the 
PCNA antibody. 
Candidate Cyelin-Dependent Kinase and eyelin Genes in the K. brevis Library 
Sixteen ESTs with homology to cyclin-dependent kinases are present in the K. 
brevisEST library as identified by BLAST and gene ontology searches in Genbank by 
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BLAST2GO (Table 1). These sixteen ESTs fold into 5 unique contigs. Two have high 
homology to CDK7 (e-56) and one has homology to CDK C (e-66). One is the reverse 
complement and the last has poor homology to known CDKs. Using PCR with the 
spliced leader as forward primer (5' TCCGTAGCCATTTTGGCTCA 3') and a gene 
specific as reverse primer (5' GTGCAGGAATGTGTTGCCGTTT 3'), the full length 
sequence for the contig with homology to CDK C was obtained (Contig 5041, Marine 
Genomics IDI08857, Table 1). This sequence has the 5' spliced leader (Figure 10) and a 
cyclin binding motif (PL TAIEK) as shown by alignment with other protist and plant 
CDKs (Figurel1). Residues conserved within CDK groups and among species that are 
involved in A TP binding have an asterisk (*) above them (Figure 11). Interestingly, the 
conserved threonine residue present in the CDK T-Ioop, which is where CDK is 
phosphorylated and activated by CDK activating kinase (CAK), is substituted with a 
serine in K. brevis. Although divergent, this residue can still be phosphorylated and 
activated by a potential CAK, yet to be characterized in K. brevis. This sequence has 
highest homology to plant CDKC (Arabidopsis, 3e-57) and a green algae CDK (C. 
reinhardtii, 2e-51). CDKC was shown not to interact with either mitotic or G 1 cyclins in 
the tomato plant (Joubes et aI., 2001), but rather to bind to RNA polymerase and regulate 
transcription. A partial alignment of the K. brevis CDKs shows that these CDKs are more 
closely related to plant (Arabidopsis), green algae (Chlamydomonas) and as expected 
Apicomplexan (Plasmodium) CDKs (Figure 12). 
Concentration Dependence of CDK Inhibitor Activity 
Since analysis of CDK sequences in the EST library did not identify a candidate 
G 1 specific CDK in K. brevis, we sought to gain insight into which (if any) type of CDK 
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might be involved in regulating S-phase proteins, using two CDK inhibitors of differing 
specificity (Figure 13). In order to investigate the effects of the CDK inhibitors, 
olomoucine and fascaplysin, in K. brevis it was first necessary to identify inhibitor 
concentrations that were effective in causing a cell cycle block, but were not toxic to the 
cells as determined by SYTOX staining (Figure 14). Fascaplysin concentration was tested 
from 0.75 - 5 J.lM (Table 2). From this range, a final concentration of 1.5JlM was selected 
for further studies since it allowed only 5% of the cell population to proceed through S-
phase, without extensive loss of viability (Table 2). Olomoucine concentration was 
tested from 6.25 - 50 JlM (Table 3). From this, a final concentration of 12.5 JlM was 
selected for further experiments as determined by viability (96%) and the percent of the 
cell population blocked in G 1 93.8% at LDTI2. 
PCNA Expression Patterns in Flask Cultures 
The growth rates of K. brevis cultures grown in 125 ml flasks were found to be 
substantially higher (K'= 0.6) than those in the liter bottles used in Chapter 3, and 
therefore flasks were used for the subsequent growth phase studies. However, because 
the cells were more synchronous, the pattern ofPCNA expression was first established as 
compared to bottle cultures. The flask cultures in this study were highly synchronous 
with --60% of the cell population in S-phase by LDT12 (Figure 15A). PCNA protein 
abundance was investigated at LDT2, 10,12,14,16, and 18. At LDT2 (G1) the 37 kDa 
form ofPCNA was already present and more abundant than the 28 kDa form, which 
dominated this time point in the bottle cultures (Figure 15B). However, the abundance of 
both forms ofPCNA was low. At all other time points, all of which had >50% of cells in 
136 
S-phase (Figure 15A), only the 37 kDa form was present (Figure 15B). Densitometry 
shows a decreasing, but variable, trend in the expression levels in LDT 18 replicates 
(Figure 15C). This corresponds to the time when the cell populations are beginning to 
exit S-phase and is consistent with our previous observations (Figure 15A). 
Effects of CDK Inhibition on PCNA Protein Abundance 
Once optimal concentrations of olomoucine and fascaplysin were determined, for 
both cellular viability and G 1 block, 5 replicate 125mL flask cultures were treated with 
12.5 11M olomoucine or DMSO carrier, 1.511M fascaplysin or water carrier, just prior to 
LDTO and sampled at LDT12 (mid-S-phase) for viability, cell cycle analysis and protein 
abundance ofPCNA. Sampling occurred 12 hours after CDK inhibitor addition when the 
cells would normally be in mid-S-phase as shown by the controls. Table 4 shows the 
results from the flow cytometry, SYTOX viability staining, and cell counts per mL. Both 
fascaplysin and olomoucine addition resulted in the expected G 1 block with only 0.84% 
and 2.54%, respectively, of the cell population proceeding through S-phase. 
PCNA protein production was absent at LDT12 when cells were treated with 
olomoucine and fascaplysin (Figure 16). Interestingly, expression of both the 28 and ---37 
kDa forms ofPCNA were blocked. In the untreated controls at LDT12, only the ---37kDa 
band was present, as expected for the peak of S-phase in the flask cultures. For 
comparison, a protein lysate showing S-phase bands from a lL bottle culture at the same 
time point had both 28 and 37 kDa bands observed previously. Fascaplysin blocked the 
production of PCNA more effectively than olomoucine (Figure 16A), however both 
inhibitors caused a significant reduction in the production of this protein when 
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normalized to untreated controls at the same time point (Figure 16B, p<O.OOOl, 
ANOV A). These results suggest both that CDK is involved in regulating the increased 
expression ofPCNA in S-phase and a CDK with CDK4-like sensitivity to fascaplysin is 
present in K. brevis and active at G l/S. 
Growth Phase Specificity of PCNA Expression may Provide a Biomarker for Bloom 
Status 
Because the 37 kDa form ofPCNA appears only during S-phase, it has the 
potential to serve as a marker of actively growing blooms of K. brevis that might find 
utility in field monitoring for the growth status of Florida red tides. We therefore 
compared the expression level of the 37 kDa band at LTD12 in actively growing 
populations (0.30 - 0.60 dive /day), slow growing populations (0.04 - 0.20 dive /day), and 
populations in stationary phase (0 diVe /day). Growth curves were produced by taking 
cell counts every other day and on the day of sampling in order to calculate divisions/day 
in each culture at the time of harvest (Figure 6A). Flow cytometry was used to assess cell 
cycle distribution in each culture and the percent of cells in S -phase was determined 
(Figure 6B). When the western blot band intensity was plotted vs. the percent of cells in 
S-phase for each sample, there was a significant linear relationship between the 37 kDa 
form of PCNA protein and the percent of cells entering S-phase (Linear correlation, 
r2=O.7812, p<O.OOOl; Figure 17), where the log phase cells show expression ofPCNA 
that increases with % of cells in S-phase, whereas stationary phase cultures express little 
to no PCNA. These results suggest that the expression of this S-phase specific form of 
PCNA may be useful as a marker for actively growing blooms. 
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DISCUSSION 
Potential Post-translational Modifications of PCNA by SUMO and Ubiquitin 
In higher organisms, PCNA undergoes two different post-translational 
modifications that regulate its activity in a cell cycle dependent manner, sumoylation and 
ubiquitination (Hoege et aI., 2002). Ubiquitin-dependent proteolysis refers to the 
conjugation of the ubiquitin polypeptide to a lysine residue on the target protein for 
degradation by the 26S proteosome. Conjugation of ubi quit in to the substrate protein is 
through a three-step pathway (Sorkin et aI., 2009): the El Ub-activating enzyme forms a 
high-energy intermediate with ubiquitin; then the E2 Ub-conjugating enzyme carries the 
activated Ub to ligase E3 which is bound to the substrate (Sorokin et aI., 2009); then, 
once the protein is presented to the proteosome, deubiquitination occurs by 
deubiquitinating enzymes (DUBs) and ubiquitin can be recycled. Substrates can either be 
mono- or polyubiquitinated, which can occur via chains or branches and leads to 
proteosome degradation. Monoubiquitination is the attachment of one ubiquitin to a 
protein (Hicke and Dunn, 2003), does not lead to degradation and can be involved in 
multiple processes. Multiubiquitination (multiple monubiquitination of severallysines on 
the substrate) leads to protein destruction by the lysosome (Haglund et aI., 2003). There 
is precedence for many proteins to be ubiquitinated at different times over the cell cycle, 
including the yeast G 1 cyclins, Cln2 and Clin3, yeast CDK inhibitors, Sicl and Farl, the 
mammalian G 1 regulators, cyclins D and E, and the mammalian CDK inhibitor p27Kip1 , 
which all require phosphorylation before ubiquitination (Ciechanover et aI., 2000). There 
are many other examples of ubi quit in modified substrates that are specific to each phase 
of the cell cycle and can be further characterized by non-proteolytic and proteolytic 
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ubiquitination (Wickliffe et aI., 2009). Specifically, there is extensive research that has 
investigated the ubiquitination ofPCNA. PCNA can be both mono and 
polyubiquitinated. PCNA monoubiquitination has been demonstrated in most 
eukaryotes, from budding and fission yeasts to human, chicken and Xenopuslaevis egg 
extracts, however polyubiquitination ofPCNA has only been clearly detected in the 
yeasts and X laevis egg extracts (Ulrich, 2009). PCNA monoubiquitination promotes 
translesion DNA repair and polyubiquitination ofPCNA promotes error-free DNA repair 
(Hoege et aI., 2002; Gill, 2004). PCNA is also ubiquitinated during normal cell cycle 
progression. In yeast, metazoans and mammalian cells, PCNA is degraded during S-
phase after it is used to prevent re-replication thus promoting genomic stability. This 
process is mediated through CRL4Cdt2 which is an E3 ubiquitin ligase (Abbas and Dutta, 
2011). 
Sumo (~mall ubiquitin-like modifier) post-translational modifications also have a 
wide range of effects within the cell (Johnson, 2004). Sumoylation is involved in cell 
cycle regulation, transcription, cellular localization, DNA repair, mitochondrial activity, 
plasma membrane ion channels, and chromatin organization (Andreou and Tavemarakis, 
2009; Hannoun et aI., 2010). Sumo only shares ~ 18% homology with ubiquitin but has a 
similar 3-dimenstional structure (Bayer et aI., 1998). Like ubiquitin, sumo modifies 
lysine residues of substrate proteins, is expressed in all eukaryotes, and has a 
conjugation-deconjugation system that is reversible (Meulmeester and Melchior, 2008). 
The sumo polypeptide is somewhat divergent in eukaryotes with variation in protein size 
from proteins ----9 - --11 kDa (Andreou and Tavemarakis, 2009; Hannoun et aI., 2010). 
The E1 activating and E2 conjugating enzymes involved in sumoylation are highly 
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related to those involved in ubiquitination, however there is only one known E2 enzyme, 
Ubc9, involved in sumoylation where there are dozens ofE2 enzymes in the ubiquitin 
pathway (Gill, 2004). There is a sumo consensus motif found on many sumo substrates 
which consists of the sequence 'P-K-X-E, where 'P is a large hydrophobic amino acid and 
K is the site of sumo conjugation (Rodriguez et aI., 2001). PCNA has been found to 
posses this motif (Ulrich, 2009) and PCNA sumoylation takes place during S-phase or 
after high doses of DNA damage (Hoege et aI., 2002). Sumoylation ofPCNA is thought 
to prevent deleterious hyper-recombination during normal replication and lack of 
sumoylation causes increased spontaneous sister chromatid recombination during mitotic 
growth (Pfander et aI., 2005). PCNA can undergo polysumoylation in yeast, however the 
function and importance of this modification is currently unclear (Parker et aI., 2008; 
Windecker and Ulrich, 2008). 
Sequence analysis shows that one subunit of K. brevis PCNA codes for a protein 
of --28kDa. There are no sequences in the cDNA library that appear to code for a protein 
with a longer amino acid sequence. Therefore, we hypothesized that the 37 and 47 kDa 
forms ofPCNA may be post-translationally modified forms ofPCNA. In eukaryotic 
cells, PCNA is ubiquitinated in response to DNA damage, promoting the bypass of 
replication-blocking lesions (Hoege et aI., 2002; Stelter and Ulrich, 2003; Kannouche et 
aI., 2004). In S. cerevisiae, PCNA becomes sumoylated in a damage-independent 
manner during S-phase, preventing unscheduled recombination events (Pfander et la., 
2005). Sumo and ubiquitin can also coexist on a single PCNA subunit in yeast 
(Windecker and Ulrich, 2008). In this study, we identified both the ubiquitin and sumo 
polypeptides in K. brevis, as well as many genes involved in the ubiquitin and ubiquitin-
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like systems, including ubiquitin precursors (polyubiquitins), ubiquitin-conjugating and 
ligating enzymes, as well as members of the 26S proteosome and a sumo-activating 
enzyme (Appendix 2), providing strong evidence that both of these post-translational 
modification systems exist in this dinoflagellate. Based on sequence analysis, the K. 
brevis ubiquitin sequence encodes a polypeptide of 8.5kDa, typical to other eukaryotes, 
and sumo for 9kDa, somewhat smaller than the typical 10 - 11kDa. By western blot, 
ubiquitin was somewhat smaller than expected, --- 6kDa; however this discrepancy in 
molecular weight on acrylamide gels is similar to what is observed in other organisms 
(Ott et aI., 1998). The sumo polypeptide migrated somewhat larger than expected at '" 17 
kDa but again free sumo has been shown to migrate at '" 17kDa in Xenopus (Wang et aI., 
2009) and ~15kDa in Arabidopsis (Colby et aI., 2006), while their sequences predict 10.7 
- 11.7kD and 11 - 12 kDa, respectively. This appears to be common in analysis of sumo 
proteins by western blotting as all known sumo proteins are ~ 100 amino acids long but 
have aberrant sizes when run on gels. For example, in human cancer cells (hep2 cells) 
sumo 1 migrates above 16.5 kDa, however the amino acid sequence codes for 11.6 kDa 
(Bailey and O'Hare, 2005)._Similarly, the human recombinant sumo 1,2 and 3 run as 
standards in the current study all migrate at approximately ---14kDa, somewhat smaller 
than the K. brevis sumo, but larger than their predicted sizes from sequence analysis (10.8 
- 11.6 kDa). 
Once it was determined that the sumo and ubiquitin polypeptides were present 
and highly conserved in K. brevis, the PCNA sequence was analyzed using a 
bioinformatic approach to investigate whether there were conserved lysine residues or 
motifs within PCNA where these modifications could occur. When the K. brevis PCNA 
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sequence was analyzed using UbPred, a ubiquitination prediction program (Radivojac et 
aI., 2009), three lysines were recognized as possible sites of ubiquitination with medium 
confidence (Figure 2). The sites identified included K184, K190 and K194, which do not 
correspond with the site ofPCNA ubiquitination (K164) in most eukaryotes (Shaheen et 
aI., 2010). A lysine residue is found in the K. brevis PCNA (at K165) and aligns with this 
site in all other eukaryotes, but is found within the amino acid context SKEG. The 
program used for this analysis was developed and trained on a combined set of 266 non-
redundant experimentally verified ubiquitination using experimental proteomic data from 
S. cerevisiae (Hitchcock et aI., 2003 and Peng et aI., 2003) and known ubiquitination sites 
involved in human disease from GenBank searches. Therefore, this program may not be 
the best predictor for dinoflagellate sequences which appear to be divergent in many 
respects from model eukaryotes for which large scale datasets are available. Ubiquitin 
biding domains are structurally diverseare found in proteins that contain a variety of 
structural features and diverse biological functions (Hicke et aI., 2005). SUMOsp (Ren et 
aI., 2009) was also used to identify potential sumoylation sites on K. brevis PCNA. The 
sites ofPCNA sumoylation are not as well characterized as those of ubi quit in at ion and do 
not appear to be as conserved. Two potential sites of sumoylation were identified in K. 
brevis PCNA (Figure 2) including K190 (DKPEE) with medium confidence, which is a 
non-consensus site and K238 (VKYE) with high confidence, which is within a well-
characterized sumoylation motif ('P-K-X-E) found in other organisms. Interestingly, 
when PCNAs from other organisms were analyzed, SUMOsp also predicted that K190 
would be sumoylated in H. sapiens and C. reinhardtii. However, the K238 sumoylation 
site appears to be unique to dinoflagellate PCN A, as this residue and its amino acid 
143 
context present in K. brevis is also found in Pyrocystis lunula (Okamoto and Hastings, 
2003), Pfiesteria piscicida (Zhang et aI., 2006), Prorocentrum donghaiense (Zhao et aI., 
2009) as well as Alexandrium catenella (Sui et aI., 2008, unpublished from GenBank), 
Karenia mikimotoi and Peridiniumfolicaceum (Hou et aI., 2009, unpublished from 
GenBank). 
Based on sequence analysis of potential PCNA post-translational modification 
sites and the dynamics ofPCNA over the cell cycle, it appears likely that K. brevis PCNA 
is modified by sumo and ubiquitin. Immunoprecipitation with anti-PCNA was 
inconsistent, but revealed both the 28 and 37 kDa forms, as well as bands at 47kDa and 
above 62kDa. We had not previously observed the ---62 kDa band. However, since 
PCNA can be both polyubiquitinated and polysumoylated (Shaheen et aI., 2010; 
Windecker and Ulrich, 2008) this higher band could be due to one of these processes. 
When a PCNA immunoprecipitate was probed with anti-SUMO, a band that appeared at 
----47kDa. This was higher than expected, based on a 9 kDa SUMO addition; however this 
band was also visibly in an S-phase whole cell lysate run in parallel and probed with anti-
SUMO. When this blot was stripped of the sumo antibody and probed with the anti-
PCNA antibody, the same band appeared, lending further evidence to that hypothesis that 
this represents sumoylated PCNA. Probing PCNA immunoprecipitates with anti-
ubiquitin was uninformative, due to inconsistency in the immunoprecipitation method to 
even yield PCNA bands. However, the comparison of ubi quit in patterns with PCNA 
patterns over the growth curve in K. brevis identifies a ---47 kDa band that co-migrates 
with the 47 kDa band recognized by anti-PCNA. Thisis an interesting result that should 
be further investigated to determine how ubiquitination is changing over the cell cycle. It 
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is expected as a cell population ages and no longer needs certain proteins for cellular 
processes, such as DNA replication, they would be degraded by the ubiquitiniproteosome 
system. 
The transition from G 1 to S-phase is a critical point when cells activate a division 
program, commit to duplicate the genome and proceed to divide (Gutierrez et aI., 2002). 
For this transition to occur, cells must pass the restriction point (RP) at some time during 
G 1 when growth factors or mitogens are optimal to ensure successful genome 
duplication. Passage through the RP, also termed the G 1 checkpoint or S TART in yeast, 
prior to the G l/S transition regulates entry into the cell cycle and subsequent DNA 
replication. Cyclin dependent kinase controls the passage through the RP. Although it 
appears that the dark to light transition is what entrains cell cycle entry in K. brevis to the 
photoperiod, this "zeitgeber" is not precisely equivalent to the RP since cells continue to 
cycle in continuous light.In the green alga, Chlamydomonasreinhardtii, a light dependent 
commitment point (restriction point) occurs in G 1 (Zachleder and Van Den Ende, 1992). 
In contrast to C. reinhardtii, in Euglena, light-dependent commitment points also occur 
post-G 1, although their biochemical equivalency to a restriction point is uncertain 
(Hagiwara et aI., 2001). The results in Chapter 3 suggest that the restriction point in K. 
brevis occurs prior to LDT2, since PCNA positive cells are present by that time. 
However, the molecular constituents of the restriction point have yet to be defined in 
dinoflagellates. The results presented in this chapter show that there is most likely a 
CDK4-like CDK involved in the G liS restriction point in K. brevis since blocking CDK 
with fascaplysin in G 1 prevents S-phase entry and PCNA production. 
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Cyclin-dependent protein kinases (CDKs) are a large family of serine/threonine 
kinases.Certain members of the CDK family regulate the cell cycle while others function 
in different cellular processes such as central regulators of transcription (Morgan, 1997; 
Liu and Kipreos, 2000). The CDKs involved in cell cycle regulation have cyclin partners 
to which they bind and these complexes act as the main drivers of the eukaryotic cell 
cycle. The activity of CDK is regulated by multiple mechanisms which include cyclin 
association, specific phosphorylations and dephosphorylations and interactions with CDK 
inhibitors (CDKls) (Sherr, 1996; Sherr et aI., 1999; Keiichi and Nakayam, 2005). 
Throughout the cell cycle, cyclins and CDKIs oscillate due to proteolysis (Murray, 2004) 
and it is the ubiquitin-proteosome pathway that mediates the degradation of these 
regulatory proteins (Weissman, 2001; Pickart, 2004). In model eukaryotes such as 
mammals, when the restriction point is reached, the CDK4/6/cyclin D complex 
phosphorylates the retinoblastoma protein (pRb) during early G 1 which leads to the 
activation of E2Fs, a family of cell cycle regulatory transcription factors that activate 
transcription of S-phase genes (Cam and Dynlacht, 2003). The E2F transcription factor 
family is comprised of 8 members (Singh et aI., 2020). E2Fs 1, 2 and 3 interact with pRb 
and have a strong transcriptional activation domain (Slansky and Farnham, 1996). E2Fs 
4 and 5 have little or no transcriptional activity and E2Fs 6-8 do not bind pRb and are 
used to repress transcription by recruitment of transcriptional co-repressors (Frolov and 
Dyson, 2004; DeGregori and Johnson, 2006). E2Fl, 2 and 3 can strongly induce S-phase 
entry and their activity is necessary for the induction of many genes required for S-phase 
progression. pRb inhibits cell cycle progression by repressing the transcriptional activity 
ofE2Fs and their target genes (Dimova and Dyson, 2005). E2Fs are absent from 
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Apicomlexans and to date, no E2Fs have been identified in dinoflagellates. Therefore, 
the activation of cell cycle proteins must be occurring through an alternative method. 
The K. brevis CDK sequences appear to be divergent from the well-studied yeast 
and mammalian CDKs and cyclins. In yeasts, there is one CDK that drives the cell cycle, 
Cdc2 in S. pombe and CDC28 in S. cerevisiae (Simanis et aI., 1987). A plant homolog of 
the CDK cdc2 was first identified in Chlamydomonas and wheat (Pisumsativum) 
followed by numerous other plant species (Francis, 2007). There are seven classes of 
plant CDKs: A-G of which the CDK As, Bs, D and Fs are involved in cell cycle control 
(Umeda et aI., 2005; Francis, 2007). Table 1 shows that the K. brevis CDKs appear to be 
closely related to plant CDK C (Arabidopsis and Oryza) as well as protist CDK7 
(Cryptosporidium). Many examples ofCDKs and cyclins have been found in protists 
such Leishmania mexicana (Hassan et aI., 1997), Toxoplasma gondii (K vaal et aI., 2002; 
Khan et aI., 2002), PlasmodiumJalciparum(Le Roch et aI., 2002) and Trypanosoma 
brucei (Ellis et aI., 2004). In L. mexicana, one CDK (or CRK, cyclin-dependent related 
kinase) has been characterized that is a homolog ofcdc2 which is human CDKI (Gomes 
et aI., 2010). This same study purified and expressed 7 putative recombinant CRKs from 
L. major. Two putative isoforms of a cdc2-related protein have been identified in T. 
gondii (Donald et aI., 2005). InT. brucei, 8 CRKs have been identified that appear to 
have different functions over the cell cycle (Gourguechon and Wang, 2009). The CDKs, 
cyclins, and a CDK effector protein in P. Jalciparum were identified using homology-
based peR and database mining approaches (Doerig et aI., 2008). It was recently found 
that a Plasmodium CDK (Pfmrk) binds to an effector protein PfMATl, a putative CDK 
activating kinase, which activates Pfmrk and this complex co-localizes to the nucleus and 
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regulates DNA synthesis (Jirage et aI., 2010). Phylogenetic analysis ofCDK sequences 
from members of the protist groups Giardia, Trypanosoma and several from Plasmodium 
showed that these CDKs do not strongly associate with any established CDK family and 
it is suggested that although they are orthologs of defined CDK groups, they have 
diverged to the point that they are not recognizable using sequence-based phylogenetic 
methods (Guo and Stiller, 2004). A cdc2-related kinase in T. brucei was shown to have a 
"PQTALRE" motif (Ellis et aI., 2004) and in P. Jalciparum, the CDK-related kinase 
PtPK6 possesses a SKCILRE motif (Bracchi-Ricard et aI., 2000). Therefore, protist 
CDKs appear to be divergent from metazoan CDKs, although functional conservation 
exists throughout eukaryotes. 
The divergence of dinoflagellate CDKlcyclins may not be suspiring based on their 
unusual cell cycle. The Apicomplexan Plasmodium, possesses 6 CDK-like kinases that 
are divergent from the typical eukaryotic CDKs and to date only 3 of these have shown 
cyclin-dependent activity in vitro (Doerig et aI, 2002). CDKs have been identified in a 
limited number of other marine phytoplankton. In the diatoms Thalassiosira pseudonana 
and Phaeodactylum tricornutum, large scale data mining of their recently sequenced 
genomes identified multiple key cell cycle regulators such as CDKs, CDK interactors and 
cyclins (Huysman et aI., 2010). Five CDKs were identified in P. tricornutum and it 
appears that both of these algal species have novel components including diatom-specific 
cyclins. Similarly, a dinoflagellate CDK5-like protein has been characterized from in 
Lingulodinium polyedrumby protein microsequencing and phylogenetic 
analysis(Bertomeu et aI., 2007) and still leaves the question of CDK control of S-phase 
entry in dinoflagellates unanswered. CDK5 in metazoans is involved in neuronal 
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development (Lalioti et aI., 2010). This dinoflagellate CDK5-like kinase was shown to 
react with an anti-PSTAIRE antibody. The PSTAIRE motif is the conserved cyclin 
binding motif on CDKs. Thus, this CDK would appear to be involved in the cell cycle. 
The K. brevis full length CDK sequence has highest homology to the plant CDKC, not 
mammalian CDK5, and has a motif (PLTAIEK) that aligns with the cyclin binding 
domain of plants (Arabidopsis), other algae (Chlamydomonas) and other protists 
(Plasmodium). However, this CDK sequence has conserved ATP binding residues and 
the CDKI studies show that there are G 1 CDK homologs in K. brevis. 
The cyclin partners ofCDKs are equally poorly characterized in dinoflagellates. 
Cyclins were originally identified because their abundance changed over the cell cycle 
(Murray, 2004). Cyclins bind to CDKs through the PSTAIRE motif on CDKs, and these 
binding motifs appear to be divergent as CDK sequence and function diverge within and 
between organisms. This is shown in this Chapter with the K. brevis eye lin binding 
domain diverging from the other motifs (Figures 11 and 12). In kinetoplastids, the CDK-
related kinases show the expected biochemical interactions of CDKs and interact with 
cyclins; however, the PSTAIRE motif is degenerate (Ellis et aI., 2004). A mitotic cyclin 
homolog was identified in the dinoflagellate L. polyedrum through construction of a 
cDNA library, followed by PCR and confinned by functional complementation assays in 
yeast to act as a mitotic cyclin (Bertomeu and Morse, 2004). Cyclin B homologs have 
been identified in both K. brevis (Barbier et aI., 2003) and Crypthecodinium 
cohnii(Barbier et aI., 1998) by immunoreactivity with a yeast cyclin B antibody. The 
identification of G I-specific CD Ks and cyclins in dinoflagellates will require additional 
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sequencing and in particular, obtaining full length sequences that are currently largely 
missing in EST collections. 
CDK Inhibition 
Since we still lack information on G I-specific CDKs or cyclins in dinoflagellates, 
in order to begin to investigate how S-phase genes may be modulated in the absence of 
transcriptional control, we investigated if their expression is dependent on CDK activity. 
To provide discrimination between CDK classes we employed both the broad inhibitor 
olomoucine and the CDK4-specific inhibitor fascaplysin in G 1 to inhibit CDK activity. 
Both CDK inhibitors prevented progression into S-phase and expression of the 37 kDa 
form ofPCNA when added to cells at the dark to light transition (LDTO). The 
olomoucine results show that there is most likely a CDK 1,2, 4 and/or 6 functional 
homolog involved in the G I/S transition. The G 1 specific block produced by fascaplysin 
points to the involvement of a CDK4-like protein in the G I/S transition. To inhibit 
CDK4, fascaplysin binds in the ATP binding pocket ofCDK4 by interacting through a 
bidentate (having two atoms from which electrons can be donated) hydrogen bond 
donor/acceptor pair, forming one hydrogen bond with the NH backbone ofVa196 via the 
carbonyl offascaplysin and Nl of the adenine ring (Soni et aI., 2000). The inhibitory 
action of fascaplysin is dependent on CDK4 being bound to its cyclin partner with an 
ICso of 0.35 JlM in mammalian cells (Huwe et aI., 2003). The specificity of fascaplysin to 
bind to CDK4 as opposed to CDK2 or CDK6 is based on the differences in structure. 
CDK4 has an acidic residue (EI44) where CDK2 has a neutral residue (QI31) and a 
neutral residue in CDK4 (T 1 02) is substituted for the positively charged K89 in CDK2, 
leading to a two-unit increase in the formal charge of the A TP biding pocket of CDK2 
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relative to CDK4 which renders a more favorable electrostatic energy with CDK4 
(Mcinnes et aI., 2004). Among mammalian CDKs there is strong sequence homology 
between the catalytic domains where A TP binds suggesting similar three-dimensional 
structure (Gray et aI., 1999). Interestingly, most of these residues are conserved among 
the CDKs within a species, for example in CDKs 1-9 in humans (Gray et aI., 1999), and 
many are conserved even in K. brevis, C. rein hardtii, a diatom and two plant species 
(Figure 11). 
Although, these results do not indicate a direct link between CDK and S-phase 
protein expression, they do suggest some CDK dependent pathway responsible for the 
translation ofPCNA in absence of transcriptional regulation. In Arabidopsis, CDKA,the 
plant cdc2 homolog active in G 1, has been found to interact with elF4a translation factor 
which suggests a direct link between the cell cycle and the regulation of translation 
(Hutchins et aI., 2004). This interaction is abundant in actively proliferating Arabidopsis 
cells and absent from cells that are not dividing. CDKI phosphorylation of the eIF-4E 
binding proteins (4 E-BP 1) during mitosis releases elF 4 allowing translation to occur in 
HeLa (cervical cancer) cells (Heesom et aI., 2001), which is another example ofCDK 
controlled cell cycle progression involving translation control. In K. brevis it may be that 
G 1 CDKs are also interacting with the translational machinery to regulate progression of 
the cell cycle. Interestingly, no CDKls, such as p2l, p27 or p57, have been identified in 
K. brevis, which are responsible for preventing the initiation of DNA replication 
(Furstenthal et aI., 2001). CDKls, such as members of the CIP and KIP families, have 
also not been identified in other protists including Plasmodium (Doerig et aI., 2002) or 
diatoms (Huysman et aI., 2010) and it has been suggested that their sequences may be too 
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divergent to allow their identification by homology searches. Clarification of the 
mechanisms by which CDK regulate S-phase proteins in dinoflagellates first requires the 
identification of the CDKs active at Gl/S. The current study suggests a protein with 
CDK4-like activity will be involved. 
Growth Rate Specific PCNA 
Because of its association with cell proliferation, PCNA has been used for 
prognosis of tumor and cancer development (Lee et aI., 1995) and has the potential for 
studying growth in phytoplankton. Examination ofPCNA at short increments over S-
phase in K. brevis showed that the --37 kDa form is quite abundant throughout DNA 
replication during log phase growth (Figure 15). It was expected that the lower band of 
28 kDa would be present at LDT2, at which time it was barely visible, and the 37 kDa 
band would gradually increase and dissipate over S-phase. However, due to the high 
synchronicity of these cultures, if there is a mechanism producing this higher band of 
PCNA such as a post-translational modification, most cells may be utilizing this 
physiological response. In the dinoflagellate P. do ngha iense, PCNA remained at a high 
level during exponential growth and decreased when cultures entered late stationary 
phase (Liu et aI., 2005). In another algal protist, the coccolithophore 
Pleurochrysiscarterae, a 36 kDa PCNA homolog was shown to have higher abundance 
during the exponential growth phase and was diminished in the stationary growth phase 
(Lin and Corstjens, 2002). 
In the dinoflagellate Pfiesteria piscicida, PCNA was found to be more abundant 
in the exponential growth phase compared to stationary phase based on western blot 
analysis (Zhang et aI., 2006). Therefore, in this study PCNA protein expression was 
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investigated over the growth curve in K. brevisto determine whether PCNA expression 
decreases predictably as cells proceed from log into stationary phase. Surprisingly, we 
repeatably found a higher molecular weight band of --47 kDa cross-reactive with the 
PCNA antibody only in late stationary phase cultures on the cusp of decline. With 
further development, we propose that this may lend itself to a marker of terminating 
blooms. In order to confirm the results, Day 6 (log phase) S-phase cultures were 
compared to Day 12 (stationary phase) S-phase cultures, and it was found that the 37kDa 
was prevalent in log phase and absent in the stationary phase cultures (Figure 8). This 
suggests that PCNA in stationary phase cultures could be marked for degradation when 
the cell no longer needs this protein for proliferation, possibly by ubiquitination. 
Potential Utility of PCNA as a Biomarker for Harmful Algal Bloom Monitoring 
The comparison of PCNA abundance in log and stationary phase cultures and 
cultures with decreased growth rate provided insight into whether PCNA might be useful 
as a biomarker for growth. PCNA expression levels were compared in log phase cells at 
different growth rates in order to determine if a linear relationship exists between S-phase 
progression and PCNA expression levels. We found significant linear correlation 
between percent of the cell population in S-phase and expression of the 37 kDa form of 
PCNA. The 37kDa band was prominent in cultures sampled during S-phase (LDTI2) on 
Day 6, mid-log phase of growth. In stationary phase cultures (Day 12)sampled at the 
exact same time (LDTI2), this band is completely absent.The neutral density samples 
provide important information in that they have reduced growth rate and when sampled at 
the typical log phase time point, there is decreased production of the PCNA protein. 
Therefore, this growth pattern along with the differences in PCNA abundance may be 
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indicative of the growth state and be informative of the phase of K. brevis bloom 
progression. Indeed, the linear correlation analysis did show a significant relationship 
between the 37kDa PCNA protein abundance and the percentage of the cell population in 
S-phase of the cell cycle (Figure 17). Therefore not only does the 37kDa PCNA have the 
potential for use as a biomarker of actively growing blooms; the 47kDa may be useful as 
well in identifying bloom termination since this protein only appears in dyeing cultures. 
It will be interesting to test the utility of these potential biomarkers and their relationship 
to bloom progression in the field. Field populations have been shown to have cell cycle 
behavior similar to those of laboratory cultures with all bloom patches tested proceeding 
through a circadian regulated G 1, S-phase and G2/Mitosis in a tightly phased and 
uniform manner (Van Dolah et aI., 2008). Also similar to laboratory cultures, there is 
variation in the percent of the cell population that proceeds through the cell cycle on any 
given day. Based on these similarities between field populations and laboratory cultures, 
testing ofPCNA protein levels at LDT12-14 could provide predictive information on 
growth phase of a bloom. Currently, measurements of in situ growth rates of blooms 
require either repeated analysis by flow cytometry to determine the fraction of cells 
dividing over the course of a 24 h period, or 24 h 14C uptake measurements as proxies of 
growth. The former method requires a research vessel to stay on a bloom patch well into 
the night, making it infeasible for routine monitoring. The latter method both requires 
radioactivity and artificially manipulates the sample, thereby introducing error in the 
measurement. With currents, weather and other physical oceanographic conditions, the 
results will most likely be different from that in a controlled laboratory setting. 
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Notwithstanding, these studies, for the first time, provide a potential protein biomarker 
for growth in K. brevisthat may be sampled during mid-day, when cells are in S-phase. 
CONCLUSIONS 
The studies presented in this Chapter provide information on how S-phase gene 
expression may be regulated in an organism that displays post-transcriptional control of 
its cell cycle. Although the analysis of CDK contigs present in the K. brevis library did 
not identify a candidate G 1 CDK, the inhibition of S-phase entry by fascaplysin provides 
evidence for a CDK4-like kinase in this transition in K. brevis. The PCNA protein 
decreased under CDKI treatment. Whether CDK is directly or indirectly interacting with 
these DNA replication proteins, in the absence of transcriptional control, begs further 
investigation. Additionally, there appears to be post-translational modifications of PCNA 
occurring not only over the cell cycle, but over the growth curve as well. Evidence is 
provided here for the potential sumoylation and ubiquitination ofPCNA over the cell 
cycle (sumoylation) and over the growth curve (ubiquitination). These post-translational 
modifications have been shown to be highly conserved across eukaryotes. Sumoylation 
is thought to be involved in genomic stability. The prevalence of this form ofPCNA in 
K. brevis may reflect the necessity for genome stability due to its unusually large 
genome, especially during DNA replication. Post-translational modification may be one 
level this unusual eukaryote is regulating cellular processes. These studies provide the 
first information on post-translational modifications in dinoflagellates. This level of 
protein regulation may be a very important system in K. brevis and other protists. The 
results presented in this chapter provide information necessary to determine the level 
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Figure 1: Multiple alignments of (A) the SUMO polypeptide and (B) ubiquitin. Outlined 
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Figure 2: K. brevis PCNA amino acid sequence used for analysis (A) DNA polymerase 
binding site (B) Conserved Ubiquitin and SUMO binding lysine residue in S. cerevisiae 
(C) RFC binding site. Boxed in red are the predicted ubiquitin binding lysine residues by 
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Figure 3: (A) The ubiquitin protein in K. brevis at LDT 2, 10, 12, 14, 16 and 18. (B) The 
sumo protein in K. brevis. The first 3 lanes are K. brevis protein extracts from LDT2 
(G1), LDT12 (S-phase) and LDT18 (G2/M). Lanes 4,5 and 6 are human recombinant 
sumo1, 2 and 3, respectively. Ten micrograms of K. brevis protein extract were loaded in 
each well and five micrograms of recombinant SUMO proteins were loaded. 
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Figure 4: Immunoprecipitation using the PCNA antibody to obtain all forms ofPCNA. 
The blot was probed for Western blotting with the same antibody used for 
immunoprecipitation. The left lane is negative control (no protein lysate) which shows a 
faint band at 50kDa, representing the heavy chain of the antibody. The right lane shows 
immunoprecipitated forms ofPCNA. 
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Figure 5: (A) Immunoprecipitation using the PCNA antibody to obtain all forms of 
PCNA. The blot was probed for Western blotting with anti-sumo. Lane 1: 
Immunoprecipitation of PCNA showing a possible sumoylated form just above 38kDa. 
Lane 2: Negative control of no protein lysate showing just the heavy (50kDa) and light 
(25kDa) chains form the antibody. Lane 3: Protein lysate from LDT14 showing 
components of the sumo pathway/sumo substrates. (B) Blot (A) stripped and probed with 
PCNA. The left lane is the immunoprecipitated PCNA that is putatively sumoylated and 
right lane is the negative control. 
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Figure 6: (A) Combined growth curve of K. brevis in 125mL flasks. Sampling dates 
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Figure 7: Western blot analysis ofPCNA over the K. brevis growth curve. (A) PCNA at 
LDT12 in 5 biological replicates (B) Densitometry of the ---37kDa PCNA (C) 
Densitometry of the ---47kDa PCNA. 
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Figure 8: PCNA in log and stationary phase cultures. (A) Western blots ofPCNA 
in flask cultures showing the ---37kDa band. During log phase at LDTI2.Flow 
cytometry data shows that 55.74% of the log phase cell population was 
proceeding through S-phase at LDT 12. (B) Western blots data showing a PCNA 
of ---45 kDa at LDT 12 in stationary phase cultures. PL=protein lysate from a log 
phase culture at LDT 12 showing S-phase bands. (C) Peptide competition assay 
showing the specificity of the ---47kDa form ofPCNA. Left panel is western blot 
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showing aLDT12 protein lysate from Day 14 (late stationary) and log phase 
cultures. Right panel is western blot with antibody incubated in the presence of 
the peptide antigen to block specificity. PL=protein lysate from a log phase flask 
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Figure 9: Pattern of ubi quit in at ion in K. brevis matches the presence of the hypothesized 
ubiquitinated PCNA in biological replicates over the growth curve. (A) Western blot with 
anti-ubiquitin antibody showing the putative ubiquitin pathway components and 
substrates in Day 10 and 12 samples. (B) Western blot ofPCNA over the growth curve in 
two sets of biological replicates. Kb 9, 20, 19 and 7 refer to the same lL biological 
replicate cultures. Highlighted in red is the culture (one biological replicate) which is 
beyond stationary phase and according to cell counts has cell death occurring. 
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···· 1···· 1 ···· 1 · ··· 1 ···· 1···· 1···· 1·· · · 1 · ··· 1·· ·· 1 · ··· 1···· 1 · ··· 1 ···· 1···· 1 · · ·· 1 · ... 1 .· ·· 1 ···· 1 · · · · 1· ··· 1 · ··· 1 ···· 1·.·· 1 
Kb CDK Contig5041 AGACCCAGAGAAGGCAGAAGCGTTCTTGGT CTTTGAATATTGCCCAAGTGAT CTGACCGGCTGATGGCATACAGAAAGCAGCGT CTGAAAATGGGCGAGAT~GTTTGATCAAGCAGC 
Spl.iced Leader 
850 860 810 880 .,0 '00 '10 '20 HO '40 '50 "0 
···· 1···· 1 ···· 1···· 1 ···· 1···· 1 · · · · 1···· 1 · ··· 1···· 1···· I · · 1 ···· 1···· 1 · · ·· 1···· 1···· 1 .... 1···· 1 ·· · · 1 · · ·· 1···· 1···· 1···· 1 
Kb CDK Contig5041 TCATGAATGCAGTCGACTTCTGCCATATGAACGGTATCATGCACCGTGACTTGAAGCCCTCCAACGTGCTGATCACAGCAAGGGGAGAGCTGAAGCTATGTGATTT CGGCCTGTCGAGAA 
Spl.iced Leader 
no ,.0 "0 1000 1010 1020 1030 1040 1050 1060 1010 1080 
···· 1···· 1···· 1···· 1···· 1 ···· 1···· 1···· 1···· 1···· 1 ···· 1···· 1 ···· 1··· · 1 · · · · 1 ···· 1.·.· 1.·.· 1···· 1 ···· 1 ···· 1··· · 1 ···· 1 ···· 1 
Kb CDK Contig5041 TATTCAGCGGATCAGGCAACTTCTCAACACGGGTGATCACATTGTGGTACC GGCCAGCTGAGCTACTT CTCGGCACGCGAACATACGATCAGAGTGTAGACGTCTGGTCGTGCGGCTGCA 
Spl.iced Leader 
lUO 1100 1110 1120 1130 1140 1150 1160 1110 1180 lUO 1200 
···· 1···· 1··· · 1 ··· · 1 ·· · ·1 · · ·· 1··· · 1 ··· · 1 ·· ·· 1 ···· 1 · · ·· 1 · · · · 1 ···· 1···· 1···· 1···· 1···· 1 · ··· 1···· 1 · · ·· 1 ···· 1···· 1···· 1···· 1 
Kb CDK Contig5041 TGCTTGGTGAGTTATT GACCGGCTATCCAATGTTTCCAGAGTCCAGCGAGACGAGGGTTTT CGTCGCTATAGCCAACAAGCTAGCCCCAGTGGAAGATCTTTGGCCAGTGGAGTTGCGGA 
Spl.iced Leader 
1210 1220 1230 1240 1250 1260 1210 1280 12,. 1300 1310 1320 
···· 1···· 1··· · 1 ···· 1 ···· ' ···· , ··· · , · ·· · , · ·· · , · · · · , ···· , ··· · , ···· ' ···· 1···· ' ···· , ···· , ··· · , · ··· , ···· , · ··· , ···. , .... , .... , 
Kb CDK Contig5041 TGCTCCCACAGTGGAACAAGCTGTGGAGTGTGAAGCAGCAGTTCACCGGGAATGAAGAGCCCAGTGACGT CGT~GCATTTTTCAGGGAAGTTGCACGTTTGTACGGCCAAGAGTCTT 
Spl.iced Leader 
1330 1340 1350 1360 1310 1380 lUO 1400 1410 1420 1430 1440 
. . .. , . ... , . .. . , ... . , ... . , .... , ... . , .... , .. . . , . ... , .... 1···· 1 ·· . , ... · ' ... · 1 ·.·· 1·· · · ' ·· ·· ' ···· 1 ···· 1 .... ' ···· 1···· ' ·· . . , 
Kb CDK Contig5041 CAGAGCTCTTGCGCTCCA CGCTGGAACTGGAGCCAAGCAAGCGCATCAGCTCGGAAGCGGTCCTGCGACATTCGTGGTTCTT CAGGGATCCGATGCCTTGTCAACCCCACGAGATAAGAC 
Spl.iced Leader 
1450 1460 1470 1480 14'0 1500 1510 1520 1530 1540 1550 1560 
· ··· , ···· ' ···· 1 · ··· , ·· · · ' ···· 1···· 1···· ' ···· ' ···· 1 ··· · 1···· 1 ···· ' · ·· · 1·· ·· 1 ···· ' ···· , ···· , ···· ' ···· 1·· · · ' · ··· ' ···· 1 .. ·. 1 
Kb CDK Contig5041 TCAACCAGAACATGTCTTTCCACGAGCTCGATGTCAAAAGACATAGGGAAAAGTTGAGGCAAGAACAAGAGAACAAGCGCAAGCGGACGCAGGAATCGATGCGCGCGGGGGCCGATGACT 
Spl.iced Leader 
1510 1588 15'0 1600 1610 1620 lnO 1640 1650 1660 
Kb CDK Contig5041 CTGA~GCiG~~~GGAG~CiGciGTTC ~GATG~GAC~AGCA~GTGG~TGG~TCT~GGCC~GTG~~~~~!~~~~~~~~~~~~~~~~~~~ ~' 
Spl.iced Leader 
Figure 10: Full length sequence of a cyclin-dependent kinase in K. brevis. The presence 
of the spliced leader at the 5' end of the sequence is shown in the box, as well as the ATG 
start codon and the poly A tail at the 3' end. 
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Figure 11: Amino acid sequence of K. brevis CDK. This sequence has highest homology 
to the plant CDKCs found in O. sativa, S. lycopersicum, as well as the diatom CDK from 
T. psuedonana and the green alga, C. reinhardtii. Shown in the black box is the cyclin 
binding domain present in CDKs. The red box highlights the residue that is 
phosphorylated, in the T -loop of CDKs, which in tum activates the CDK. The asterisks 
(*) represent the residues that are involved in ATP binding and that are conserved in this 
K. brevis CDK. 
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US -
Plasmodium CDK 7 
K. brevis CDK 7-like 
K. brevis CDK 7-like 
K. brevis CDK C-like 
Arabidopsis CDK C 
Chl~dmmonas CDK Cp 
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I· ... I ........................ ... 
Figure 12: Partial alignment of K. brevis cyclin dependent kinases (CDKs) and CDK 7 
from Plasmodiumfalciparum, CDK C from Arabidopsis thaliana, and a CDK from 






Figure 13: Cyclin-dependent kinase inhibitors used for the CDKI studies. (A) 




Figure 14: SYTOX staining of K. brevis showing (A) live cells with no nuclear staining 
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Figure 15: PCNA abundance throughout S-phase. (A) Flow cytometry data showing 
---60% of the cell population proceeding through S-phase between LDT12 and 14. (B) 
Western blot analysis of PCNA throughout S-phase where the 28kDa PCNA is only 
present in a small amount at LDT2. A long exposure was necessary for this band to 
appear. (C) Densitometry of the ---37kDa band shows a higher significant difference 
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Figure 16: PCNA protein abundance at LDT12 after inhibition with CDKls. "S-phase 
bands" refers to the positive control for both forms of PCNA from a 1 liter culture. (A) 
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Figure 17: Linear correlation analysisof percent of the cell population in S-phase 
and the 37kDa PCNA protein abundance. R2=O.7812, p<O.OOOI. 
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Table 1: Sequences from K. brevis with homology to cyclin dependent kinases. Shown 
are the top hit organisms and the e-values. 
Marine Genomics 10 Protein Species EValue 
108857 cyclin dependent kinase C Arabidopsis Iyrata 3.00E-57 
2031566 cell cycle-related kinase Esoxlucius 5.00E-22 
105637 cyclin-dependent kinase-related kinase Cryptosporidium hominis 1E-53 
2033180 cycl i n-dependent ki nase-rel ated ki nase C. hominis 6.16E-66 
2031949 cyclin-dependent kinase 1; p34cdc2 Dunaliella tertio/ecta 3.00E-09 
107238 cyclin G associated kinase 80s taurus 4E-29 
2079904 cdc2 DrosoDhiia me/anoaaster 3.00E-08 
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Table 2: Fascaplysin range finder study results. The concentration determined to induce 
the highest percent G 1 block with the highest viability and best reproducibility was 
1.5JlM. 
%Gl %S %G2/M %Viability 
Control 39.40 60.60 0.00 95.5 
H,O 40.30 59.53 0.17 98 
Fascaplysin SIlM 90.40 0.27 9.37 84.5 
Fascaplysin 2.SIlM 95.50 1.00 3.53 37 
Fascaplysin 1.SIlM 92.17 5.00 2.83 80.4 
Fascaplysin 0.7SIlM 75.73 21.83 2.40 68 
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Table 3: Olomoucine range finder study results. The concentration determined to induce 
the highest percent G 1 block with highest viability and the best reproducibility was 
12.5I1M. 
%Gl %S %G2/M %Viability 
Control 51 48.85 0.15 100 
Olomoucine 50J.l,M 97.8 0 2.2 86 
DMSO (37.25 J.l,L) 79.6 16.1 4.35 95 
Olomoucine 25J.1,M 98.5 0 1.5 92 
Olomoucine 12.5J1M 93.8 0.47 5.73 96 
DMSO (9.3125 J.l,L) 26.5 68.05 5.5 96 
Olomoucine 6.25J.1,M 83.97 13.5 2.5 93.5 
DMSO (4.656 ~LJ 44.35 55.3 0.35 92 
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Table 4: Flow cytometry of K. brevis cell populations at LDT12 after inhibition with the 
CDKIs, olomoucine or fascaplysin,for 12 hours. Percent viability refers to percent of the 
cell population viable after a 12 hour exposure to the CDKIs as determined by SYTOX 
staining. Samples from this study were used for protein abundance analysis. 
%Gl %S %G2/M % Viability Cell Counts (Ave. celis/mLl 
Control 39.6 55.54 4.86 96.8 15,206 
H,O 41.94 54.34 3.76 98.6 15,675 
Fascaplysin 1.51lM 95.84 0.84 3.32 80 15,917 
DMSO 58.78 39.58 1.62 98.6 15,354 
Olomoucine 12.51lM 94.84 2.54 2.64 99 13,369 
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Chapter 5: Conclusions, Significance and Future Directions 
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The studies presented in this dissertation were undertaken to gain better 
understanding of processes that regulate the cell division cycle in the dinoflagellate K. 
brevis. K. brevis is responsible for toxic red tides that occur almost annually in the Gulf 
of Mexico that cause marine animal mortalities, human illness and economic loss by 
impacting fisheries and tourism. The study of growth in this organism will lead to better 
understanding of processes driving bloom formation and the development of field 
biomarkers for assessing bloom status that will improve modeling and mitigation efforts. 
Since growth in blooms results primarily from vegetative cell division, processes 
regulating the cell cycle are central to bloom growth. The cell cycle of dinoflagellates has 
been studied for many decades (Sweeney and Hastings, 1958; Olsen and Chisholm, 1986; 
Homma and Hastings, 1989; Roenneberg, 1996; Taroncher-Oldenburg, 1997; Van Dolah 
and Leighfield, 1999; Leighfield and Van Dolah, 2001, Litaker et aI., 2002; Dagenais-
Bellefuielle et aI., 2008). However this has mostly been investigated in terms of cellular 
physiology and only in the past decade with the development of genomics tools has the 
molecular biology of these organisms begun to be elucidated. 
Dinoflagellates are a unique group of organisms in which to study cell cycle 
based on their position in the tree of life and many novel adaptations found only in this 
group of primitive, unicellular eukaryotes. The diversity of cellular and molecular 
systems in microbial eukaryotes is staggering, and some emerging patterns are indicative 
of convergent evolution which appears to have played a major role in shaping the overall 
organization of eukaryotic cells at all levels (Lukes et aI., 2009). Dinoflagellates have 
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acquired photosynthesis through secondary (and in the case of K. brevis, tertiary) 
endosymbiotic events and through these evolutionary events, have obtained 3 genomes 
(nuclear, chloroplastic and mitochondrial (Keeling, 2009). Dinoflagellates deviate from 
the canonical view of gene expression, and the central dogma, in that they use trans-
splicing and have polycistronic messages which are unlike prokaryotic polycistronic 
messages in that they seem to contain tandemly repeated copies of the same gene (Zhang 
et aI., 2007, Lidie and Van Dolah, 2007, Bachvaroffand Place, 2008; reviewed in Lukes 
et aI., 2009). These characteristics are missing from their nearest neighbors, the 
apicomplexans and ciliates, and thus appear to be a secondarily evolved state. 
Kinetoplastids, such as the parasitic Trypansoma, also possess these unusual molecular 
biological characteristics, which are absent from their evolutionary neighbors the 
Euglenids, although they are separated from dinoflagellates by more than 900 million 
years. As parasites, trypanosomes have to deal with stressful transitions between 
environments found in different host species in which these organisms have different life 
stages. It is unclear what conditions have driven their convergent evolution, but both 
trans-splicing and polycistronic messages appear to confer adaptive advantage to 
dinoflagellates and kinetoplastids despite their different life styles. 
The overarching objective of this project was to determine how K. brevis 
regulates its cell cycle in the absence of transcriptional control of gene expression. As 
the cell cycle is one of many processes tightly coupled to the photoperiod, this project 
first investigated diel patterns of protein expression in K. brevis. Unlike the dinoflagellate 
L. polyedrum,which has been shown to have a circadian rhythm of translation where 
translation takes place only during the night, we determined that in K. brevis there does 
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not appear to be circadian regulation of global protein synthesis, and therefore we might 
expect to see cell cycle proteins synthesized at times corresponding to the cell cycle 
phases in which they are needed. Proteomic analysis using DIGE found only 4% of the 
--500 proteins resolved from total cellular protein to be changing in expression over the 
diel cycle, and these changes followed varying patterns that would appear to correspond 
with their needs, rather than a bulk turnover during the dark as suggested by the studies in 
L. polyedrum. Because whole cell protein extracts resolved only the highest expressed 
proteins in the cell, subcellular fractionation followed by two dimensional gel proteomic 
methods were developed that succeeded in identifying nuclear proteins for which there no 
previously published data in dinoflagellates. We found that nuclear isolation in 
combination with LTQ MS/MS was essential to obtain successful protein identifications 
because we currently lack genomic sequence data from which to derive adequate mass 
peptide fingerprints for K. brevis proteins. The identification of nuclear proteins clearly 
shows that this method can be used successfully to study K. brevis. Additionally, once 
mass spectra are obtained, such as those from the studies presented in Chapter 2, the 
spectra can later be searched against newly acquired sequence information with the hopes 
of identifying more proteins from previous experiments. Nuclear proteomics should 
provide a wealth of information on dinoflagellate biology since this organism has an 
unusual nucleus. Nuclear proteomics has recently proved to be a useful tool in studying 
plant biology, since the plant nucleus also possesses some significant differences in 
appearance and composition from other eukaryotes, which indicates specific molecular 
pathways (Erhardt et aI., 2010). The nucleus is a dynamic organelle and proteins are 
constantly moving into and out this compartment (Gonzalez-Melendi et aI., 2000). 
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Therefore, an interesting experiment would be to investigate the nuclear proteome of K. 
brevis over the cell cycle since this organism displays post-transcriptional control, 
appears to use translational control and possibly post-translational modifications to 
regulate cellular processes and nuclear proteins are now able to be successfully identified. 
We had hoped to identify DNA replication proteins in K. brevis nuclei as has been done 
in the chickpea C. arietinum. Proteins identified in this plant found a variety of protein 
classes including those involved in signaling, gene regulation, DNA replication and 
transcription (Panday et aI., 2006). U sing a large amount of K. brevis nuclear protein 
may overcome the problem of identifying proteins of specific interest since nuclear 
protein samples have low protein quantity and concentration (Erhardt et aI., 2010). 
Genomic studies in K. brevis have provided a wealth of information that, without EST 
sequencing and development of a microarray, would have been impossible. However, 
there are limitations with genomic analysis in that it cannot provide complete information 
of cellular and subcellular functions, in which proteins, not genes, govern the functions 
(Klein and Thongboonkerd, 2004). Proteins are dynamic and many functions are 
regulated by post-translational modifications, which are unable to be investigated using a 
genomics approach. This becomes especially important in an organism such as K. brevis 
that uses post-transcriptional control of gene expression. As additional information on 
the genome of K. brevis becomes available through deep transcriptome sequencing via 
second generation sequencing technologies, the use ofproteomics will become easier and 
more fruitful. 
While this project was underway, a 5' trans-spliced leader sequence was 
identified on diverse mRNAs in dinoflagellates, including K. brevis (Lidie and Van 
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Dolah, 2007; Zhang et aI., 2007). The presence of the spliced leader sequence and 
polycistronic messages in dinoflagellates suggests a constitutive transcription program 
similar to the Trypanosomatids, and much of our current insight into dinoflagellates 
comes from studies on their well characterized system of post-transcriptional regulation. 
In Chapter 3 we reported the presence of the spliced leader sequence on the 5' end ofS-
phase genes, suggesting that S-phase might be regulated by post-transcriptional 
mechanisms, and consistent with this we saw no changes in their transcript abundance 
over the cell cycle. Turning to the trypanosome cell cycle for a model, we found the 
trypanosomatid,CrithidiaJasciculata possesses polyA binding proteins that stabilize the 
mRNAs of DNA metabolism proteins such as RPA1 specifically during S-phase (Pasion 
et aI., 1994). These polyA binding proteins bind to an octomer sequence present in 
transcripts required for the cell cycle-dependent regulation of the mRNA levels that cycle 
and it is thought that the binding of these proteins varies during the cell cycle in parallel 
with the levels of putative target mRNAs (Mittra and Ray, 2004). However, we have not 
identified a similar octomeric motif, or any other conserved motif, in the 5' or 3' UTR of 
K. brevis S-phase genes. Therefore, it would seem that dinoflagellates have a different 
solution to the problem of cell cycle phase-specific protein expression. It might be 
informative to do a comparative study of this process in dinoflagellates and 
apicomplexans, the nearest relatives to dinoflagellates. Apicomplexans lack the spliced 
leader mechanism and transcription in the apicomplexan, Plasmodium Jalciparum, is 
monocistronic; however, the genome contains a dearth of genes encoding transcription 
factors compared with other eukaryotic genomes and comparative genomic analysis 
shows a disproportionately high number of proteins involved in mRNA stability and 
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deadenylase activity in the genome, suggesting post-transcriptional control of gene 
expression to some extent (Coulson et aI., 2004; Le Roch et aI., 2004). It is thought that 
these mechanisms may confer advantages for the Plasmodium parasites to quickly adapt 
to environmental changes and could explain the common usage of these mechanisms 
throughout Apicomplexa (Le Roch et aI., 2004). Since dinoflagellates evolved from a 
common ancestor to the apicomplexans, it may be that dinoflagellates are using a similar 
approach to life, with enhancement of the spliced-leader to mediate mRNA processing. 
At the start of this project ESTs for a number of cell cycle genes had been 
identified in K. brevis but they had not been fully characterized. The studies in Chapter 3 
found some unusual phenomena in K. brevis cell cycle proteins. The first is the high 
copy number of PCNA genes, as evidenced by 11 unique contigs that encode 9 different 
amino acid sequences that vary only at 20 conserved polymorphic sites. PCNA is also 
highly amplified in other dinoflagellates species. The alveolate Perkinsusmarinus, which 
is the closest relative to dinoflagellates, seems to represent an intermediate state between 
the true dinoflagellates and the true apicomplexans. Perkensis has over 10 copies of the 
PCNA gene, with identical gene structures, similar nucleotide sequences (88-99%) and 
almost identical amino acid sequences (Zhang et aI., 2010). A spliced leader sequence 
was also found at the 5' end of P. marinus PCNA. It may be that this highly important 
gene has not only been conserved throughout evolution but in these unusual protists 
which have high copy number of certain genes such as PCNA, the duplication events 
have also been retained. Another gene also highly amplified was RnRI. However, its 
partner RnR2, as well as RFC and RP A seem to be in low copy number based on EST 
diversity. If this is the case it must be that correct protein stoichiometry is achieved at the 
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level of translation. In Chapter 3 we observed S-phase specific increases in protein levels 
of these proteins, in the absence of increases in their transcript levels. In Trypanosoma 
cruzi, PCNA mRNA and protein are detected throughout the cell cycle similar to K. 
brevis; however in T. cruzi, there is an increase in both mRNA and protein during S-
\ 
phase (Calderano et aI., 2007). The PCNA protein is always present in the nuclear space 
but varies over the cell cycle with· replication sites at the nuclear periphery indicating that 
there are storage pools of PCNA in T. cruzi (Calderano et aI., 2007). In contrast, in K. 
brevis anti-PCNA strongly labeled replication sites distributed throughout the nucleus 
during S-phase. In this case, peripheral pools were apparent in Gland G2. This 
indicates that replication forks in K . brevis, which have not been previously 
characteriz~d, are distributed throughout the chromatin during S-phase. 
The investigation of dinoflagellate CDK and cyclin sequences in Chapter 4 
revealed that they had limited sequence siniilarity to the well-characterized CDKs, being 
more similar CDKC in plants (Barroco et aI., 2003) and CDK 7 in other alveolates such 
as P. Jalciparum (Srinivasan and Krupa, 2005). The K. brevis CDKe-like protein has 
conserved ATP binding sites but a divergent cyclin binding motif. We have likely not 
identified all of the CDKs in K. brevis in the existing EST library. CDK i$ibitor studies 
in Chapter 4 using fascaplysin, which is highly selective for CDK4, points to the presence 
of a CDK4-like protein, as this inhibitor blocked DNA replication as well as PCNA 
protein production. The timing of the restriction point in K. brevis is currently unknown 
and the block in S-phase progression by fascaplysin addition at LDTO (Gl by flow 
cytometry analysis) may be indicative of the restriction point occurring sometime around 
the dark to light transition. This is suggested by the fact that PCNA is present at LDT2, 
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suggesting a subpopulation of cells that have already passed through the restriction point 
and are primed to proceed into S-phase. By flow cytometry, S-phase does not begin until 
--LDT6; however, by the time flow cytometry can identify a cell as being in S-phase 
based on fluorescent DNA staining, it has already carried out significant DNA 
replication. Together, these results lead to the possibility that there is/are functional 
homolog(s) ofGl CDKs in K. brevis that control cell cycle progression. A question that 
is raised from the sequence analysis and cell physiology studies involving CDK is how 
many CDKs might be involved in cell cycle progression in K. brevis. A phylogenetic 
study ofCDKs across phyla identified 14 CDK members in C. elegans, 13 in D. 
melanogaster, 8 inS. pombe, 7 in S. cerevisiae and 21 in H. sapiens (Liu and Kipreos, 
2000) and 6 have been identified in P. Jalciparum (Jirage et aI., 2010). It will be 
interesting to determine the number of cell cycle CDKs in dinoflagellates and how they 
drive the K. brevis cell cycle, given the apparent absence ofCDK-dependent 
transcription. 
The presence of multiple forms ofPCNA protein in Chapter 3 led to the 
investigation in Chapter 4 of possible post-translational modification mechanisms in K. 
brevis, specifically sumoylation and ubiquitination. This level of regulation may be 
essential in dinoflagellate cell cycle control and it has been neglected in dinoflagellate 
research. In general, eukaryotes use a multitude of post-translational modifications to 
regulate the cell cycle including but not limited to phosphorylation by cyclin dependent 
kinases and other kinases, acetylation of histones by histone acetyltransferases (HATs), 
ubiquitination by the anaphase promoting complex and other by other ubiquitin pathway 
components, and by the more recently discovered sumoylation of transcription factors 
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and PCNA. The fact that K. brevis and other dinoflagellates use mostly post-
transcriptional regulation of gene expression leads to the hypothesis that not only 
translational control but post-translational modifications may play an even larger role in 
cellular processes than in other eukaryotes. For example, PCNA can be ubiquitinated, 
sumoylated, and acetylated and in yeast PCNA it appears that ubiquitin and sumo can 
coexist in a single PCNA subunit. Therefore, this protein has multiple levels of 
regulation and these PTMs could be occurring in the dinoflagellate since they are 
reversible and provide flexibility for the cell. 
Chapter 4 provides the first evidence of sumoylation in a dinoflagellate which 
warrants further study. In the yeast S. cerevisiae, a recent study found that in 
exponentially growing cultures that PCNA modification by SUMO is more extensive 
than previously reported and includes oligomeric chains on 2 different lysine residues, 
K164 and K127 (Windecker and Ulrich, 2008). Changes in molecular weight of K. 
brevis PCNA during S-phase are consistent sumoylation during S-phase in exponentially 
growing cultures. A single homolog for SUMO was identified in the K. brevis EST 
library. Single SUMO homo logs are also found in a variety of protists including 
Trypanosoma brucei, T. cruzi, Leishmania major, P.Jalciparum, Theileria annulata, 
Entomaeba histolytica, Cryptosporirium parvum and C. hominis (Ponder and Bogyo, 
2007), as well as yeast. Immunoprecipitation studies in P. Jalciparum showed that the 
nuclear protein Sir2 is sumoylated in this protist and it is suggested that this PTM may 
play an important role in this parasite (Issar et aI., 2008). Preliminary data generated here 
suggesting that PCNA is sumoylated should be confinned. An infonnative experiment to 
further detennine PCNA sumoylation in K. brevis would be to produce a recombinant 
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PCNA and either Western blot with an anti-SUMO antibody (which has not proved 
trivial) or perform an in vitro sumoylation assay to verify whether PCNA can be 
sumoylated. Alternatively, a mass spectrometry approach could be used to obtain 
information on sumoylated PCNA. There are signatures that could be indentified such as 
the lysine on PCNA to which the sumo G-G motif binds. In the SUMO sequence, there 
is a conserved threonine residue on the amino side of the motif that is unique to this 
ubiquitin-like modifier which would aid in its identification. This method may prove 
difficult due to the fact that sumo can form chains similar to ubiquitin. Additionally, 
although the ubiquitin studies were not conclusive, an interesting study would be to 
inhibit the ubiquitin pathway, for example using MG 132, and determine if PCNA is 
modified. Investigation of post-translational control, specifically of growth related 
proteins, in dinoflagellates will ultimately be necessary in order to gain in depth 
information on important cellular processes and how they are controlled. 
The last objective of this project included an effort to determine whether PCNA 
might provide a useful biomarker for growth in Florida red tides. In order to develop 
successful biomarkers for growth in dinoflagellates, there is a need for understanding the 
basic biology of this organism. K. brevis HAB forecasting is currently done using 
satellite derived image products, wind predictions and models derived from previous 
observations and research (Stumpf et aI., 2009) which involve integrating physical and 
biological oceanographic measurements. There is limited data on the physiological 
processes of K. brevis that are critical to growth of cells and populations in different 
environments (Sinclair et aI., 2009). Therefore it would be valuable to implement 
biomarkers that can fine-tune forecasting models by determining bloom trajectory (i.e., 
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growing or declining) on a cellular scale. The results of this study suggested PCNA at 
the protein level could prove useful since this dinoflagellate is regulating its cell cycle at 
the post-transcriptional level, such that PCR-based methods would not be infonnative. 
The analyses in Chapter 4 show that there is a significant linear correlation between the 
expression of S-phase specific 37kDa PCNA and the growth rate of the population. This 
protein is virtually absent from stationary phase making this protein a particularly 
promising tool for biomarker development. An unexpected result of Chapter 4 was the 
identification of a 47 kDa form ofPCNA only in cultures beginning to decline. If the 
hypothesis of PCNA ubiquitination during stationary phase presented in Chapter four 
proves correct, there is potential for this protein to be developed into a bloom termination 
biomarker. 
In summary, the studies presented in this body of research provide a new level of 
insight into the regulation of protein expression in K. brevis, and in particular the 
expression S-phase proteins that are regulated in a cell cycle dependent manner. The new 
information gained has both theoretical and applied value. As K. brevis uses post-
transcriptional control of the cell cycle unlike most eukaryotes, the insight gained from 
these studies will contribute to our understanding of cell cycle regulation from an 
evolutionary standpoint. This research has laid the groundwork for further investigations 
on cell cycle regulation at the translational or post-translational level in this organism. 
Additionally, this work identified an applied endpoint with the potential ofPCNA to be 
used as a biomarker for K. brevis bloom progression. 
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Appendix 1: Cell cycle genes present in K. brevis. Contigs with homology to S-phase 
genes are shaded. Contigs in bold are S-phase genes investigated in this study. Marine 







Gene Ontologies #GOs 
Genomics 10 Length e-value Similarity 
P:mitosis; C:spindle; C:centrosome; F:ATP binding; F:microtubule-
MGI D1986592 aaa atpase 737 10 1.63E-62 71.90% 7 severing ATPase activity; P:cell division; C:microtubule 
C:cytoplasm; C:dynein complex; F:protein binding; P:mitosis; 
P:nervous system development; F:motor activity; C:spindle pole; 
MGID103202 aaa atpase 571 10 3.39E-17 54.50010 8 C:microtubule 
F:DNA ligase (ATP) activity; P:cell cycle; P:DNA repair; F:ATP binding; 
F:DNA binding; P:cell division; P:DNA replication; P:DNA 
MGID2059523 atp-dependent dna ligase 1700 10 2.27E-05 45.90% 8 recombination 
P:apoptosis; F:protein serine/threonine kinase activity; P:cell division; 
F:ATP bi nding; P:mitosis; C:outer kinetochore of condensed 
chromosome; P:negative regulation of cell cycle; C:cytoplasm; 
C:nucleus; P:protein amino acid phosphorylation; P:serine family 
MGID2033955 budding uninhibited by benzimidazoles 1 beta 969 10 l.28E-16 53.60'10 11 amino acid metabolic process 
MGIDl961650 budding uninhibited by benzimidazoles 3 homolog 752 3 1. 88E-05 46.67% 0 
P:ciliary orflagellar motility; P:mitosis; F:calcium ion binding; 
MGI D2079501 caltractin ame: full=centrin 1295 10 l.37E-09 63.10010 6 C:centrosome; C:bacterial-type flagellum; P:cell division 
P:ciliary orflagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGIDl944632 caltractin ame: full=centrin 438 10 2.59E-31 79.30010 5 F:calcium ion binding; P:cell division 
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID1950142 caltractin ame: full=centrin 381 10 6.95E-16 62.00% 5 F:calcium ion binding; P:cell division 
c:cytosol; F:bindi ng; P:negative regulation of ubiquitin-protein ligase 
activity duri ng mitotic cell cycle; P:mitotic metaphase plate 
congression; P:cell division; P:anaphase-promoting complex-
dependent proteasomal ubiquitin-dependent protein catabolic 
process; P:G1 phase of mitotic cell cycle; P:positive regulation of 
ubiquitin-protein I igase activity during mitotic cell cycle; P:regulation 
of exit from mitosis; P:regulation of mitotic metaphase/anaphase 
transition; C:nucleoplasm; C:anaphase-promoti ng complex 
MGID1986476 cdc23 (cell division cycle homolog) 696 10 1.72E-15 53.80010 12 
MGI D2025806 cdc27 nuc2-like protein 1010 10 7.28E-18 52.60'10 1 F:binding 
P:protein amino acid phosphorylation; F:ATP binding; F:protein 
serine/threonine kinase activity; P:serine family amino acid metabolic 
MGI D2063280 cdc2-like protein 460 10 3.62E-41 71.10010 4 process 
P:peptidyl-tyrosine phosphorylation; F:ATP binding; F:protein tyrosine 
kinase activity; C:nucleus; P:protein amino acid autophosphorylation; 
F:protein serine/threonine kinase activity; P:serine family amino acid 
MGID1984286 cdc-like kinase 2 769 8 l.23E-15 55.25% 7 metabolic process 
P:protein amino acid phosphorylation; P:cell cycle; F:ATP binding; 
C:nucleus; F:cyclin-dependent protein kinase activity; P:cell division; ; 
MGI D2031566 cell cycle related kinase 1453 10 l.75E-56 53.90010 8 P:serine family amino acid metabolic process 
MGI D2079185 cell division 908 10 1. 11E-27 55.70010 2 P:cell cycle; F:binding 
C:cytoplasm; F:exonuclease activity; F:nucleic acid binding; P:rRNA 
MGID1950185 cell division control protei n 696 4 8.03E-05 43.25% 5 processing; C:nucleus 
F:RNA polymerase II carboxy-terminal domain kinase activity; 
C:midbody; C:spindle microtubule; P:mitotic cell cycle G2/M transition 
DNA damage checkpoint; P:cell division; P:anti-apoptosis; F:ATP 
binding; P:mitosis; F:cyclin-dependent protein kinase activity; 
C:nucleus; P:protein amino acid phosphorylation; F:Hsp70 protein 
binding; P:serine family amino acid metabolic process; 
MGIDl944473 cell division control protein 2 512 10 2.D4E-32 73.40010 14 
P:regulation of mitotic metaphase/anaphase transition; F:binding; 
MGID2062699 cell division cycle protein 23 747 10 2.27E-27 59.50010 3 C:anaphase-promoting complex 
F:nucleoside-triphosphatase activity; F:ATP-dependent peptidase 
activity; F:ATP binding; P:proteolysis; F:serine-type endopeptidase 
activity; P:cell division; P:ATP-dependent proteolysis 
MGID106856 cell division cycle protein 48 594 10 1. 13E-64 70.70010 7 
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MGI D2053020 cell division protein 758 7 2.5OE-05 47.29% 0 
F:identical protein binding; F:serine-type endopeptidase activity; 
P:response to cadmium ion; C:plasma membrane; C:cell wall; F:ATP 
binding; F:nucleoside-triphosphatase activity; P:proteolysis; F:ATP-
dependent peptidase activity; P:cell division; P:ATP-dependent 
MGID2075292 cell division protein 880 10 3.40E-I13 81.40% 11 proteolysis 
MGIDI988475 cell division transporter substrate-bi nding protein 796 10 7.53E-ll 44.100A. 2 P:biological_process; C:cellular component 
P:ciliary or flagellar motility; C:bacterial-type flagellum; F:calcium ion 
MGIDI942943 centri n 304 10 8.53E-13 79.10% 3 binding 
F:ATP-dependent helicase activity; F:nucleic acid binding; P:mitosis; 
F:calcium ion binding; C:centrosome; F:ATP binding; P:cell division 
MGID1952319 centrin 500 10 6. 84E-14 91.80% 7 
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGIDI950294 centrin 647 10 1.28E-51 80.00% 5 F:calcium ion binding; P:cell division 
F:ATP-dependent helicase activity; F:nucleic acid bindi ng; P:mitosis; 
F:calcium ion binding; C:centrosome; F:ATP binding; P:cell division 
MGID1939358 centrin 410 10 1. 14E-10 80.20% 7 
F:ATP-dependent helicase activity; P:ciliary orflagellar motility; 
F:nucleic acid binding; F:calcium ion binding; F:ATP binding; C:bacterial 
MGID2035389 centrin 1074 10 5. 13E-57 82.90% 6 type flagellum 
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID2035650 centrin 769 10 1.39E-75 87.60% 5 F:calcium ion binding; P:cell division 
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID2035920 centrin 672 10 1.C6E-75 87.60% 5 F:calcium ion binding; P:cell division 
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID2039572 centrin 764 10 1.37E-75 87.60% 5 F:calcium ion binding; P:cell division 
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID2039826 centrin 826 10 1. 59E-75 87.60% 5 F:calcium ion binding; P:cell division 
P:ciliary orflagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGI D2040229 centrin 774 10 2.85E-76 88.20% 5 F:calcium ion binding; P:cell division 
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID2021179 centrin 815 10 1. 54E-75 87.60% 5 F:calcium ion binding; P:cell division 
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID2043662 centrin 768 10 1.39E·75 87.60% 5 F:calcium ion binding; P:cell division 
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID2045393 centrin 794 10 1. 48E·75 87.60% 5 F:calcium ion binding; P:cell division 
P:cil iary or flagellar motil ity; P:mitosis; C:bacterial-type flagellum; 
MGID2046404 centrin 770 10 6. 24E-76 88.200A. 5 F:calcium ion binding; P:cell division 
P:ciliary orflagellar motility; P:mitosis; C:bacterial-type flagellum; 
MG1D2047451 centrin 792 10 1.48E-75 87.60% 5 F:calcium ion binding; P:cell division 
F:ATP-dependent he I icase activity; F:nucleic acid bindi ng; P:mitosis; 
F:calcium ion binding; C:centrosome; F:ATP binding; P:cell division 
MGID2053478 centrin 602 10 2. 11E-31 81.200Ai 7 
P:ciliary orflagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID2055568 centrin 817 10 1.56E-75 87.60% 5 F:calcium ion binding; P:cell division 
P:ciliary orflagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID2057811 centrin 787 10 2.94E-76 88.20% 5 F:calcium ion binding; P:cell division 
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum; 
MGID2072941 centrin 789 10 1.47E-75 87.600Ai 5 F:calcium ion binding; P:cell division 
MGID2033952 centromere protein zwl0 1370 10 7.88E-19 44.90% 3 C:chromosome, centromeric region; P:mitosis; C:nucleus 
MGIDI06806 centrosomal protein 860 1 5.44E-05 46.00% 0 
MGID2036S40 centrosomal protein 110 847 10 5.65E-07 50.90% 3 C:centrosome; F:protein binding; P:cell division 
MGID1991453 centrosomal protein 164kda isoform 4 890 4 3.70E-04 48.00% 0 
MGIDI985334 centrosomal protein 2 isoform 1 isoform 2 739 10 1.27E-06 44.90% 2 C:cilium; P:cell cycle 
MG1D198649O centrosomal protein 250 642 10 5. 21E-OS 43.10% 2 C:cilium; P:cell cycle 
MGID2020556 centrosomal protein 290kda 1075 1 5.04E-04 48.oooA. 0 
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P:vesicle-mediated transport; C:cytosol ; P:cell projection organization; 
F:microtubule minus-end binding; P:eye photoreceptor cell 
development; C:cell surface; C:centrosome; P:hindbrain development; 
F:transcription activator activity; C:photoreceptor connecting cilium; 
P:otic vesicle formation; C:gamma-tubulin complex; P:pronephros 
development; P:protein transport; C:membrane; C:nucleus; C:tubulin 
complex; P:positive regulation of transcription 
MGID2042570 centrosomal protein 290kda 1247 10 8.70E-06 43.00010 18 
C:chromosome, centromeric region; F:zinc ion binding; P:cell cycle; 
P:regulation of transcription, DNA-dependent; P:chromatin assembly 
or disassembly; F:histone methyltransferase activity (H3-K9 specific) ; 
P:histone H3-K9 methylation; C:nuclear heterochromatin; P:cell 
differentiation; F:chromatin binding; P:chromatin remodeling 
MGID1952149 chromodomain protein (hp1-like) 432 10 l.00E-06 65.90% 11 
F:kinesin binding; P:centrosome organization; P:cell cycle; C:ci liary 
rootlet; P:cell projection organization; C:centriole; F:structural 
MGID1965108 ciliary rootlet coiled- rootletin 815 10 2.35E-07 40.90% 8 molecule activity; C:kinesin complex 
P:protein amino acid phosphorylation; P:positive regulation of cell 
proliferation; P:multicellular organismal development; P:regulation of 
mitosis; F:ATP binding; F:cyclin-dependent protein kinase activity; 
P:cell division; ; P:serine family amino acid metabolic process 
MG ID 108857 cyclin dependent kinase 804 10 1.52E-51 62.10% 9 
MGID1990865 cyclin domain protein f -box protein 717 6 4.26E-08 54.50% 0 
MGID2032522 cyclin domain protein f -box protein 1507 10 5.08E-14 47.70% 2 F:protein binding; F:calcium ion binding 
MGID2022329 cyclin fold protein 1 isoform 2 430 3 1.00E-12 58.00010 1 C:nucleus 
P:protein amino acid phosphorylation; F:ATP binding; F:protein 
serine/threonine kinase activity; P:serine family amino acid metabolic 
MGID2031949 cyclin -dependent kinase 1 p34cdc2 1332 10 1.87E-09 45.70% 4 process 
P:protein amino acid phosphorylation; F:ATP binding; F:protein 
serine/threonine kinase activity; F:protein tyrosine kinase activity; 
MGID2033180 cyclin-dependent kinase-related kinase 1309 10 6. 16E-66 61.00010 5 P:serine family amino acid metabolic process 
F:DNA binding; F:ATP-dependent DNA helicase activity; F:ATP binding; 
MGID2021802 dna repair helicase rad25 family protein 1249 10 2.39E-96 68.80% 6 P:nucleotide-excision repair; C:nucleus; C:replication fork 
P:DNA replication; F:ATP binding; F:zinc ion binding; F:DNA ligase 
MGID2045460 dna ligase 1198 10 6.88E-61 56.10% 6 (ATP) activity; P:DNA recombination; P:DNA repair 
F:protein tyrosine phosphatase activity; P:DNA replication; P:protein 
amino acid dephosphorylation; F:ATP binding; F:nucleoside-
triphosphatase activity; F:DNA ligase (ATP) activity; P:DNA 
MGID2021309 dna ligase iii -like protein 956 10 6.38E-37 54.40% 9 recombination; P:DNA repair; P:tyrosine metabolic process 
C:focal adhesion; P:positive regulation of neurogenesis; P:response to 
X-ray; P:response to gamma radiation; F:protein C-terminus binding; 
P:central nervous system development; P:single strand break repair; 
P:chromosome organization; P:immunoglobulin V(D)J recombination; 
P:double-strand break repair via nonhomologous end joining; 
P:nucleotide-excision repair, DNA gap filling; P:cell division; 
C:cytoplasm; P:somatic stem cell maintenance; P:negative regulation 
of neuron apoptosis; C:DNA-dependent protein kinase-DNA ligase 4 
complex; P:DNA ligation involved in DNA repair; F:DNA binding; 
C:condensed chromosome; P:T cell differentiation in the thymus; 
P:provirus integration; P:DNA ligation involved in DNA recombination ; 
P:Tcell receptor V(D)J recombination; P:positive regulation of 
fibroblast proliferation; P:pro-B cell differentiation; F:DNA ligase 
(ATP) activity; C:DNA ligase IV complex; P:initiation of viral infection; 
F:ATP binding; P:in utero embryonic development; P:DNA replication; 
P:cell cycle; P:isotype switching 
MGID1960453 DNA ligase IV 809 10 1.76E-23 56.90% 33 
MGID2073646 DNA ligase-like 655 6 1.00E-17 48% 3 F:ligase activty; F:methyltransferase activity; C:plastid 
213 
F:DNA-directed DNA polymerase activity; P:DNA replication; 
F:exonuclease activity; F:DNA bi nding; F:two-component sensor 
activity; C:membrane; C:DNA polymerase complex; P:two-component 
signal transduction system (phosphorelay); C:protein histidine kinase 
MGID107892 dna polymerase epsilon subunit 803 10 8.10E-13 45.80% 10 complex; P:phosphorylation 
F:DNA-directed DNA polymerase activity; P:DNA replication; F:DNA 
binding; C:DNA polymerase III complex; F:ATP binding; F:nucleoside-
MGID1970469 dna polymerase iii (subunit gamma tau) 744 1 2.05E-04 40.00% 7 triphosphatase activity; C:nucleus 
MGID1971927 dna polymerase kappa 793 10 5.89E-32 59.20% 1 P:DNA repair 
F:N-acetyltransferase activity; F:DNA binding; C:intracellular; 
F:aspartic-type endopeptidase activity; F:zinc ion binding; P:DNA 
MGID1993226 dna polymerase lambda (pol lambda) 828 5 3.50E-06 49.60"10 7 integration; P:acyl -carrier-protein biosynthetic process 
MGID2053352 dna replication complex gins protein psfl 850 10 9.65E-23 54.70% 1 C:integral to membrane 
F:ATP binding; C:nucleus; F:DNA binding; P:DNA replication initiation 
MGID1984213 dna replication licenSing factor mcm6 852 10 1. 18E-44 57.40% 4 
P:regulation of DNA replication initiation; P:cytokinesis; F:zinc ion 
binding; P:embryonic development ending in birth or egg hatching; 
P:cell cycle; P:regulation of transcription, DNA-dependent; P:ONA 
unwinding involved in replication; C:MCM complex; P:reproduction; 
F:DNA binding; F:ATP binding; C:chromatin; F:ATPase activity; 
MGID2054360 dna replication licensing factor mcm6 1816 10 4.97E-98 60.60% 14 F:chromatin binding 
P:DNA replication initiation; F:DNA binding; F:ATP binding; 
MGID2060973 dna replication licensing factor mcm7 578 10 1.63E-06 57.00% 5 F:nucleoside-triphosphatase activity; C:nucleus 
F:nucleoside-triphosphatase activity; P:cell cycle; C:integral to 
membrane; F:ATP binding; F:DNA binding; P:cell division; 
MGIDl948832 dna segregation atpase related protein 459 3 4. 17E-05 50.33% 7 P:chromosome segregation 
F:nucleoside-triphosphatase activity; P:cell cycle; C:integral to 
membrane; F:ATP binding; F:DNA binding; P:cell division; 
MGID2067895 dna segregation atpase related protein 480 4 4.18E-05 51.50% 7 P:chromosome segregation 
C:cytoplasm; P:negative regulation of cell cycle; C:nucleus; F:protein 
MGID1960293 dph1 homolog 786 10 2.59E-48 69.70% 5 binding; P:cell proliferation 
P:ciliary or flagellar motility; F:ATP-dependent helicase activity; 
F:nucleicacid binding; P:mitosis; F:calcium ion binding; C:centrosome; 
F:ATP binding; C:bacterial -type flagellum; P:cell division 
MGID1964053 ef-hand 1 613 10 1.31E-31 80.80% 9 
C:cytoplasm; P:microtubule-based movement; C:microtubule 
associated complex; P:mitosis; F:ATP binding; P:cell division; 
MGID2059101 kinesin-related motor protein eg5 1 1523 10 2.85E-47 54.30% 8 F:microtubule motor activity; C:microtubule 
F:sequence-specific DNA binding; C:nucleus; F:flap endonudease 
activity; F:5'-3' exonuclease activity; P:DNA repair; P:DNA catabolic 
MGID1947619 flap endonuclease 1 541 10 2.47E-08 60.70% 6 process 
P:cell cycle; C:intracellular; P:barrier septum formation; F:GTP binding 
MGID1947939 gtp-binding prote in 358 10 1.03E-19 57.40% 4 
F:protein transporter activity; F:protein binding, bridging; 
P:chromosome condensation; C:nuclear pore; P:M phase of mitotic cell 
cycle ; P:NLS-bearing substrate import into nucleus; C:cytoplasm; 
P:response to stress; F:GTP binding; P:regulation of mitotic cell cycle 
MGI02073891 importin alpha 1766 10 1.62E-38 46.80% 10 
MGI02032753 katanin p80 (wd repeat containing) subunit b 1 813 10 4.40E-22 54.90% 5 P:mitosis; C:spindle; C:centrosome; C:microtubule; P:cell division 
P:negative regulation of microtubule depolymerization; P:positive 
regulation of microtubule depolymerization; C:axon; c:microtubule; 
C:spindle pole; C:centrosome; P:cell division ; F:microtubule-severing 
ATPase activity; F:dynein binding; P:mitosis; F:prote in 
heterodimerization activity; C:dynein complex 
MGID2032756 katan in p80 subunit 785 10 5.06E-12 49.50% 12 
P:microtubule-based movement; P:cell proliferation; F:DNA binding; 
P:mitosis; C:spindle; C:plus-end kinesin complex; C:centrosome; F:ATP 
binding; F:microtubule motor activity; C:microtubule 
MG101974388 kinesin family member 15 764 10 7.87E-15 57.90% 10 
C:cytoskeleton; C:nudeoplasm; F:protein binding; C:focal adheSion; 
MGID2021441 mediator of dna damage checkpoint 1 840 10 3.6OE-14 54.20% 6 P:cell cycle ; P:DNA repair 
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MGID2031034 minichromosome maintenance complex component 10 833 10 1.22E-06 43.50"10 3 C:nucieus; F:zinc ion binding; P:DNA replication 
F:DNA helicase activity; F:nucieoside-triphosphatase activity; 
C:nucieolus; P:regulation of transcription, DNA-dependent; P:DNA 
unwinding involved in replication; F:ATP binding; F:protein binding; 
P:DNA replication initiation; F:single-stranded DNA bind ing; 
MGID2036751 minichromosome maintenance complex component 4 1312 10 5.63E-43 57.20% 11 C:nucieoplasm; C:replication fork 
F:DNA helicase activity; F:nucieoside-triphosphatase activity; 
C:nucieolus; P:regulation of transcription, DNA-dependent; P:DNA 
unwinding involved in replication; F:ATP binding; F:protein binding; 
P:DNA replication initiation; F:single-stranded DNA binding; 
MGID2036754 minichromosome maintenance complex component 4 823 10 3.44E-30 57.90% 11 C:nucieoplasm; C:repl ication fork 
MGID2058230 minichromosome maintenance prote in 3 597 3.ooE-07 0 
MGID1973770 mitotic checkpoint protein 751 10 5.99E-44 67.00% 1 F:protein binding 
MGIDl944670 mitotic checkpoint prote in bub3 449 10 3.35E-18 57.90% 2 P:bio logica l process; C:CUL4 RING ubiquitin ligase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MG I 0107271 proliferating cell nuclear antigen 936 10 1.11E-134 94.50% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MG I 01938210 proliferating cell nuclear antigen 702 10 2.S4E-123 95.10% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MG I 01942569 proliferating cell nuclear antigen 834 10 6.37E-21 89.70% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGIOl942792 proliferating cell nuclear antigen 779 10 1.44E-43 85.20% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGI019S0082 proliferating cell nuclear antigen 660 10 3.20E-S2 76.30% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:ONA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGIOl9S0735 proliferating cell nuclear antigen 731 10 1.94E-l0 54.40% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MG I 01959915 proliferating cell nuclear antigen 596 10 1.66E-73 83.00% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MG I 01964521 proliferating cell nuclear antigen 793 10 5.14E-137 95.50% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGIOl964522 proliferating cell nuclear antigen 827 10 2.18E-117 94.20% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:ONA 
MGIOl994890 proliferating cell nuclear antigen 789 10 9.39E-115 94.50% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGI02019375 proliferating cell nuclear antigen 78> 10 5.38E-131 94.70% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGI02027046 proliferating cell nuclear antigen 994 10 2.28E-141 94.90% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MG I 02047621 proliferating cell nuclear antigen 992 10 5.OSE-141 95.50% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGI02OS2699 proliferating cell nuclear antigen 901 10 1.22E-135 95.40% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGI02OS7215 proliferating cell nuclear antigen 945 10 9.41E-142 95.10% 6 polymerase complex 
215 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGID2060175 proliferating cell nuclear antigen 440 10 1. 16E-47 94.30% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGID2063631 proliferating cell nuclear antigen 669 10 6.10£-116 95.00% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGID2063966 proliferating cell nuclear antigen 1921 10 1.13E-141 95.10% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGID2069044 proliferating cell nuclear antigen 626 10 1.65E-45 92.30% 6 polymerase complex 
F:DNA polymerase processivity factor activity; F:DNA binding; 
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA 
MGID2077091 proliferating cell nuclear antigen 1008 10 2.43E-13O 90.50% 6 polymerase complex 
F:manganese ion binding; P:regulation of DNA replication; F:protein C-
terminus binding; P:ceramide metabolic process; C:protein 
phosphatase type 2A complex; P:response to organic substance; 
C:microtubule cytoskeleton; P:negative regulation of tyrosine 
phosphorylation of Stat3 prote i n; P:regulation of cell adhesion; 
P:mesoderm development; C:cytosol ; F:protein heterodimerization 
activity; P:regulation of Wnt receptor signaling pathway; P:RNA 
splicing; P:regulation of cell cycle; F:iron ion bind ing; P:induction of 
apoptosis; P:negative regulation of cell growth; P:i nactivation of MAPK 
activity; P:regulation of cell differentiation; P:prote in amino acid 
dephosphorylation; P:regulation of transcription; P:second-messenger 
mediated signaling; C:plasma membrane; C:soluble fraction; 
C:nucleus; F:prote in serine/threonine phosphatase activity; 
MGID207S819 prote in phosphatase 2 catalytic alpha isoform 1392 10 8.S8E-138 84.70% 28 C:mitochondrion 
P:cell cycle; F:ATP binding; F:nucleoside-triphosphatase activity; 
MGID20811S7 rad17 homolog 1067 10 3. llE-14 42.30"10 S C:nucleus; P:DNA repair 
P:DNA replication; P:nucleotide-excision repair, DNA gap filling; 
C:nucleoplasm; F:DNA clamp loader activity; C:DNA replication factor C 
complex; F:ATP binding; F:enzyme binding; C:DNA polymerase 
MGID20S6083 replication factor c (activator 1) 1298 10 8.76E-81 66.30% 8 complex 
P:DNA replication; F:ATPase activity; F:DNA binding; C:DNA replication 
factor C complex; F:protein binding; F:ATP binding; C:nucleus 
MGID106618 replication factor c (activator 1) 38kda 864 10 7.34E-5O 64.20% 7 
P:DNA replication; F:DNA clamp loader activity; C:DNA replication 
factor C complex; F:ATP binding; C:nucleus; C:DNA polymerase 
MGID1942001 replication factor c 36 kda subunit 498 10 1. 16E-21 61.70% 6 complex 
P:nucleotide-excision repair, DNA damage removal; P:DNA 
recombination; P:meiosis; F:zinc ion binding; C:cytoskeleton; P:DNA-
dependent DNA replication; P:nucleotide-exdsion repair, DNA gap 
filling; C:PML body; F:protein binding; C:condensed chromosome; 
F:single-stranded DNA binding; C:cytoplasm; F:chromatin binding; 
C:DNA replication factor A complex; C:chromatin 
MGID2026854 replication protein 70kda 1690 10 2.8OE-48 50.30% 15 
P:DNA replication; P:chromatin modif ication; P:cell cycle; C:nucleus; 
MGID19S7189 retinoblastoma binding protein 4 44G 10 G.81E-OS 49.70% S P:regulation of transcription, DNA-dependent 
C:cytosol; P:purine nucleoside metabolic process; P:S phase of mitotic 
cell cycle; F:ribonucleoside-diphosphate reductase activity; 
P:oxidation reduction; F:ATP binding; P:purine deoxyribonucleoside 
triphosphate biosynthetic process; F:protein binding; P:pyrimidine 
deoxyribonucleoside triphosphate biosynthetic process; 
C:ribonucleoside-diphosphate reductase complex; P:regulation of 
DNA replication; P:purine base metabolic process; P:pyrimidlne base 
metabolic process; P:deoxyribonucleoside diphosphate metabolic 
MGID1964781 ribonucleoside-diphosphate alpha subunit 841 10 2.44E-95 71.80% 14 process 
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C:ribonucleoside-diphosphate reductase complex; P:DNA replication; 
F:protein binding; P:oxidatlon reduction; F:AlP binding; 
F:ribonucleoside-diphosphate reductase activity; P:purine base 
metabolic process; P:pyrimidine base metabolic process; 
MGI02022197 ribonucleoside-diphosphate alpha subunit 1153 10 1.56E-147 82.50% 9 P:deoxyribonucleoside diphosphate metabolic process 
P:oxidation reduction; C:ribonudeoside-diphosphate reductase 
complex; F:protein binding; F:ribonucleoside-diphosphate reductase 
activity; P:DNA replication; P:purine base metabolic process; 
P:pyrimidine base metabolic process; P:deoxyribonucleoside 
MGI02033417 ribonucleoside-diphosphate alpha subunit 807 10 1.51E-91 78.80% 8 diphosphate metabolic process 
P:oxidation reduction; C:ribonudeoside-diphosphate reductase 
complex; F:protein binding; F:ribonucleoside-diphosphate reductase 
activity; P:ONA replication; P:purine base metabolic process; 
P:pyrimidine base metabolic process; P:deoxyribonucleoside 
MGI02033632 ribonucleoside-diphosphate alpha subunit 821 10 6.99E-92 79.10% 8 diphosphate metabolic process 
C:ribonucleoside-diphosphate reductase complex; P:DNA replication; 
F:protein binding; P:oxidation reduction; F:AlP binding; 
F:ribonucleoside-diphosphate reductase activity; P:purine base 
metabolic process; P:pyrimidine base metabolic process; 
MGI02044150 ribonucleoside-diphosphate alpha subunit 2782 10 0 80.60% 9 P:deoxyribonucleoside diphosphate metabolic process 
C:ribonucleoside-diphosphate reductase complex; P:ONA replication; 
F:protein binding; P:oxidation reduction; F:AlP binding; 
F:ribonucleoside-diphosphate reductase activity; P:purine base 
metabolic process; P:pyrimidine base metabolic process; 
MGI01954849 ribonucleoside-diphosphate large 161 10 9.46E-13 84.80% 9 P:deoxyribonucleoside diphosphate metabolic process 
C:ribonucleoside-diphosphate reductase complex; P:ONA replication; 
F:protein binding; P:oxidation reduction; F:AlP binding; 
F:ribonucleoside-diphosphate reductase activity; P:purine base 
metabolic process; P:pyrimidine base metabolic process; 
MGI02030200 ribonucleoside-diphosphate large 837 10 3.41E-65 85.20% 9 P:deoxyribonucleoside diphosphate metabolic process 
C:ribonucleoside-diphosphate reductase complex; P:ONA replication; 
F:protein binding; P:oxidation reduction; F:AlP binding; 
F:ribonucleoside-diphosphate reductase activity; P:purine base 
metabolic process; P:pyrimidine base metabolic process; 
MGI02046113 ribonucleoside-diphosphate large 892 10 8.44E-65 86.50% 9 P:deoxyribonucleoside diphosphate metabolic process 
C:ribonucleoside-diphosphate reductase complex; P:ONA replication; 
F:protein binding; P:growth or development of symbiont on or near 
host; P:oxidation reduction; F:ribonucleoside-diphosphate reductase 
activity; P:purine base metabolic process; P:pyrimidine base metabolic 
process; P:deoxyribonudeoside diphosphate metabolic process 
MG I 02063679 ribonucleoside-diphosphate large 494 10 1.11E-21 83.10% 9 
MGI02057891 ribonucleoside-diphosphate reductase large chain 1n4 10 1.17E-161 79.70% 9 C:ribonucleoside-diphosphate reductase complex; P:DNA replication; 
MGI02056546 ribonucleotide-diphosphate small 1399 10 8.38E-125 80.90% 8 P:oxidation reduction; F:iron ion binding; F:ribonudeoside-
P:chromatin modification; F:DNA-dependent ATPase activity; 
F:hel icase activity; F:DNA bind ing; F:ATP binding; C:nucleus; F:zinc ion 
MGID105468 similar to Plasmodium falciparum. DNA helicase 861 10 8.39E-30 63.30% 7 binding 
MGID108507 snf2 family dna-dependent atpase 588 10 8.11E-2S 62.00"10 8 P:intein-mediated prote in spl ici ng; F:hel icase activity; F:DNA binding; 
P:ubiquitin-dependent protein catabolic process; F:protein binding 
MGID2051432 s-phase kinase-associated 1309 10 7.57E-48 69.60% 2 
P:regulation of DNA repl ication during S phase; C:nuclear chromatin; 
P:DNA replication checkpoint; P:cell division; P:replication fork 
protection; P:intra-S DNA damage checkpoint; F:protein binding; 
P:mitosis; P:positive regulation of cell proliferation; C:cytoplasm 
MGID2026304 timeless interacting protein 1486 10 5. 34E-08 45.40% 10 
217 
Appendix 2: Genes involved in post-translational modifications, including the 
ubiquitination and sumoylation pathways, present in K. brevis. The contigs with 
homology to ubiquitin and SUMO polypeptide genes are shaded. Marine genomics ID is 





Minimum Mean #GOs Gene Ontologies 
ID Length eValue Similarity 
C:protein complex; P:protein catabolic process; F:ATP binding; 
MGID2030002 26s protease regulatory subunit 8 1418 10 0 88.10% 6 F:nucleoside-triphosphatase activity; C:nucleus; C:cytosol 
C:protein complex; P:protein catabolic process; F:ATP binding; 
MG I 02034299 26s proteasome regulatory atpase subunit 1407 10 0 90.00% 6 F:nucleoside-triphosphatase activity; C:nucleus; c:cytosol 
C:cytoplasm; F:peptidase activity; F:ATPase activity; P:ubiquitin-
MGID1978797 26s proteasome regulatory particle triple-a atpase su 325 9 1.89E-29 68.22% 6 dependent protein catabolic process; F:ATP binding; C:nucleus 
MG102021373 ankyrin partial 802 10 9.57E-06 55.70% 2 C:cytoplasm; P:u biquitin-dependent protein catabolic process 
F:ubiquitin-protein ligase activity; C:intracellular; P:ubiquitin 
MG I 02040404 ankyrin unc44 853 8 1.41E-05 54.63% 4 cycle; P:protein ubiquitination 
F:protein binding; P:protein ubiquitination; F:ubiquitin-protein 
MGID2026032 ariadne homolog 2 791 10 6.29E-I0 40.70% 6 ligase activity; C:nucleus; F:zinc ion binding; C:cytosol 
F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex; 
MGID2033025 arm repeat-containing protein 774 8 4.06E-06 40.75% 4 F:binding; P:protein ubiquitination 
C:eytoplasmic membrane-bounded vesicle; P:protein 
ubiquitination; F:ubiquitin-protein ligase activity; F:zinc ion 
MGID1969538 atlg15100 f911 3 599 10 7.95E-07 56.80% 6 binding; C:plastid; C:ubiquitin ligase complex 
C:cytoplasm; C:protein complex; P:ubiquitin-dependent protein 
MGID2034824 btb domain containing 1 1611 10 3.47E-08 38.90% 4 catabolic process; F:protein binding 
P:protein ubiquitination; F:ubiquitin-protein ligase activity; F:zinc 
MGID1975704 calcium ion binding protein 733 7 7,61E-04 56.29% 4 ion binding; C:ubiquitin ligase complex 
C:cytosol; F:binding; P:negative regulation of ubiquitin-protein 
ligase activity during mitotic cell cycle; P:mitotic metaphase plate 
congression; P:cell division; P:anaphase-promoting complex-
dependent proteasomal ubiquitin-dependent protein catabolic 
process; P:G1 phase of mitotic cell cycle; P:positive regulation of 
ubiquitin-protein ligase activity during mitotic cell cycle; 
P:regulation of exit from mitosis; P:regulation of mitotic 
metaphase/anaphase transition; C:nucleoplasm; C:anaphase-
MGID1986476 edcB (cell division cycle homolog) 696 10 1.72E-15 53,80% 12 promoting complex 
; F:ubiquitin-protein ligase activity; C:intracellular; P:ubiquitin 
MG1D2047165 chp-rich zinc finger 899 10 1.39E-06 46.40% 6 cycle; F:zinc ion binding; P:protein ubiquitination 
C:cytoplasm; C:nucleolus; F:protein binding; P:ubiquitin-
dependent protein catabolic process; F:ubiquitin thiolesterase 
MGID1982613 clan family ubiquitin hydrolase-like cysteine peptidas 757 10 1.97E-18 45.90% 6 activity; P:protein deubiquitination 
C:cytoplasm; F:binding; P:mRNA transport; P:ubiquitin cycle; 
MG102038778 deltex 4 homolog 1182 10 6.21E-06 46.90% 6 F:ubiquitin-protein ligase activity; P:protein ubiquitination 
C:cytoplasm; F:ONA-dependent ATPase activity; F:helicase 
activity; F:DNA binding; F:protein binding; P:protein 
ubiquitination; F:ATP binding; F:ubiquitin-protein ligase activity; 
C:nucleus; F:zinc ion binding; C:ubiquitin ligase complex; P:DNA 
MGID1944780 dna repair protein 344 10 l.29E-09 56.30% 12 repair 
P:protein modification process; P:proteasomal ubiquitin-
dependent protein catabolic process; F:damaged DNA binding; 
MG I 02028070 dna repair...erotein putatitve 1021 10 1.96E-IO 56.50% 5 P:nucleotide-excision repair; C:nucleus 
P:protein modification process; P:proteasomal ubiquitin-
dependent protein catabolic process; F:damaged DNA binding; 
MGID2057998 dna repair protein rad23 619 10 4.40E-19 56.00% 5 P:nucleotide-excision repair; C:nucleus 
F:ubiquitin-protein ligase activity; C:SCF ubiquitin ligase complex; 
MGI01958756 f-box and leucine-rich repeatIlrotein 14b 785 10 4.44E-08 46.20% 4 FJlfotein binding; P]>!,otein ubiquitination 
C:cytoplasm; P:ubiquitin-dependent protein catabolic process; 
MGID2041513 f-box and leucine-rich repeat protein 20 831 10 8.11E-19 43.30% 3 F:protein binding 
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P:ubiquitin-dependent protein catabolic process; F:zinc ion 
binding; F:peptidyl-arginine C-methyltransferase activity; 
F:ubiquitin-protein ligase activity; P:protein ubiquitination; 
F:protein binding; F:histone-arginine N-methyltransferase 
activity; C:ubiquitin ligase complex; P:sensory perception of 
MGID2039744 f-box only protein 1923 10 6.40E-75 54.40% 12 sound; C:cytoplasm; C:nucleus; P:protein amino acid methylation 
F:protein binding; P:ubiquitin cycle; F:ubiquitin-protein ligase 
MGID2023224 hect domain and ankyrin repeat e3 ubiquitin protein 852 10 4.66E-33 52.60% 5 activity; C:endoplasmic reticulum; P:protein ubiquitination 
P:ubiquitin-dependent protein catabolic process; F:zinc ion 
binding; C:mitochondrial inner membrane; F:guanyl-nucleotide 
exchange factor activity; P:spermatogenesis; F:ubiquitin-protein 
ligase activity; F:ATP binding; F:protein binding; F:heme binding; 
P:regulation of mitotic metaphase/anaphase transition; 
P:intraceUular protein transport; P:protein amino acid 
phosphorylation; C:anaphase-promoting complex; P:regulation 
MGID2033139 hect domain and rid 2 744 10 2.04E-12 48.60% 15 of GTPase activity; P:protein ubiquitination 
P:regulation of mitotic metaphase/anaphase transition; F:protein 
binding; F:heme binding; P:ubiquitin cycle; F:ubiquitin-protein 
ligase activity; F:zinc ion binding; C:anaphase-promoting 
MGID2039182 hect domain and rid 2 674 10 2.84E-12 54.10% 8 complex; P:protein ubiquitination 
C:intracellular; P:ubiquitin-dependent protein catabolic process; 
MGID1992109 hect domain and rid 3 833 10 5.43E-15 44.80% 4 F:acid-amino acid ligase activity; P:protein modification process 
P:regulation of mitotic metaphase/anaphase transition; F:protein 
binding; P:protein ubiquitination; F:heme binding; F:ubiquitin-
protein ligase activity; F:zinc ion binding; C:anaphase-promoting 
MGID2057691 hect domain and rid partial 1194 10 2.77E-13 56.70% 7 complex 
F:ubiquitin-protein ligase activity; C:intracellular; P:ubiquitin 
MGID2029262 hect domain-containing family protein 757 10 2.10E·28 51.00% 4 cycle; P:protein ubiquitination 
P:negative regulation of microtubule depolymerization; 
P:chromatin modification; P:ubiquitin-dependent protein 
catabolic process; F:histone deacetylase activity; F:zinc ion 
binding; P:protein amino acid deacetylation; P:protein 
polyubiquitination; C:microtubule; P:regulation of transcription, 
DNA-dependent; F:tubulin deacetylase activity; C:histone 
deacetylase complex; F:actin binding; C:cytoplasm; F:histone 
deacetylase binding; P:nitrogen compound metabolic process; 
MG1D1977338 histone deacetylase 6 739 10 1.77E-16 40.70% 16 C:tubulin complex 
P:negative regulation of microtubule depolymerization; 
P:chromatin modification; P:ubiquitin-dependent protein 
catabolic process; F:histone deacetylase activity; F:zinc ion 
binding; P:protein amino acid deacetylation; P:protein 
polyubiquitination; C:microtubule; P:regulation oftranscription, 
DNA-dependent; F:tubulin deacetylase activity; C:histone 
deacetylase complex; F:actin binding; c:cytoplasm; F:histone 
deacetylase binding; P:nitrogen compound metabolic process; 
MGID2037051 histone deacetylase 6 998 10 3.92E-16 51.20% 16 C:tubulin complex 
P:negative regulation of microtubule depolymerization; 
P:chromatin modification; P:ubiquitin-dependent protein 
catabolic process; F:histone deacetylase activity; F:zinc ion 
binding; P:protein amino acid deacetylation; P:protein 
polyubiquitination; C:microtubule; P:regulation of transcription, 
DNA·dependent; F:tubulin deacetylase activity; C:histone 
deacetylase complex; F:actin binding; C:cytoplasm; F:histone 
deacetylase binding; P:nitrogen compound metabolic process; 
MGID2076755 histone deacetylase 6 1607 10 7.44E-19 55.90% 16 C:tubulin complex 
P:protein folding; F:binding; P:mycelium development; P:protein 
ubiquitination; F:ubiquitin-protein ligase activity; C:nucleus; 
MGID2040793 hsp chaperone complex subunit 815 10 3.39E-06 50.00% 8 C:cytosol; C:ubiquitin ligase complex 
P:protein folding; F:binding; P:mycelium development; P:protein 
ubiquitination; F:ubiquitin-protein ligase activity; C:nucleus; 
MGID2075692 hsp chaperone complex subunit 1607 1.23E-05 48.88% 8 C:cytosol; C:ubiquitin ligase complex 
F:binding; P:protein ubiquitination; F:ubiquitin-protein ligase 
MGID2054805 immediate-early fungal elicitor protein cmpg1 811 10 3.04E-07 51.00% 6 activity; C:plastid; C:mitochondrion; C:ubiquitin ligase complex 
P:Wnt receptor signaling pathway; F:protein binding; 
P:multicellular organismal development; P:ubiquitin-dependent 
MGID2068259 klh12 xenia ame: full=kelch-like protein 12 1129 10 6.12E-40 47.40% 5 protein catabolic process; P:ubiquitin cycle 
C:cytoplasm; P:ubiquitin-dependent protein catabolic process; 
MGID1946605 leucine rich repeat family expressed 389 10 2.08E-12 51.50% 4 F:protein binding; P:protein modification process 
C:neuron projection; P:positive regulation of MAPKKK cascade; 
P:activation of MAP KKK activity; P:regulation of exocytosis; 
P:exocrine system development; P:neurotransmitter secretion; 
P:regulation oftranscription, DNA-dependent; C:intrinsic to 
plasma membrane; F:GTP binding; F:calcium ion binding; 
P:protein transport; P:small GTPase mediated signal 
transduction; F:ubiquitin-protein ligase activity; P:protein 
ubiquitination; F:identical protein binding; C:perinuclear region 
of cytoplasm; F:GTPase activity; P:regulation of apoptosis; 
F:transcription factor binding; F:ATP binding; C:transcription 
MGID2054783 member ras oncogene family 1042 10 l.34E-22 54.70% 21 factor complex 
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P:regulation of receptor internalization; P:ubiquitin-dependent 
protein catabolic process; P:melanocyte differentiation; F:zinc 
ion binding; F:signal transducer activity; P:Notch signaling 
pathway; C:cytoplasmic vesicle; P:positive regulation of I-kappaS 
kinase/NF-kappaS cascade; C:eariy endosome; F:ubiquitin-
protein ligase activity; F:actin binding; P:protein 
autoubiquitination; C:ubiquitin ligase complex; C:perinuclear 
MGID2079469 mib2 protein 1262 10 1.05E-06 48.60% 15 region of cytoplasm; F:protein homodimerization activity 
MGID1944670 mitotic checkpoint protein bub3 449 10 3.35E-18 57.90% 2 P:biological process; C:CUL4 RING ubiquitin ligase complex 
P:ubiquitin-dependent protein catabolic process; F:ubiquitin 
thiolesterase activity; F:squalene-hopene cyclase activity; F:zinc 
MGID2054988 mynd finger family protein 851 10 l.27E-06 53.00% 5 ion binding; P:protein deubiquitination 
P:ubiquitin-dependent protein catabolic process; F:ubiquitin 
thiolesterase activity; F:squalene-hopene cyclase activity; F:zinc 
MGID2075908 mynd finger family protein 1362 10 2.00E-06 52.70% 5 ion binding; P:protein deubiquitination 
F:NAD or NADH binding; F:zinc ion binding; P:protein amino acid 
deacetylation; F:histone acetyltransferase binding; 
C:microtubule; C:chromatin silencing complex; P:negative 
regulation of striated muscle tissue development; F:tubulin 
deacetylase activity; F:ubiquitin binding; P:cell division; F:DNA 
binding; P:chromatin silencing; F:NAD-dependent histone 
deacetylase activity; P:mitosis; F:transcription factor binding; 
C:cytoplasm; F:histone deacetylase binding; P:nitrogen 
compound metabolic process; C:tubulin complex; C:histone 
MGID2027142 nad-dependent histone deacetylase 1330 10 4.28E-22 53.80% 21 deacetylase complex; C:transcription factor complex 
F:ubiquitin-protein ligase activity; C:intracellular; P:ubiquitin 
MGID1985341 nedd4 protein 693 8 3.06E-04 52.75% 5 cycle; F:protein binding; P:protein ubiquitination 
P:sodium ion transport; P:ubiquitin-dependent protein catabolic 
process; P:response to metal ion; P:cellular sodium ion 
homeostasis; P:positive regulation of endocytosis; F:sodium 
channel regulator activity; F:ubiquitin-protein ligase activity; 
P:excretion; P:protein ubiquitination; F:protein binding; 
P:regulation of protein catabolic process; P:interspecies 
interaction between organisms; C:cytoplasm; P:water 
MGID2055265 nedd4 protein 1633 10 9.01E-12 58.30% 14 homeostasis 
P:ubiquitin-dependent protein catabolic process; P:sarcomere 
organization; F:zinc ion binding; F:ligase activity; F:protein 
MGID2048506 neuralized homolog 594 10 6.41E-09 65.30% 7 binding; C:muscle tendon junction; C:VCS complex 
P:immune response; P:ubiquitin-dependent protein catabolic 
MGID2036338 otu ubiquitin aldehyde binding 1 1845 10 2.76E-12 45 .30% 3 process; F:cysteine-type peptidase activity 
P:ubiquitin-dependent protein catabolic process; F:ubiquitin 
thiolesterase activity; P:ubiquitin cycle; P:protein 
MGID1991203 peptidase c19 family protein 736 10 1.10E-26 56.40% 4 deubiquitination 
C:cytoplasm; P:positive regulation oftranscription; 
F:transcription regulator activity; F:protein binding; P:protein 
MGID107043 plasmodium falciparum polyubiquitin 904 10 8. llE-63 78.80% 6 ubiquitination; C:nucleus 
C:cytoplasm; C:cell wall; C:nucleus; P:protein modification 
MGID2042393 polyubiquitin 1 1206 10 2.06E-04 50.50% 5 process; C:plasma membrane 
MGID1973919 polyubiquitin 2 708 10 2.03E-43 87.50% 2 F:zinc ion binding; P:protein modification process 
MGID2025451 polyubiquitin ubi4 824 10 1.77E-18 74.60% 2 F:zinc ion binding; P:protein modification process 
F:RNA binding; P:negative regulation of ubiquitin-protein ligase 
activity during mitotic cell cycle; C:mitochondrion; F:threonine-
type endopeptidase activity; P:anaphase-promoting complex-
dependent proteasomal ubiquitin-dependent protein catabolic 
process; P:positive regulation of ubiquitin-protein ligase activity 
during mitotic cell cycle; F:protein binding; C:proteasome core 
MGID2048982 [proteasome ( macropain) alpha 6 967 10 5.84E-70 73.00% 9 complex; C:nucleus 
P:negative regulation of SMP signaling pathway; P:negative 
regulation of ossification; C:intracellular; F:ubiquitin-protein 
ligase activity; P:cell differentiation; F:protein binding; 
P:ectoderm development; P:protein ubiquitination during 
MGID1947361 smad ubiquitination regulatory factor 1 533 10 2.57E-07 46.00% 8 ubiquitin-dependent protein catabolic process 
MGID1945086 small ubiquitin-like modifier 516 10 2.88E-37 70.90% 1 P:protein modification process 
F:small protein activating enzyme activity; P:ubiquitin cycle; 
MGID2030454 sumo-1 activating enzyme e1 n subunit 1121 10 2.65E-27 51.30% 5 F:binding; C:nucleus; F:ligase activity 
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P:cell differentiation; F:DNA binding; P:mRNA transport; 
F:ubiquitin-protein ligase activity; C:nucleus; P:protein 
MGID2030838 uba and wwe domain containing 1 1119 10 1.86E-26 57.70% 6 ubiquitination 
C:integral to membrane; P:regulation of protein metabolic 
process; F:small conjugating protein ligase activity; P:post-
MGID107380 ubc6p like ubiquiting conjugating enzyme possible tr 927 10 2.17E-50 75.20% 4 translational protein modification 
MGID1945979 ubiQuitin 300 10 5.29E-32 100.00% 1 P:protein modification process 
C:ribosome; P:protein modification process; F:structural 
constituent of ribosome; F:zinc ion binding; P:translation; 
MG1D2041303 ubiquitin 40s ribosomal protein s27a fusion 834 10 8.17E-19 85.20% 6 P:ribosome biogenesis 
P:ubiquitin-dependent protein catabolic process; F:calcium ion 
binding; F:ubiquitin thiolesterase activity; C:membrane; 
MGID1984359 ubiquitin carboxyl -terminal 664 10 5.74E-10 40.90% 5 P:protein deubiquitination 
P:RNA splicing; F:protein binding; P:ubiquitin-dependent protein 
catabolic process; P:mRNA processing; F:ubiquitin thiolesterase 
MGID2052656 ubiquitin carboxyl -terminal 1234 10 9.00E-96 65.00% 8 activity; C:nucleus; F:zinc ion binding; P:protein deubiquitination 
C:cytoplasm; P:protein deubiquitination; P:eating behavior; 
P:ubiquitin-dependent protein catabolic process; F:ubiquitin 
MGID2078878 ubiquitin carboxyl-terminal esterase 13 958 10 2.87E-53 60.90% 6 thiolesterase activity; P:adult walking behavior 
P:ubiquitin-dependent protein catabolic process; F:ubiquitin 
thiolesterase activity; P:ubiquitin cycle; P:protein 
MGID2055229 ubiquitin carboxyl-terminal hydrolase 1402 10 8.96E-10 37.60% 4 deubiquitination 
MGID1963697 ubiquitin carboxyl-terminal hydrolase 6 831 10 2.21E-08 57.50% 0 
P:ubiquitin-dependent protein catabolic process; F:ubiquitin 
MGID1945063 ubiquitin carboxyl -terminal hydrolase family protein 454 10 1.11E-05 60.40% 3 thiolesterase activity; P:protein deubiquitination 
P:ubiquitin-dependent protein catabolic process; F:ubiquitin 
thiolesterase activity; P:ubiquitin cycle; P:protein 
MGID2049337 ubiquitin carboxyl-terminal hydrolase family protein 804 10 3.07E-36 56.80% 4 deubiquitination 
C:intracellular; P:ubiquitin-dependent protein catabolic process; 
MGID2028135 ubiquitin carboxyl-terminal hydrolase isozyme 13 1028 10 3.68E-57 58.30% 4 F:ubiquitin thiolesterase activity; P:protein deubiquitination 
MGID1987082 ubiquitin conjugating enzyme 791 10 2.16E-10 49.40% 1 P:protein modification process 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1984306 ubiquitin conjugating enzyme 806 8 2.26E-55 84.25% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1946804 ubiquitin conjugating enzyme 336 10 2.06E-10 65.70% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2024467 ubiquitin conjugating enzyme 865 10 3.61E-81 79.50% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1976492 ubiquitin conjugating enzyme 1 331 1 4.98E-06 85.00% 3 F:small conjugating protein ligase activity 
MGID1968753 ubiquitin conjugating enzyme 7 interacting protein 865 6 l.31E-06 60.83% 2 F:zinc ion binding; F:protein binding 
MGID2022383 ubiquitin conjugating enzyme 7 interacting protein 788 10 6.90E-09 57.50% 3 F:zinc ion binding; F:nucleic acid binding; F:protein binding 
P:nuclear migration; P:ubiquitin-dependent protein catabolic 
process; F:ubiquitin thiolesterase activity; P:germ cell migration; 
P:cellularization; P:negative regulation of proteolysis; P:mystery 
cell fate differentiation; P:embryonic development; 
MGID1957111 ubiquitin domain-containing protein 696 10 9.16E-09 59.60% 11 P:endocytosis; P:protein deubiquitination; C:cytoplasm 
MGID2063489 ubiquitin domain-containing protein 620 10 7.79E-08 48.40% 1 P:protein modification process 
MGID1948161 ubiquitin family protein 435 10 7.24E-74 98.20% 1 P:protein modification process 
MGID2032537 ubiquitin family protein 1157 4 1.48E-04 68.25% 1 P:protein modification process 
C:extracellular region; P:intein-mediated protein splicing; 
MGID2039702 ubiquitin family protein 862 10 6.23E-09 47.80% 3 P:pathogenesis 
C:cytoplasm; F:ubiquitin protein ligase binding; P:protein 
autoubiquitination; F:chaperone binding; P:protein 
polyubiquitination; F:ubiquitin-protein ligase activity; 
P:embryonic development ending in birth or egg hatching; 
MGID2020514 ubiquitin fusion degradation (yeast ufd homolog) fam 872 10 3.81E-06 55.10% 9 C:nucleus; C:ubiquitin ligase complex 
MGID2051780 ubiquitin isoform cra a 1313 10 4.65E-13 51.30% 2 C:nucleus; P:protein modification process 
MGID1962857 ubiquitin ligase complex f-box protein 802 10 9.24E-09 55.70% 1 F:protein binding 
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C:cytoplasm; F:ubiquitin-specific protease activity; C:nucleolus; 
F:protein binding; P:ubiquitin-dependent protein catabolic 
MGID1991202 ubiquitin specific peptidase 15 755 10 6.93E-24 62.40% 6 process; P:protein deubiquitination 
P:ubiquitin-dependent protein catabolic process; F:ubiquitin 
thiolesterase activity; F:zinc ion binding; P:protein 
MGIDI06568 ubiquitin specific peptidase 3 923 10 2.03E-08 40.80% 4 deubiquitination 
F:Rab GTPase activator activity; C:lysosome; P:ubiquitin-
dependent protein catabolic process; F:ubiquitin thiolesterase 
activity; F:nudeic acid binding; F:ca1cium ion binding; F:cysteine-
type endopeptidase activity; P:regulation of Rab GTPase activity; 
MGID2073584 ubiquitin specific peptidase 32 1086 10 2.30E-20 45.20% 10 F:protein binding; P:protein deubiquitination 
F:glycylpeptide N-tetradecanoyltransferase activity; P:ubiquitin-
dependent protein catabolic process; P:N-terminal protein 
myristoylation; F:ubiquitin thiolesterase activity; C:nucleus; 
P:acyl,arrier-protein biosynthetic process; P:protein 
MGID2031434 ubiquitin specific peptidase 36 948 10 1.31E-50 59.70% 7 deubiquitination 
C:cytoplasm; P:ubiquitin-dependent protein catabolic process; 
MGID2031330 ubiquitin specific protease 31 817 10 4.30E-17 46.90% 4 F:ubiquitin thiolesterase activity; P:protein deubiquitination 
P:ubiquitin-dependent protein catabolic process; F:ubiquitin 
thiolesterase activity; F:transcription initiation factor activity; 
F:zinc ion binding; P:transcription initiation; F:DNA binding; 
P:ubiquitin cycle; F:queuine tRNA-ribosyltransferase activity; 
C:transcription factor TFII 0 complex; P:queuosine biosynthetic 
MGID1994290 ubiquitin specific protease 43 709 10 3.98E-23 50.80% 12lprocess; P:protein deubiQuitination; P:regulation of transcription 
F:ATP binding; F:ubiquitin-protein ligase activity; F:small protein 
activating enzyme activity; P:ubiquitin cycle; P:protein 
MGID109427 ubiquitin-activating enzyme el 263 10 5.0SE-06 61.90% 5 ubiquitination 
MGID1974830 ubiquitin-associated domain,ontaining 770 3 1.46E-24 57.00% 0 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1976634 ubiquitin-conjugating enzyme 466 10 2.92E-54 86.30% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1976063 ubiquitin-conjugating enzyme 800 10 4.41E-43 73.20% 3 F:small conjugating protein ligase activity 
C:cytosol; P:negative regulation of ubiquitin-protein ligase 
activity during mitotic cell cycle; P:protein polyubiquitination; 
P:positive regulation of protein ubiquitination; P:BMP signaling 
pathway; P:anaphase-promoting complex-dependent 
proteasomal ubiquitin-dependent protein catabolic process; 
F:ubiquitin-protein ligase activity; P:positive regulation of 
ubiquitin-protein ligase activity during mitotic cell cycle; 
MGID1976064 ubiquitin-conjugating enzyme 817 10 4.59E-19 74.50% 9 C:nucleoplasm 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1975837 ubiquitin-conjugating enzyme 698 10 1.22E-4S 91.00% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1965228 ubiquitin-conjugating enzyme 662 10 1.62E-65 90.30% 3 F:small coniugatiOl1. protein ligase activity 
P:regulation of protein metabolic process; F:small conjugating 
MGID1964821 ubiquitin-conjugating enzyme 765 10 1.10E-32 68.30% 3 protein ligase activity; P:post-translational protein modification 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1962935 ubiquitin-conjugating enzyme 614 10 3.81E-23 89.50% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1954817 ubiquitin-conjugating enzyme 446 10 2.76E-44 81.30% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1944212 ubiquitin-conjugating enzyme 590 10 1.41E-69 87.40% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1949460 ubiquitin-conjugating enzyme 529 10 4.55E-41 70.30% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID1941007 ubiquitin-conjugating enzyme 663 10 5.13E-51 74.40% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2036731 ubiquitin-conjugating enzyme 821 10 5.97E-59 88.00% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2038699 ubiquitin-conjugating enzyme 1117 10 1.50E-30 62.50% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2040596 ubiquitin-conjugating enzyme 614 10 2.43E-70 88.60% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2041278 ubiQuitin-conjugating enzyme 644 10 4.05E-66 90.30% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2046806 ubiquitin-conjugating enzyme 1050 10 2.70E-71 89.20% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2049051 ubiquitin-conjugating enzyme 840 10 2.47E-55 84.00% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2056449 ubiquitin-conjugating enzyme 620 10 1.14E-67 88.30% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2058457 ubiquitin.conjugating enzyme 626 10 4.03E-68 88.90% 3 F:small conjugating protein ligase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2062954 ubiquitin-conjugating enzyme 360 10 3.90E-35 91.30% 3 F:small ConiURatinR protein liRase activity 
P:ubiquitin cycle; P:regulation of protein metabolic process; 
MGID2066195 ubiquitin-conjugating enzyme 554 10 6.35E-39 69.60% 3 F:small conjugating protein ligase activity 
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F:ubiquitin-protein ligase activity; P:ubiquitin cycle; P:regulation 
MG1D2041887 ubiquitin-conjugating enzyme e2 578 10 2.32E-53 76.20% 4 of protein metabolic process; P:protein ubiquitination 
P:regulation of protein metabolic process; F:small conjugating 
MGID1985696 ubiquitin-conjugating enzyme e2 z-like 730 10 3.72E-27 55.10% 3 protein ligase activity; P:post-translational protein modification 
C:cytoplasm; C:nucleolus; P:apoptosis; P:ubiquitin-dependent 
protein catabolic process; F:ubiquitin-protein ligase activity; 
P:regulation of protein metabolic process; P:protein 
MGID2027441 ubiquitin-conjugating enzyme e2z 1036 10 1.20E-31 52.10% 7 ubiquitination 
MGID2045222 ubiquitin-fold modifier 1 472 10 5.51E-13 68.20% 1 P:ubiquitin cycle 
MGID1984819 ubiquitin-fusion protein 758 10 7.02E-16 69.20% 1 P:protein modification process 
C:Golgi apparatus; F:protein binding; P:protein ubiquitination; 
MGID2057562 ubiquitin-protein ligase e3 636 10 1.69[-16 57.30% 5 P:signal transduction; F:ubiquitin-protein ligase activity 
C:cytoplasmic membrane-bounded veSicle; F:zinc ion binding; 
MGID2061456 ubiquitin-protein ligase e3 2152 10 2. 91E-08 65.80% 3 F:protein binding 
MGID2053073 ubiquitin-protein ligase-like 830 5.99E-06 54.57% 1 F:zinc ion binding 
C:cytoplasm; F:ubiquitin protein ligase binding; P:protein 
autoubiquitination; F:chaperone binding; P:protein 
polyubiquitination; F:ubiquitin-protein ligase activity; 
P:embryonic development ending in birth or egg hatching; 
MGID1985376 u-box domain protein 887 10 1.77E-06 51.70% 9 C:nucleus; C:ubiquitin ligase complex 
F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex; 
MGID1964714 U-bOK domain protein 762 10 1.10E-08 59.00% 3 P:protein ubiquitination 
F:protein binding; P:protein ubiquitination; F:ubiquitin-protein 
ligase activity; F:zinc ion binding; C:plastid; C:ubiquitin ligase 
MGID2020548 u-box domain protein 854 10 8.83E-08 53.50% 6 complex 
F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex; 
MGID2022434 u-box domain protein 838 10 1.36E-05 58.80% 4 F:binding; P:protein ubiquitination 
F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex; 
MGID1958259 von willebrand factor type a domain containing prote 836 10 6.68E-21 64.70% 4 P:protein ubiquitination; P:intein-mediated protein splicing 
F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex; 
MGID2021019 von willebrand factor type a domain containing prote 784 10 1.05E-25 59.00% 4 P:protein ubiquitination; P:intein-mediated protein spliCing 
F :ubiquitin-protein ligase activity; C:ubiquiti n ligase complex; 
MGID2056311 wd sam and u-box domain containing 1 830 10 1.47E-12 69.90% 3 P:protein ubiquitination 
P:protein amino acid phosphorylation; P:response to stress; 
P:protein ubiquitination; F:ATP binding; F:ubiquitin-protein ligase 
activity; F:protein serine/threonine kinase activity; C:ubiquitin 
MGID104206 wd sam and u-box domain containing 1 680 10 6.93E-14 60.00% 8 ligase complex; P:serine family amino acid metabolic process 
F:receptor activity; P:protein amino acid phosphorylation; 
P:protein ubiquitination; F:ATP binding; F:ubiquitin-protein ligase 
activity; F:protein serine/threonine kinase activity; C:ubiquitin 
ligase complex; P:signal transduction; P:serine family amino acid 
MGI02053718 wd sterile alpha motif and u-box domain containing 1 810 10 1.46E-09 62.30% 9 metabolic process 
F:hydrolase activity, hydrolyzing O-glycosyl compounds; 
P:carbohydrate metabolic process; P:protein ubiquitination; 
MGID1987113 wd40 repeat protein 673 3.37E-05 43.50% 5 F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex 
P:innate immune response; P:protein ubiquitination; C:intrinsic 
to membrane; P:signal transduction; F:ubiquitin-protein ligase 
activity; F:transmembrane receptor activity; C:ubiquitin ligase 
MGID1976985 wd-40 repeat protein 760 10 1. 12E-29 51.60% 7 complex 
F:protein binding; P:ubiquitin-dependent protein catabolic 
process; p:ubiquitin cycle; P:locomotion; F:ubiquitin-protein 
ligase activity; P:embryonic development ending in birth or egg 
hatching; P:entry of virus into host cell; C:ubiquitin ligase 
MGID2080865 ww domain containing protein 819 10 5.87E-06 42.90% 9 complex; P:protein ubiquitination 
P:ubiquitin-dependent protein catabolic process; C:axon; F:zinc 
ion binding; P:negative regulation of axon extension; F:DNA 
binding; F:ubiquitin-protein ligase activity; C:PML body; 
F:transcription activator activity; F:protein binding; P:positive 
regulation oftranscription, DNA-dependent; C:cytoplasm; 
MGID1943053 zinc finger 571 10 3.07E-10 53.90% 12 P:protein ubiquitination 
P:defense response to fungus; F:ubiquitin-protein ligase activity; 
P:response to chitin; F:zinc ion binding; F:protein binding; 
MGID2028256 zinc finger (c3hc4-type ring finger) family protein 1073 10 9. 77E-08 65.30% 6 P:protein ubiquitination 
C:proteasome core complex; F:threonine-type endopeptidase 
activity; P:ubiquitin-dependent protein catabolic process; 
MGID2019194 proteasome (prosome macropain) subunit beta type 1022 10 3.09E-48 65.20% 4 C:nucleus 
C:proteasome core complex; F:threonine-type endopeptidase 
activity; P:ubiquitin-dependent protein catabolic process; 
MGID2066412 Iproteasome subunit beta type 7-a precursor 583 10 1.58EAl 75.90% 4 C:nucleus 
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